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The research described in this thesis concerns the structure and function(s) of the enterovirus 
2B protein. In this chapter, an overview will be given of the viral genome organization, viral genome 
replication, the virus-induced modifi cations of the host cell, and the functional role of the 2B protein in 
the viral life cycle.
ENTEROVIRUS CLASSIFICATION AND PATHOGENESIS
The genus Enterovirus belongs to the family of the Picornaviridae (Fig. 1), a large group of 
small, non-enveloped viruses that includes a number of important human and animal pathogens. 
The Picornavirus family consists of nine genera and a number of additional, unassigned viruses. The 
Enterovirus, Rhinovirus (causative agents of the common cold), Hepatovirus (e.g., hepatitis A virus), 
Aphthovirus (e.g., foot-and-mouth disease virus) and Cardiovirus (e.g., encephalomyocarditis virus) 
genera are the most well known. The Enterovirus genus consists of nine species; the poliovirus species, 
human enterovirus species A (HEV-A), HEV-B, HEV-C, HEV-D, and four animal enterovirus species. 
In addition, a number of serotypes have not been assigned to a specifi c species. 
Enteroviruses are common human pathogens. Enterovirus infections generally elapse 
asymptomatically. However, enteroviruses have been implicated in wide spectrum of illnesses, 
including both acute and chronic diseases. Enteroviruses are so named because they reproduce 
initially in the gastrointestinal tract after infection occurs. Despite this, infection usually does not 
lead to intestinal symptoms. Their spread to other organs, such as the nervous system, heart and skin 
causes disease. Enteroviruses have been recognized in a number of acute syndromes like poliomyelitis, 
polioencephalitis, respiratory illnesses and aseptic meningitis, and in a number of chronic infl ammatory 
diseases like myocarditis and juvenile (type-1) diabetes mellitus [1; 2].
Figure 1. Classifi cation of 
the Picornaviridae. The 
Picornavirus family consists 
of nine genera and a number 
of unassigned viruses. The 
enterovirus genus consists 
of ten species in which the 
individual serotypes are 
grouped. Coxsackievirus 
B3 belongs to the human 
enterovirus-B (HEV-B) 
species.
GENOME ORGANIZATION
All enteroviruses have a similar genome organization (Fig. 2). The enteroviral genome typically 
consists of an RNA molecule of positive polarity that is approximately 7,500 nucleotides in length and 
contains one single large open reading frame (ORF). The ORF is preceded by a long 5’ untranslated 
region (UTR), which is covalently linked to a small viral protein (VPg), and followed by a small 3’ 
UTR and a genetically encoded poly(A)-tail. The UTR’s contain so-called cis-acting elements that are 
involved in translation and replication of the viral RNA. Recently, an additional cis-acting replication 
element (cre) was identifi ed in the ORF of the RNA [3]. 
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Kobuvirus
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Enterovirus-A
Enterovirus-B
Enterovirus-C
Enterovirus-D
Bovine enterovirus
Porcine enterovirus-A
Porcine enterovirus-B
Simian enterovirus-A
Simian enteroviruses
Swine vesicular disease virus
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The 5’ UTR is approximately 750 nucleotides in length and contains a number of higher order 
RNA structures. The cloverleaf (CL), which is present within the fi rst 100 nucleotides of this region, 
is a specifi c structural element at which a functional ribonucleoprotein complex is assembled that is 
required for viral RNA synthesis [4; 5]. The 5’ UTR contains a second highly structured element, the 
internal ribosome entry site (IRES), required for the cap-independent initiation of virus translation [6; 
7]. The 3’ UTR consists of approximately 75 nucleotides and also contains higher order RNA structures. 
Although the exact function of the 3’ UTR is unclear, it has been suggested to play a role in the initiation 
of negative strand RNA synthesis [8-10]. In enteroviruses, the cre within the coding region of the 
genome is located in the region encoding the 2C protein (cre(2C)) [3]. Sequences within the loop of this 
hairpin structure are involved in the synthesis of the viral peptide primer that is used for RNA synthesis 
(see ‘The viral life cycle’ below).
Translation of the viral RNA yields a polyprotein of approximately 220 kD that is processed 
by virus-encoded proteases (2Apro, 3Cpro and 3CDpro) to generate the individual structural (capsid) 
proteins and nonstructural (replication) proteins. The ORF is divided into three segments. The P1 region 
encodes the structural proteins 1A (VP4), 1B (VP2), 1C (VP3) and 1D (VP1) that form the protein 
shell in which the progeny RNA is encapsidated. The P2 and P3 regions encode the nonstructural 
proteins 2Apro, 2B, 2C, 3A, 3B (VPg), 3Cpro, 3Dpol and the cleavage intermediates 2BC, 3AB and 
3CDpro, which are relatively stable and may serve other functions than the individual constituents. The 
nonstructural proteins are involved in RNA replication, either directly or by creating the conditions 
required for RNA replication [11; 12].
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Figure 2. Schematic overview of the enterovirus genome.
The enterovirus genome consists of an RNA molecule of 7.5 kb and positive polarity that contains the small viral VPg protein at 
its 5’ end. The RNA contains a large untranslated region at its 5’ end and a short untranslated region at its 3’ end (5’ UTR and 3’ 
UTR, respectively), that are highly structured and contain cis-acting translation and replication elements. The 5’ UTR contains 
the cloverleaf (CL) and the internal ribosome entry site (IRES), and the 3’ UTR consists of three stem-loop structure (X, Y and Z) 
and a genetically encoded poly(A) tail. Within the coding region, an additional cis-acting replication element is present (cre(2C)). 
The open reading frame (ORF) encodes one single large polyprotein that is proteolytically processed by virus-encoded proteases 
into the P1 capsid proteins and the P2 and P3 replication proteins. Polyprotein processing yields the individual proteins as well 
as the relatively stable cleavage intermediates VP0, 2BC, 3AB and 3CD.
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THE VIRAL LIFE CYCLE
Enteroviruses have a lytic infection cycle, i.e., enterovirus infection ultimately results in lysis 
of the host cell. The viral life cycle (Fig. 3) starts with binding of the virus particle to a cellular 
receptor that is present on the plasma membrane. For most, but not all enteroviruses, the receptor 
has been identifi ed. Polioviruses bind to CD155 (poliovirus receptor, Pvr) [13], whereas coxsackie B 
viruses bind to the Coxsackievirus-Adenovirus receptor (CAR) [14]. Most ECHOviruses make use 
of decay-accelerating factor (DAF or CD55) for binding to the cell [15], yet a second or accessory 
factor (i.e., heparan sulfate) seems necessary for viral proliferation [16]. Some coxsackie A viruses use 
intracellular adhesion molecule-1 (ICAM-1 or CD54) as their receptor [17; 18], whereas the receptor 
of other coxsackie A viruses has not yet been identifi ed. After binding to the receptor, the virus particle 
enters the cell and the viral RNA is released into the cytoplasm via an unknown mechanism [19]. The 
5’-terminal VPg protein is removed from the viral RNA by a cellular enzyme [20] and the RNA is 
subsequently translated to yield the viral proteins. Translation is suggested to proceed until a critical 
concentration of 3CDpro accumulates in the infected cell. It is thought that binding of 3CDpro to the 
cloverleaf then represses viral translation, after which replication is initiated [21]. Replication of the 
viral RNA is a two-step process that starts with the synthesis of a negative strand RNA molecule that is 
complementary to the viral genome, generating a double stranded intermediate named the ‘replicative 
form’ (RF) [22]. The negative strand then serves as a template for the generation of a large number 
of new positive strands, via an intermediate named the ‘replicative intermediate’ (RI) [22]. Synthesis 
of both negative and positive strand RNA molecules requires the activity of the viral RNA-dependent 
RNA polymerase, 3Dpol. In addition to its function in the elongation of the viral RNA strands [23; 24], 
it was recently demonstrated that 3Dpol possesses the ability to link UMP to the hydroxyl group of a 
tyrosine residue in VPg. This reaction yields the VPgpU and VPgpUpU peptide primers that are used 
Figure 3. Schematic representation of the enterovirus life-cycle. Enterovirus infection starts with binding of the virus to a 
specifi c receptor on the plasma membrane of the host cell. After uptake of the virus, the viral RNA is released and translated 
into a single large polyprotein that is proteolytically processed to yield the individual viral proteins. The genomic RNA is used 
as a template to synthesize a complementary negative strand RNA molecule that in turn is used as a template to generate large 
numbers of new positive strand RNA molecules. The newly formed positive strand RNA molecules are encapsidated by the capsid 
proteins to produce new viruses. The viral progeny is released via lysis of the host cell.
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by 3Dpol for negative and positive strand RNA synthesis [24]. Sequences present in the loop of cre(2C) 
were shown to serve as the template for uridylylation of VPg [25]. While the structural requirements for 
negative strand RNA synthesis are still poorly understood, positive strand RNA synthesis was shown 
to take place in specialized compartments, the replication complexes, which are present on membrane 
vesicles that accumulate in the cytoplasm of infected cells [26]. The nature and origin of these membrane 
vesicles will be described below (see ‘Modifi cations of host cell structures and functions’). Newly 
formed positive strands are released from the replication complexes and may either be used in a next 
cycle of translation and replication, or be encapsidated by the viral capsid proteins [19]. The release of 
viral progeny is not dependent on the host secretory apparatus, because enteroviruses are nonenveloped 
viruses that do not bud from the cell. Virus release is achieved by lysis of the host cell.
MODIFICATION OF HOST CELL STRUCTURES AND FUNCTIONS
Enterovirus infection causes dramatic alterations in host cell functions and structures. In the 
following paragraph, a number of these modifi cations will be described in greater detail. In some cases, 
the advantages of these modifi cations for the viral life cycle are recognized. However, of most of the 
cellular alterations, the relevance for the virus is not, or only partially, understood.
INHIBITION OF HOST CELL TRANSCRIPTION AND TRANSLATION
Shortly after infection (within 2-3 hours), cap-dependent translation of cellular mRNAs is inhibited 
[27]. The enterovirus 2A protease (2Apro) plays an essential role in this process by proteolytically 
cleaving eukaryotic initiation factor eIF4G [28; 29], which is an essential component of the cap-binding 
protein complex that is formed at the 5’ end of cellular mRNAs [30]. The cap-independent, IRES-driven 
initiation of translation of enteroviral RNA does not require eIF4G, and is not affected by the ‘shut-off’ 
of host cell translation [31]. In addition, the virus inhibits host cell transcription [32]. The 3C protease 
(3Cpro) is responsible for this effect by cleaving TBP (TATA-binding protein) [33], which is required 
for the generation of RNA polymerase I, II, and III transcripts [34]. Together, these modifi cations serve 
to manipulate the transcription and translation machinery in such a way that within a few hours the host 
cell is almost exclusively producing viral proteins. The shut off of host cell transcription and translation 
likely serves to increase the pool of metabolites that are used by the RNA-dependent RNA polymerase 
to replicate the viral genome [35] and to increase viral gene expression [34]. In addition, it may serve 
to inhibit synthesis of molecules that are involved in anti-viral responses.
hyg B
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Figure 4. Modifi cation of host cell 
membrane permeability in enterovirus-
infected cells. The modifi cations of host 
cell membrane permeability start with the 
release of calcium from the intracellular 
calcium stores, the ER and Golgi complex, 
which is evident within the fi rst 1-2 
hours postinfection. This is followed by 
the disruption of ion gradients over the 
plasma membrane, resulting in the infl ux 
of calcium and sodium and the effl ux of 
potassium. Later in infection, also low-
molecular-weight compounds, like the 
small inhibitor of translation hygromycin 
B (hyg B), effi ciently pass the plasma 
membrane.
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PROTEOLYTIC CLEAVAGE OF CYTOSKELETAL PROTEINS
The cytoskeleton is composed of three major elements: microfi laments (composed of actin 
subunits), microtubules (composed of tubulin subunits), and intermediate fi laments (composed of 
cytokeratin subunits). Enterovirus infection causes profound changes in host cell cytoskeleton, most 
likely affecting all three major elements. Recent evidence has implicated 2Apro in some cytoskeletal 
alterations that take place in infected cells. Purifi ed recombinant 2Apro cleaves dystrophin in cell lysates 
of myocytes [36; 37], a cleavage event that is also observed in coxsackievirus B3-infected cultured 
myocytes and in the hearts of coxsackievirus B3-infected mice [31]. Cleavage of dystrophin, which 
connects the actin fi laments with the ß-dystroglycan, disrupts the interaction of microfi laments with 
membranes. The 2Apro proteins of human rhinovirus and coxsackievirus B4 were shown to cleave 
cytokeratin 8, a member of the intermediate fi lament proteins [38]. Poliovirus 3Cpro cleaves the 
microtubule-associated protein 4 (MAP-4), an event that coincides with a collapse of microtubles [39; 
40]. It is as yet unclear if and how the alterations in cytoskeleton, which all appear to take place late in 
infection, are of benefi t for the virus.
MODIFICATION OF HOST CELL MEMBRANE PERMEABILITY
Enteroviruses severely alter morphology and functions of host cell membranes. These membrane 
alterations include the modifi cation of membrane permeability. Enteroviruses increase the permeability 
of both intracellular membranes and the plasma membrane. Increased plasma membrane permeability 
occurs at two well-defi ned time points during the viral infection cycle. First, when virus particles enter 
the cell, there is an increase in plasma membrane permeability to various compounds that normally 
do not enter the cell. This modifi cation of plasma membrane permeability, which is only temporary, is 
dependent on the virus:receptor interaction and does not require viral gene expression [41]. 
Later in infection, there is an increase in membrane permeability that requires viral gene 
expression [41]. After about 1-2 h, the Ca2+ level in the intracellular stores starts to decline [42]. From 
approximately 2-3 hours postinfection, there is an increase in plasma membrane permeability to ions. 
Gradients of Na+ and K+ are disturbed, which is accompanied by a drastic drop in membrane potential 
[43; 44], and extracellular Ca2+ enters the cell, resulting in elevated Ca2+ levels in the cytosol [42; 
45]. Later in infection, also low-molecular-weight compounds like hygromycin B, a small hydrophilic 
translation inhibitor that under physiological conditions poorly passes the plasma membrane, start to 
accumulate in the infected cell (Fig. 4) [41; 46; 47]. 
The requirement of viral gene expression suggests that one or more viral proteins are responsible 
for these later modifi cations [41]. The enterovirus 2B protein (as well as its precursor protein 2BC) has 
been implicated in the increased host cell membrane permeability [42; 46-49]. 
REARRANGEMENT OF HOST CELL MEMBRANES
Another important membrane modifi cation that takes place in enterovirus-infected cells is the 
cytoplasmic accumulation of membrane vesicles (Fig. 5) [26]. These vesicles contain at their outer 
surface the viral proteins that are involved in RNA replication as well as newly synthesized RNA [26; 
50-54], indicating that the process of viral RNA replication takes place at these membrane vesicles. 
Expression of the 2BC precursor protein is suffi cient for the cytoplasmic accumulation of the vesicles 
[52; 55-57]. Early in infection, i.e., within the fi rst hours, the formation of the replication vesicles is 
homologous to the formation of anterograde transport vesicles in uninfected cells [57], suggesting that 
the vesicles are derived from the early secretory pathway. This observation is further supported by the 
fi nding that enterovirus RNA replication is strongly inhibited by brefeldin A (BFA), an inhibitor of 
COPI-dependent membrane traffi c [58-60], which suggest that COPI-dependent membrane traffi cking 
may be required for the generation of the vesicles of the replication complex. The accumulation of 
anterograde transport vesicles in the cytosol of infected cells suggests that their traffi cking is somehow 
inhibited. Later in infection, i.e., from about 4-5 h, also autophagic vacuoles may contribute to the 
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membranes at which replication takes place. At these time points, the virus-induced membrane 
structures contain markers from throughout the secretory pathway. Moreover, they contain double lipid 
bilayers that surround cytosolic material, a feature typical of autophagy [61; 62]. 
INHIBITION OF HOST CELL PROTEIN SECRETION
Another important modifi cation of host cell functions is the virus-induced inhibition of 
protein secretion. This inhibition may be advantageous for the virus by preventing anti-viral host cell 
responses like major histocompatibility complex expression (MHC I [63]), secretion of interferon 
and interleukines (IFN-ß, IL-6, IL-8 [64]) and exposure of the TNF receptor at the cell surface [65]. 
Individual expression of the enterovirus non-structural proteins has shown that both the 2B protein and 
the 3A protein are endowed with the ability to inhibit protein secretion [46; 47]. The 3A protein was 
shown to inhibit ER-to-Golgi transport [66]. The step at which the 2B protein interferes with protein 
traffi cking was not identifi ed. 
MANIPULATION OF CELLULAR DEATH PATHWAYS
The functional and morphological alterations of the host cell that take place during enterovirus-
infection are directed to create the environmental conditions required for virus RNA replication. 
However, they may also be sensed by the host cell and initiate a defensive response, aimed at curtailing 
virus replication. As it was shown that drug-induced inhibition of transcription and/or translation 
(e.g., by actinomycin D and cycloheximide) triggers an apoptotic reaction [67], it may be expected 
that the virus-induced inhibition of transcription and translation also leads to the development of 
apoptosis. Indeed, individual expression of the viral proteases 2Apro (which inhibits cap-dependent 
translation) or 3Cpro (which inhibits host cell transcription) was indeed shown to result in apoptotic 
cell death [68; 69]. However, enterovirus-infected cells do not die of apoptosis. Enterovirus infection 
leads to the development of the so-called cytopathic effect (CPE), a necrosis-like type of cell death 
that is characterized by rounding up of the infected cells, distortion and displacement of the nuclei, 
condensation of chromatin, and increased plasma membrane permeability [70]. This suggests that 
enteroviruses somehow suppress or delay the pro-apoptotic action of 2Apro and 3Cpro, most likely by 
the action of a virus-encoded anti-apoptotic function. Indeed, several reports have suggested that the 
development of CPE is a complex interplay between apoptosis-inducing and apoptosis-suppressing 
functions encoded by the enterovirus genome [70-72]. The enteroviral protein that is responsible for the 
suppression of anti-viral apoptotic host cell responses has not yet been identifi ed. 
Figure 5. Membrane rearrangements in enterovirus-infected cells. (A) Electron micrograph of a poliovirus-infected HeLa 
cell showing the virus-induced accumulation of small vesicles. (B) Rosette of virus-induced vesicles (V) surrounding a granular 
structure containing the replicating viral RNA, thus representing the actual replication complex (RC). Such rosettes are isolated 
from infected cells by sucrose gradient centrifugation and synthesize viral plus-strand RNA in the RI in vitro. Both images were 
kindly provided by Dr. K. Bienz, University of Basel, Schwitzerland.
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OTHER MODIFICATIONS OF HOST CELL FUNCTIONS
A number of other modifi cations of host cell functions are reported in enterovirus-infected cells. 
Enteroviruses interfere with nuclear import, resulting in the cytoplasmic accumulation of a number of 
nuclear proteins [73]. Two proteins of the nuclear pore complex (NPC) were shown to be proteolytically 
degraded, yet the exact mechanism and the viral protein(s) responsible for the inhibition of nuclear 
import are as yet unknown [73]. The interference with nuclear import is thought to be (another) 
mechanism by which the virus, by preventing signal transduction to the nucleus, evades anti-viral host 
cell responses.
The activity of some phospholipases is markedly altered during infection, indicating that 
enteroviruses also manipulate phospholipid metabolism. A drastic blockade of phospholipase A2 (PLA2) 
was observed in virus-infected cells [74]. In contrast, the activity of phospholipase C (PLC) is enhanced 
in virus-infected cells, as demonstrated by the release of breakdown products of phosphatidylcholine 
(choline, phosphorylcholine) in the medium [74; 75]. It has been suggested that the increased activity 
of PLC leads to enhancement of de novo phospholipid synthesis, via a feedback mechanism that is 
sensitive to PLC breakdown products [76]. Indeed, enterovirus infected cells displayed increased 
phospholipid biosynthesis [77]. The observation that virus RNA replication is sensitive to cerulin, 
an inhibitor of de novo lipid synthesis [78], suggests that de novo phospholipid synthesis is required 
for viral RNA replication. In contrast, Cho and colleagues did not fi nd evidence for enhanced lipid 
synthesis in infected cells [55]. Thus, whether alterations in phospholipid metabolism are involved in 
the massive membrane proliferation that is observed in virus-infected cells is still a matter of debate. 
THE ENTEROVIRUS 2B, 2C AND 2BC PROTEINS
The enterovirus 2B, 2C and 2BC proteins have been implicated in the modifi cations of host cell 
membrane structures and functions that occur in the infected cell. To get a better understanding of these 
proteins, their properties and functions will be described below.
THE 2BC PROTEIN
The 2BC protein is a relatively stable precursor protein that is exclusively localized to the 
membranes of the replication complex [55]. In infected cells 2B, 2C and 2BC are all present, yet the 
functional relevance of the presence of the precursor as well as the individual constituents is unclear. 
The activities of the individual 2B and 2C proteins (see below) are also performed by the 2BC precursor 
protein. On the other hand, the accumulation of the replication vesicles requires the activity of the 
2BC precursor protein, rather than of 2B, 2C or the combined activity of 2B and 2C [55; 56; 62; 79; 
80]. These data suggest that the presence of 2BC is suffi cient to execute 2B, 2C and 2BC functions. 
However, this is not the case: mutations at the 2B/2C junction that result in poor cleavage of the 2BC 
precursor interfere with virus replication [81]. This suggests that the liberation of 2B and/or 2BC is at 
some step required in the process of viral RNA replication.
THE 2B PROTEIN
The enterovirus 2B protein is a small, hydrophobic protein that is present on the outer surface 
of the membrane vesicles at which viral replication takes place [51]. The 2B protein fulfi ls a crucial 
role in viral RNA replication, as demonstrated by the fi nding that mutations in the 2B proteins caused 
defects early in replication [82-84]. The enterovirus 2B protein has been implicated in the alterations in 
membrane permeability that occur in the virus-infected cell. Expression of the 2B protein was shown 
to be suffi cient to increase hygromycin B entry [46-48]. Initial experiments suggest that the 2B protein 
also may be responsible for the reduction in the fi lling state of the intracellular Ca2+ stores [42]. Firm 
evidence that 2B indeed reduces the fi lling state of the Ca2+ stores is still lacking.
The enterovirus 2B protein consists of 97-99 amino acids and contains two hydrophobic regions 
that were designated HR1 and HR2, respectively (Fig. 6A and 6B) [83; 84]. The fi rst hydrophobic region 
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Figure 7. Putative topologies 
of the enterovirus 2B protein. 
The barrel-stave model (left) 
suggests that the 2B protein 
forms homomultimers, in 
which both hydrophobic 
regions span the phospholipid 
bilayer. The hydrophilic faces 
of the amphipathic α-helix are 
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to create an aqueous pore. The 
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that monomers of the 2B 
protein are orientated parallel 
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to penetrate a few Ångstroms in 
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is predicted to form a cationic amphipathic α-helix (Fig. 6C) [84] that displays characteristics typical 
for the group of lytic polypeptides [85]. Mutations in the coxsackievirus 2B protein that interfered with 
the cationic or the amphipathic character of HR1 caused severe defects in the ability of the 2B protein 
to modify plasma membrane permeability to hygromycin B [47] and to support viral RNA replication 
[84], demonstrating the functional importance of the predicted cationic amphipathic α-helix. Mutations 
in HR2 also resulted in defects in the ability to modify plasma membrane permeability to hygromycin 
B [47] and to support RNA replication [83]. These results suggest that the hydrophobic regions are 
cooperatively involved in the structure and function of the 2B protein.
Two models have been proposed to explain the membrane-disturbing properties of lytic 
polypeptides, and may be used to explain the ability of the 2B protein to increase membrane permeability 
(Fig. 7). The barrel-stave model suggests that lytic polypeptides disturb membrane integrity by building 
membrane-integral pores, formed by multimers that expose their hydrophobic faces to the lipid bilayer 
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Figure 6. Properties of the enterovirus 2B 
protein. All enterovirus 2B proteins display 
a high degree of similarity, although the 
amino acid sequence varies. Enterovirus 
2B proteins consist of 97-99 amino acids. 
In this fi gure, the characteristics of the 2B 
protein of coxsackievirus B3 (CBV3) are 
depicted.  (A) Hydropathy plot of the CBV3 
2B protein according to Kyte and Doolittle 
(98), using a window size of 9 residues. 
The 2B protein contains two hydrophobic 
regions, which are designated HR1 and 
HR2. (B) Schematic representation of the 
CBV3 2B protein, in which HR1 and HR2 
are indicated. The amino acid sequence 
of HR1, HR2 and the hydrophilic region 
between the two hydrophobic regions is 
depicted. (C) Helical wheel diagram of 
the putative amphipathic α-helix formed 
by HR1. The hydrophobic residues (boxed) 
are positioned at one face of the α-helix, the 
charged and polar residues are positioned 
at the other face of the α-helix.
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and their hydrophilic faces towards each other to form an aqueous interior [86; 87]. Alternatively, 
the carpet model suggests that lytic polypeptides disturb membrane integrity by lying parallel to the 
membrane plane. The amphipathic α-helix is thought to penetrate a few Ångstroms in the membrane 
and thus increase membrane curvature and destabilize the membrane [88]. 
The enterovirus 2B protein also has the ability to inhibit protein secretion. Individual expression 
of 2B is suffi cient to inhibit secretion of the soluble reporter protein A1PI (alpha-1 proteinase inhibitor) 
into the extracellular medium [46; 47], and to cause the accumulation of the membrane-bound reporter 
glycoprotein VSV-G (vesicular stomatitis virus glycoprotein) in an ER-specifi c, endoglucosidase H-
sensitive glycosylation state [46]. Whether the inhibition of secretion is connected to the ability of the 
2B protein to increase membrane permeability is as yet unknown. The relevance of these activities for 
the role of the 2B protein in viral RNA replication also requires further investigation.
THE 2C PROTEIN
The 2C protein consists of approximately 330 amino acids and is the most conserved protein 
among picornaviruses. All picornavirus 2C proteins contain an NTPase domain, which is responsible 
for the high degree of conservation of the picornavirus 2C protein [89; 90]. ATPase activity of the 2C 
protein was demonstrated [91; 92], and is required for viral RNA replication [93], yet the specifi c step 
in replication that requires the ATPase activity is still unknown. The 2C protein shares three motifs with 
the superfamily III helicases; the ‘A’ and ‘B’ motifs of the ‘Walker’ NTP binding domain and a ‘C’ motif 
that is specifi c for the helicase superfamily III [94; 95]. Nevertheless, helicase activity of 2C could not 
be demonstrated in vitro [91]. Moreover, the observation that 3Dpol has the ability to unwind dsRNA 
in vitro [96] suggests that 2C helicase activity is not required for unwinding the double-stranded RNA 
replication intermediate. The 2C protein has both RNA-binding and membrane-binding activities [89; 
91; 97] and was therefore suggested to be responsible for the attachment of the viral RNA to vesicular 
membranes of the replication complex. The NTPase activity of 2C is not involved in the 2BC-induced 
rearrangements of intracellular membranes, as mutations in this domain did not affect vesicle induction 
[55].
AIM AND OUTLINE OF THE THESIS
At the start of this project, the mechanism by which the enteroviral 2B protein increases host cell 
membrane permeability was unknown. In analogy with the membrane-lytic polypeptides, two models 
were proposed to explain the membrane active nature of 2B; the barel-stave model and the carpet model 
(Fig. 7). The experiments described in this thesis were designed to decide which of these two models is 
correct, and to advance our understanding of the relevance of the 2B-induced modifi cations in host cell 
membrane permeability for host cell functions and virus replication. As a model protein we used the 2B 
protein of coxsackievirus B3, a member of the HEV-B species. 
An essential feature of the barrel-stave model is that the 2B protein forms membrane-integral 
homomultimers in which the hydrophobic backbones of the amphipathic α-helices are facing the 
phospholipid bilayer, and the hydrophilic faces are orientated towards each other (Fig. 7). In Chapter 
2, a mammalian two-hybrid approach was used to address the question whether the 2B protein can 
form homomultimers and to determine the domains and amino acid residues that are relevant to this 
feature. The experiments described in Chapters 3 and 4 were undertaken to map the domains and 
amino acid residues of the 2B protein that are important for its membrane interaction, membrane active 
nature, subcellular localization and function in viral RNA replication. Chapter 5 addresses the question 
whether 2B homomultimerization occurs also in vivo by investigating the ability of wild-type 2B to 
restore the altered localization of 2B mutants. 
Together, the results described in Chapters 2 to 5 strongly suggested that the 2B protein forms 
pores in membranes of the endoplasmic reticulum (ER) and Golgi complex. Because these organelles 
are the major intracellular Ca2+ stores, the effect of the 2B protein on the Ca2+ fi lling state of these 
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organelles and the process of intracellular Ca2+ handling was investigated in Chapters 6 and 7. 
Furthermore, experiments were conducted to assess whether the putative pores formed by the 2B protein 
allowed the passage of ions other than Ca2+. In these chapters also the functional consequences of the 
2B-induced alterations in membrane permeability and ion homeostasis were investigated. Chapter 6 
deals with the possibility that 2B-induced alterations in intracellular Ca2+ homeostasis play a role in 
viral modulation of cell death, whereas Chapter 7 studies the option that the 2B-induced alterations in 
ER and Golgi ion homeostasis are involved in viral inhibition of protein secretion. Chapter 8 addresses 
the question whether the activities and functions of the enterovirus 2B protein are conserved among the 
2B proteins of other members of the picornavirus family. The experimental data described in this thesis 
are summarized and discussed in Chapter 9.
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Recently, homomultimerization and heteromultimerization reactions of the 
poliovirus P2 region proteins were described using a yeast two-hybrid approach 
[99]. In this study, we investigated multimerization reactions of the 2B, 2C, and 2BC 
proteins of the closely related coxsackie B3 virus (CBV3) using a mammalian two-
hybrid system. This systems allows the characterization of protein:protein interactions 
within a cellular environment that more closely mimics the native protein environment. 
Homomultimerization reactions were observed with the 2BC protein and, albeit weakly, 
with the 2B protein, but not with the 2C protein. To identify the determinants involved 
in the 2BC and 2B homomultimerization reactions, several mutants containing deletions 
or point mutations in the 2B region were tested. Disruption of the hydrophobic character 
of either the cationic amphipathic α-helix [84] or the second hydrophobic domain of 
the 2B protein [83] disturbed both the 2BC:2BC and the 2B:2B homomultimerization 
reactions. Disruption of either the cationic or the amphipathic character of the α-helix or 
deletion of the N-terminal 30 amino acids of the 2B protein, however, had no effect on 
the 2BC and 2B homomultimerization reactions. Heteromultimerization reactions were 
observed between proteins 2BC and 2B, and also between proteins 2BC and 2C, but 
not between the 2B and 2C proteins. The 2BC:2B and 2BC:2C heteromultimerization 
reactions were also mediated by hydrophobic determinants located in the amphipathic 
α-helix and the second hydrophobic domain. The nature of the interactions and their 
implications for the viral life cycle are discussed. 
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Figure 1. (A) Schematic representation of the 7.5 kb 
enterovirus RNA genome. The polyprotein encoding 
region (boxed) is fl anked by the 5’ nontranslated 
region (NTR) and the 3’ NTR, which contains a 
polyadenylate tract at its end. Vertical lines within the 
polyprotein indicate proteinase cleavage sites. The 2B 
protein is enlarged and the 2B amino acid sequence 
is shown. The amphipathic α-helix (also referred to 
as HR1) and the second hydrophobic domain (also 
referred to as HR2) are indicated. The positions of 
the deletions ∆HR1 (deletion of aa 34-56), ∆HR2 
(deletion of aa 64-80), and ∆30N (deletion of the N-
terminal 30 aa) are indicated. Due to the construction 
procedure, leucine[63] is changed into a valine in the 
∆HR2 construct. (B) Amino acid sequences of the 
amphipathic α-helix (HR1) point mutants and the 
second hydrophobic domain (HR2) point mutants used 
in this study. Periods indicate unchanged residues, 
and triangles indicate locations in which aa have 
been inserted, not substituted. (C) Helical wheel 
representations of the putative amphipathic α-helix 
formed by 2B aa 37-54 and the corresponding domains 
of the insertion (ins) mutants ins41[L] and ins48[L]. 
Charged residues are indicated. Boxed residues 
represent hydrophobic residues. 
INTRODUCTION
Enteroviruses (poliovirus, coxsackievirus, ECHOvirus and several unnamed enteroviruses) are 
admirable effi cient viruses. These cytolytic viruses posses a relatively small plus-strand RNA genome 
(7.5 kb) that harbors the genetic information for only a limited number of proteins. The nonstructural 
replication proteins are required both for the physical process of vRNA replication, which takes place 
in the cytoplasm, as well as for the induction of a variety of host cell modifi cations (e.g., inhibition of 
host cell transcription and translation, remodeling of the vesicular membrane system, permeabilization 
of host cell membranes, inhibition of protein secretion, inhibition of nucleocytoplasmic transport) in 
order to create the microenvironment required for vRNA replication, to circumvent antiviral host cell 
responses, and to induce cell lysis [11; 12]. To execute all of these complex functions, enteroviruses 
have developed elegant strategies to optimally benefi t the limited size of the vRNA genome. Processing 
of the viral polyprotein not only yields the P1 capsid proteins and the mature nonstructural P2 and P3 
region proteins (2Apro, 2B, 2C, 3A, 3B, 3Cpro, 3Dpol) but also a number of stable cleavage intermediates 
(2BC, 3AB and 3CDpro) with functions distinct from their cleavage products. Furthermore, most of the 
nonstructural proteins are equipped with multiple functions, and the nonstructural proteins may exhibit 
different activities upon interaction with different binding partners [100].  
Recently, the yeast two-hybrid system has been successfully applied to catalogue interactions 
between the P2 and P3 region nonstructural proteins of poliovirus (PV) [99; 101; 102]. Using this 
approach, several homomultimerization and heteromultimerization reactions between the nonstructural 
proteins were observed. Among the interactions of the P2 region proteins were homomultimerization 
reactions of the 2B and 2BC proteins and heteromultimerization reactions between the 2B, 2C and 2BC 
proteins. These proteins are localized at the outer surface of the virus-induced membrane vesicles that 
accumulate in the cytoplasm of the infected cell and which are the sites at which vRNA replication takes 
place [54]. The 2BC protein is the viral protein responsible for the proliferation and accumulation of 
these membrane vesicles [26; 55; 80], possibly in conjunction with the 3A protein [62]. A number of 
functions have been ascribed to the 2B and 2C proteins but the relevance of these functions for the viral 
life cycle remains to be established. The 2B protein is a small protein that contains two hydrophobic 
domains, of which one is predicted to form an amphipathic α-helix (Fig. 1C) [84]. The 2B protein has 
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been implicated in the modifi cation of membrane permeability [42; 46-48], the inhibition of protein 
secretion [46; 47], and the disassembly of the Golgi complex [103]. The identifi cation of 2B mutations 
that interfere with virus growth but that do not disturb the ability of the 2B protein to inhibit protein 
secretion or increase membrane permeability argues for additional functions of the 2B protein or its 
precursor 2BC [47]. The 2C protein is a nucleoside triphosphatase that is endowed with RNA binding 
capacities [91; 92; 104], and therefore may be the viral protein that mediates attachment of the vRNA 
to the membranous replication complex. Moreover, a role for the 2C protein in the initiation of negative 
strand RNA synthesis has been proposed [105]. 
In this study, we investigated multimerization reactions of the 2B, 2C and 2BC proteins of 
coxsackie B3 virus (CBV3) using a mammalian two-hybrid system. Mammalian two-hybrid systems 
are used to confi rm putative protein:protein interactions in vivo that were initially identifi ed by the yeast 
two-hybrid system or by in vitro biochemical methods. The mammalian two-hybrid system allows 
characterization of protein:protein interactions within a cellular environment that more closely mimics 
the native protein environment. Differences exist between yeast and mammalian cells in patterns of 
posttranslational modifi cations as well as in the intracellular localization of proteins. These differences, 
as well as other unique factors or modulators present in mammalian cells, may infl uence the ability 
of protein domains to interact. Here, we report the homomultimerization and heteromultimerization 
characteristics of the CBV3 proteins 2BC, 2B and 2C in mammalian cells and the identifi cation of the 
domains and amino acids (aa) involved in these interactions.
RESULTS
DESCRIPTION OF THE MAMMALIAN TWO-HYBRID SYSTEM
Testing of putative interacting proteins using the mammalian two hybrid system requires 
cotransfection of three plasmids into eukaryotic cells. The pACT plasmid provides the activation 
domain of herpes simplex virus type 1 VP16 (aa 411-456) and an added nuclear localization sequence, 
followed by a multiple cloning site for the insertion of the DNA sequence of interest. The pBIND 
plasmid provides the DNA binding domain of a yeast GAL4 gene product (aa 1-147), which contains 
an endogenous nuclear localization sequence, followed by a multiple cloning site. Both plasmids 
contain the CMV immediate-early promoter to drive high level expression of the VP16 and GAL4 
fusion proteins. A chimeric intron and the late SV40 polyadenylation signal sequence serve to provide 
effi cient processing and optimized steady-state levels of the transcribed RNA. The VP16 and GAL4 
chimeric proteins expressed in the transfected cells are tested for functional protein:protein interactions 
in combination with the reporter plasmid pG5luc, which contains fi ve GAL4 binding sites upstream of 
a minimal TATA box that precedes the fi rely luciferase gene (Fig. 2A). 
HOMOMULTIMERIZATION REACTIONS OF THE 2B, 2C, AND 2BC PROTEINS
The CBV3 proteins 2B, 2C and 2BC were cloned in the two-hybrid plasmids pACT and pBIND 
and tested for homomultimerization reactions. The amounts of fi refl y luciferase produced by the 
combination of the VP16-fusion protein and the GAL4-fusion protein were compared to the amounts 
of fi refl y luciferase produced by the combination of the VP16-fusion protein and the non-fused GAL4 
binding domain (provided by the empty pBIND plasmid) and the combination of the GAL4-fusion 
protein and the non-fused VP16 activation domain (provided by the empty pACT plasmid). These 
two controls were included to exclude to possibility that the fi refl y luciferase production is due to an 
interaction of either one the fusion proteins with the non-fused VP16 or GAL4 domains.  
Figure 2A shows that a strong homomultimerization reaction was observed of the 2BC protein. 
The amount of fi refl y luciferase produced in COS-1 cells by the VP16-2BC and GAL4-2BC fusion 
proteins was in all experiments about 10- to 20-fold higher than those observed with the two control 
transfections. A weak interaction was observed between the VP16-2B and GAL4-2B fusion proteins. 
The amount of fi refl y luciferase produced by the VP16-2B and GAL4-2B fusion proteins was about 
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Figure 2. (A) Homomultimerization reactions of the CBV3 
proteins 2B, 2C and 2BC expressed as fusion proteins 
to the HSV VP16 activation domain (as encoded by the 
pACT plasmids) or the yeast GAL4 DNA binding domain 
(as encoded by the pBIND plasmids). COS-1 cells were 
transfected with the indicated constructs and assayed for 
luciferase production at 48 h posttransfection. A hyphen 
indicates the expression of a non-fused VP16 or GAL4 
protein. LU, light units. Values represent means ± standard 
errors of measurements of four independent experiments. 
(B) Western-blot analysis of the expression of the GAL4 
fusion proteins. COS-1 cells were transfected with the 
indicated constructs and assayed for protein expression 
at 48 h posttransfection. Cell lysates were prepared, 
separated by SDS-PAGE, and transferred to nitrocellulose 
membranes. The blot was probed with a monoclonal 
antibody against the GAL4 DNA binding domain.  
3- to 4-fold higher than those observed with the two control transfections. No interaction was observed 
between the VP16-2C and GAL4-2C fusion proteins. Western blot analysis showed that transfected 
COS-1 cells correctly expressed fusion products of the expected molecular weight (Fig. 2B). 
HETEROMULTIMERIZATION REACTIONS OF THE 2B, 2C AND 2BC PROTEINS
To test for heteromultimerization reactions of the 2B, 2C and 2BC proteins, COS-1 cells were 
transfected with all possible pair wise combinations and assayed for protein:protein interactions (Fig. 
3). The VP16-2B fusion protein was found to interact with the GAL4-2BC fusion protein, but not 
with the GAL4-2C fusion protein (Fig. 3A). The VP16-2C also interacted with the GAL4-2BC fusion 
protein, but not with the GAL4-2B fusion protein (Fig. 3B). The VP16-2BC fusion protein displayed 
strong interactions with both the GAL4-2B and the GAL4-2C fusion proteins (Fig. 3C). The 2BC 
protein was also tested for interactions with the CBV3 3A protein, a small (89 aa) hydrophobic viral 
protein. No interaction was observed between the VP16-2BC fusion protein and the GAL4-3A fusion 
protein (Fig. 3C), a fusion protein that was effi ciently expressed (data not shown). Collectively, these 
results provide evidence for specifi c heteromultimerization reactions between the proteins 2BC and 2B 
and between the proteins 2BC and 2C, but not between the proteins 2B and 2C.
The data in Figure 3 demonstrate that the strength of both the 2BC:2B interaction and the 2BC:
2C interaction was vector-dependent. The 2BC:2B and 2BC:2C interactions were always stronger when 
the 2BC protein was fused to the VP16 activation domain than to the GAL4 DNA binding domain. 
Vector-dependence (also referred to as “directionality” or “polarity”) has been reported in many two-
hybrid system studies and was also observed in the yeast two-hybrid interaction analysis of the PV P2 
region proteins [99]. 
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Figure 3. Heteromultimerization reactions of the CBV3 
proteins (A) 2B,  (B) 2C, and (C) 2BC. COS-1 cells were 
transfected with all possible pair wise combinations of pACT 
and pBIND plasmids that drive expression of 2B, 2C, or 2BC 
either as fusion protein to the HSV VP16 activation domain or 
the yeast GAL4 DNA binding domain, respectively. To test the 
specifi city of the 2BC heteromultimerization reactions, also 
interaction with the 3A protein was assayed. Values represent 
means ± standard errors of measurements of two independent 
experiments.  
CONSTRUCTION OF MUTANT 2BC AND 2B FUSION PROTEINS
To gain more insight into the molecular determinants involved in the homomultimerization and 
heteromultimerization reactions of the 2BC and 2B proteins, several pACT and pBIND plasmids driving 
expression of 2BC and 2B fusion proteins containing either in frame deletions or point mutations in 
the 2B coding region were generated. In the deletion mutants, either the N-terminal 30 aa (30N), the 
amphipathic α-helix (i.e., the fi rst hydrophobic region, HR1), or the second hydrophobic region (HR2) 
were deleted (Fig. 1A). 
The point mutants contained well-characterized aa substitutions or insertions in HR1 or HR2 (Fig. 
1B). The amphipathic α-helix mutants are designated HR1.2, HR1.7, HR1.9, HR1.11 and HR1.13. In 
mutant HR1.2, the three lysines in the hydrophilic part of the amphipathic α-helix are replaced with 
glutamic acid residues (mutation K[41,44,48]E). Mutants HR1.7 and HR1.9 contain insertions of leucine 
residues at 2B positions 41 or 48 (mutations ins[41]L and ins[48]L, respectively). These insertions lead 
to a dispersion of the charged residues and, as a consequence, a decrease in the amphipathic character 
of the α-helix, without disturbing the overall hydrophobicity of the domain (Fig. 1C). Mutant HR1.11 
contains a replacement of the three lysines in the hydrophilic part of the amphipathic α-helix with 
leucine residues (mutation K[41,44,48]L). Mutant HR1.13 contains a replacement of four hydrophobic 
residues in the hydrophobic part of the amphipathic α-helix with polar asparagine residues (mutation 
L[46]N/V[47]N/I[49]N/I[50]N). Viral RNAs carrying these HR1 mutations were all nonviable due to a 
primary defect of the 2B protein in vRNA replication [84](van Kuppeveld et al., unpublished results). 
The second hydrophobic domain mutants are designated HR2.3, HR2.6, and HR2.9 (Fig. 1B). 
In mutant HR2.3, cysteine-75 and serine-77 are replaced with more hydrophobic methionine residues 
(mutation C[75]M/S[77]M). In mutants HR2.6 and HR2.9, the overall hydrophobic character of HR2 
is diminished. In mutant HR2.6, isoleucine-64 and valine-66 are replaced with polar serine residues 
(mutation I[64]S/V[66]S). In mutant HR2.9, alanine-71 and isoleucine-73 are replaced with glutamic 
acid residues (mutation A[71]E/I[73]E). All of these HR2 mutations caused a primary defect in vRNA 
replication, rendering the viral RNA either quasi-infectious (mutation C[75]M/S[77]M) or nonviable 
(mutations I[64]S/V[66]S and A[71]E/I[73]E) [83].
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Figure 4. Homomultimerization 
reactions of (A) 2BC deletion mutants, 
(B) 2BC point mutants carrying amino 
acid alterations in the amphipathic α-
helix, (C) 2BC point mutants carrying 
amino acid alterations in the second 
hydrophobic domain, and (D) mutant 
VP16-2BC fusion proteins with the 
wild-type GAL4-2BC fusion protein. 
The 2BC deletion mutants (Fig. 1A) 
lacked either the amphipathic α-helix 
(∆HR1), the second hydrophobic 
domain (∆HR2), or the N-terminal 30 
aa (∆30N) of the 2B region. The 2BC 
point mutants (Fig. 1B) contained 
specifi c amino acid substitutions or 
insertions in either the amphipathic 
α-helix (HR1 mutants) or the second 
hydrophobic domain (HR2 mutants). 
Values represent means ± standard 
errors of measurements of three 
independent experiments. (E) Western 
blot analysis of the expression of the 
GAL4-2BC deletion mutants and 
point mutants. Western blot analysis 
was performed as described in the 
legend of Fig. 2.  
HOMOMULTIMERIZATION REACTIONS OF MUTANT 2BC FUSION PROTEINS
Analysis of the homomultimerization reactions of the 2BC deletion mutants showed that the 
N-terminal 30 aa are not required for this activity (Fig. 4A). Deletion of either HR1 or HR2, however, 
abolished the homomultimerization reaction of the 2BC protein, suggesting that the integrity of each 
of these domains is required for the formation of 2BC homomultimers. All 2BC deletion mutants were 
effi ciently expressed (Fig. 4E), arguing that the lack of interaction of the 2BC∆HR1 and  2BC∆HR2 
proteins is not due to impaired protein production or stability.  
Analysis of the homomultimerization reactions of the amphipathic α-helix point mutants (Fig. 
4B) showed that mutants HR1.2, HR1.7, HR1.9, and HR1.11 effi ciently formed homomultimers. Thus, 
neither the cationic character nor the amphipathic character of the α-helix is absolutely required for 
the ability of the 2BC protein to form homomultimers. Mutant HR1.13, however, was unable to form 
homomultimers, indicating that the hydrophobic character of the amphipathic α-helix is required 
for the homomultimerization reaction of the 2BC protein. Analysis of the homomultimerization 
reactions of the second hydrophobic domain mutants (Fig. 4C) showed that mutant HR2.3 effi ciently 
formed homomultimers. Mutants HR2.6 and HR2.9, however, were no longer capable of forming 
homomultimers, indicating that the hydrophobic character of the second hydrophobic domain is also 
required for the ability of protein 2BC to homomultimerize. Similar results were obtained when the 
VP16-2BC mutants were tested for interactions with the GAL4-2BC wild-type protein (Fig. 4D). 
Western blot analysis showed that all 2BC point mutants were correctly expressed (Fig. 4E). Taken 
together, these data provide evidence that the homomultimerization reaction of the 2BC protein depends 
on hydrophobic determinants in both the amphipathic α-helix and the second hydrophobic domain of 
the 2B protein. 
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Figure 5. Homomultimerization reactions of 2B point mutants 
carrying amino acid alterations in (A) the amphipathic α-
helix, or (B) the second hydrophobic domain. Values represent 
means ± standard errors of measurements of two independent 
experiments. (C) Western blot analysis of the expression of the 
GAL4-2B point mutants. Western blot analysis was performed 
as described in the legend of Fig. 2.  
HOMOMULTIMERIZATION REACTIONS OF MUTANT 2B FUSION PROTEINS
Analysis of the homomultimerization reactions of the 2B deletion mutants showed that the N-
terminal 30 aa are not required for this activity (data not shown). Analysis of the homomultimerization 
reactions of 2B point mutants (Figs 5A and 5B) showed that the mutants HR1.2, HR1.7, HR1.9 and 
HR1.11, and HR2.3 had retained the ability to form homomultimers. Mutants HR1.13, HR2.6 and 
HR2.9, however, displayed a severe defect in the ability to homomultimerize. Similar results were 
obtained when the VP16-2B point mutants were tested with the wild-type GAL4-2B fusion protein 
(data not shown). All point mutants were correctly expressed (Fig. 5C), indicating that the differences 
observed in the multimerization reactions are not due to impaired protein production or stability. Thus, 
the homomultimerization reaction of the 2B protein also depends on hydrophobic determinants in the 
amphipathic α-helix and the second hydrophobic domain.
HETEROMULTIMERIZATION REACTIONS BETWEEN MUTANT 2BC AND 2B FUSION PROTEINS
To investigate the 2BC:2B heteromultimerization determinants, interactions were assayed 
between mutant VP16-2BC fusion proteins and the wild-type GAL4-2B fusion protein (Fig. 6A) and 
between the VP16-2BC wild-type protein and GAL4-2B point mutants (Fig. 6B). Essentially, the 
same results were observed as for the 2BC:2BC and 2B:2B homomultimerization reactions (Figs. 4 
and 5, respectively). Intriguing results, however, were observed with the VP16-2BC wild-type protein 
and the GAL4-2B point mutants 2B-HR2.3 and 2B-HR2.6 (Fig. 6B). Mutant 2B-HR2.3 was only 
partially effi cient (~50% relative to 2B wt) in forming heteromultimers with the 2BC protein. This 
fi nding is surprising because the 2BC-HR2.3 protein showed a wild-type phenotype in the 2BC:2B 
heteromultimerization reaction (Fig. 6A), and because proteins 2BC-HR2.3 and 2B-HR2.3 showed 
effi cient homomultimerization reactions (Figs. 4 and 5). Mutant 2B-HR2.6 was also partially effi cient 
(~40% relative to 2B wt) in forming 2BC:2B heteromultimers, which is surprising because the 2BC-
HR2.6 protein was severely disabled in forming 2BC:2B heteromultimers (Fig. 6A) and because proteins 
2BC-HR2.6 and 2B-HR2.6 were unable to form homomultimers. These results suggest that the 2BC:2B 
heteromultimerization reaction may not simply refl ect a 2B:2B homomultimerization reaction.    
CHAPTER 226
2
MULTIMERIZATION REACTIONS OF THE COXSACKIEVIRUS PROTEINS 2B, 2C, AND 2BC: 
A MAMMALIAN TWO-HYBRID ANALYSIS
27
2
Figure 6. Heteromultimerization reactions of (A) VP16-2BC deletion mutants and point mutants with the wild-type GAL4-2B 
fusion protein, and (B) VP16-2BC wild-type fusion protein and GAL4-2B point mutants. Values represent means ± standard 
errors of measurements of three independent experiments.
HETEROMULTIMERIZATION REACTIONS BETWEEN 2BC MUTANTS AND THE 2C FUSION PROTEIN
The 2BC protein also showed a strong heteromultimerization reaction with the 2C protein (Fig. 
3). To investigate  the role of the 2B region in this heteromultimerization reaction, interactions between 
mutant VP16-2BC fusion proteins and the wild-type GAL4-2C fusion protein were assayed (Fig. 7). 
Deletion of the N-terminal 30 aa of the 2BC protein had no effect on the interaction with the 2C protein, 
whereas deletion of either HR1 or HR2 completely abolished the 2BC:2C interaction. Analysis of the 
heteromultimerization reactions between the 2BC point mutants and the 2C protein showed that the 
mutants HR1.2, HR1.7, HR1.9, HR1.11, and HR2.3 effi ciently interacted with the GAL4-2C fusion 
protein. Mutants HR1.13, HR2.6 and HR2.9, however, failed to form heteromultimers with the 2C 
protein. Thus, the same mutations that disrupted the formation of 2BC homomultimers (Fig. 4) also 
abolished heteromultimerization reactions between the 2BC and 2C proteins. 
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Figure 7. Heteromultimerization reactions of VP16-2BC 
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of measurements of two independent experiments.
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DISCUSSION
In this study, we have characterized homomultimerization and heteromultimerization reactions 
of the CBV3 nonstructural 2B, 2C and 2BC proteins using a mammalian two-hybrid system, a system 
that allows the characterization of protein:protein interactions within a cellular environment that 
provides the native protein environment with regard to posttranslational modifi cations and subcellular 
localization of the viral proteins. We have performed the mammalian two-hybrid analysis in COS-1 
cells, a cell line that permits CBV3 replication and thereby provides the appropriate host cell proteins 
that may be involved in regulating or modulating viral protein interactions. 
HOMOMULTIMERIZATION REACTIONS OF THE 2BC, 2B AND 2C PROTEINS
Homomultimerization reactions were observed with the 2BC protein and, albeit weakly, with 
the 2B protein, but not with the 2C protein. Western blot analysis demonstrated the effi cient expression 
of the 2C protein arguing that it is unlikely that the failure to detect a 2C:2C interaction was due to 
impaired protein synthesis or stability. The possibility that either the GAL4-2C or the VP16-2C fusion 
protein was misfolded or unable to be transported to the nucleus seems also unlikely because protein:
protein interactions were observed with both the GAL4-2C fusion protein (in combination with VP16-
2BC) and the VP16-2C fusion protein (in combination with GAL4-2BC). Taken together, these date 
strongly suggest that the 2C protein is unable to form homomultimers. Multimerization of the poliovirus 
2C protein was suggested by Tolskaya et al. [106] on the basis of complementation experiments. 
It should be stated, however, that trans-rescue of a genetic defect merely provides evidence for the 
requirement of a functional version of the protein rather than that it provides proof for the requirement 
of homomultimerization.  
Analysis of mutant proteins carrying deletions or well-defi ned point mutations in the 2B region 
revealed that both the 2BC:2BC and 2B:2B homomultimerization reactions were dependent on 
hydrophobic determinants located in both the cationic amphipathic α-helix (aa 37-54) and the second 
hydrophobic domain (aa 63-80) of protein 2B. Deletion of the amino-terminal 30 aa of the 2B protein, 
as well as mutations that interfered with the cationic or the amphipathic character of the predicted 
cationic amphipathic α-helix, which is well conserved among all enterovirus 2B proteins [84], did not 
interfere with the homomultimerization reactions of the 2BC and 2B proteins. The observations that 
(i) the 2BC and the 2B homomultimerization reactions are sensitive to the same mutations in the 2B 
region, and (ii) the 2BC:2BC interaction was completely inhibited by specifi c point mutations in the 
2B region, strongly suggest that the homomultimerization reactions of the 2BC proteins depend on an 
intermolecular 2B:2B interaction mediated by hydrophobic determinants located in the amphipathic 
α-helix and the second hydrophobic domain.  
Do these results correlate with the yeast two-hybrid results obtained by Cuconati et al. [99] 
These authors also observed homomultimerization reactions of the PV 2B and 2BC proteins, but not 
of the 2C protein. These authors, however, found that the 2BC:2BC interaction may be aided by, or 
is even dependent on, interaction of the 2C moieties and does not occur exclusively through 2B:2B 
or 2B:2C interactions. In this study, no evidence for an absolute dependence of the 2C protein was 
observed. As mentioned above, specifi c point mutations in the 2B region completely abolished the 
homomultimerization reaction of CBV3 protein 2BC. If there were a contribution of the 2C protein 
in the 2BC:2BC interaction, then a residual interaction should have been expected. Our observations, 
however, do not exclude the possibility that an effi cient 2BC homomultimerization reaction is dependent 
on both the 2B and 2C moieties, whereby specifi c determinants in the 2B moiety catalyze the initiation 
of the 2BC:2BC multimerization reaction, whereas the 2C moiety serves to stabilize this intermolecular 
interaction. This possibility is in agreement with our observation that the homomultimerization reaction 
of the 2BC protein was much stronger than the homomultimerization reaction of the 2B protein, even 
though the 2B protein was expressed at much higher amounts than the 2BC protein. However, it 
should be emphasized that care should be taken in drawing conclusions from the level of reporter gene 
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transcription, because this does not necessarily refl ect the strength of the protein:protein interaction. 
Factors like fusion protein folding and the effi ciency by which the interacting protein complex is 
transported to the nucleus (which may be different for the 2B and 2BC fusion proteins) may be of 
importance as well. Therefore, no conclusions can be drawn on the potential role of the 2C moiety in 
the 2BC homomultimerization reaction.  
HETEROMULTIMERIZATION REACTIONS OF THE 2BC, 2B AND 2C PROTEINS
In this study, heteromultimerization reactions were observed between the CBV3 2BC and 2B 
proteins, and between the 2BC and 2C proteins, but not between the 2B and 2C proteins. Analysis of 
the 2BC:2B interaction using 2BC point mutants showed that the heteromultimerization reaction was 
sensitive to the same mutations that disrupted the 2BC:2BC and 2B:2B homomultimerization reactions, 
indicating that the 2BC:2B interaction may be mediated by an interaction between the 2B moieties. 
However, analysis of the 2BC:2B heteromultimerization reaction using 2B point mutants identifi ed a 
mutation (HR2.6, I[64]S/V[66]S) that only partially inhibited the formation of 2BC:2B heteromultimers 
but completely prevented the formation of 2BC:2BC and 2B:2B homomultimers. This fi nding indicates 
that the 2BC:2B interaction may not simply refl ect a 2B:2B interaction. Possible explanations for this 
remarkable observation are addressed below.
The 2BC:2C interaction was sensitive to the same mutations that disrupted the 2BC:2BC and 
2B:2B homomultimerization reactions. A possible interpretation for this fi nding is that the same 2B 
determinants in the 2BC protein that govern the interaction with another 2B moiety also mediate 
interaction with the 2C protein. Although this possibility cannot be excluded, it seems unlikely given 
the absence of a 2B:2C interaction. Moreover, it is diffi cult to envisage how a certain protein domain 
mediates specifi c interactions with two different polypeptides which bear no homology in amino 
acid sequence. Alternative explanations should be considered. A possible explanation is that the 
folding of the 2BC protein gives rise to new protein interaction domains which are absent in the 2B 
and 2C polypeptides alone. Disruption of the 2BC protein structure, which may depend on specifi c 
hydrophobic determinants in the 2B moiety, may disrupt the formation or the exposure of the 2BC-
specifi c interaction domains and thereby disturb the interaction with the 2C protein. Another alternative 
explanation is that higher order protein complexes are formed. VP16-2BC fusion proteins may form 
homomultimers that provide a scaffold for the interaction with the GAL4-2C fusion protein, which may 
interact either with determinants located in the 2B moiety, the 2C moiety or 2BC-specifi c interaction 
determinants. Mutations in the 2B moiety that disturb the 2BC homomultimerization reaction may 
thereby interfere with the 2BC:2C heteromultimerization reaction.  
These alternative explanations may of course also be valid for the 2BC:2B heteromultimerization 
reaction. The 2B protein may interact with 2BC-specifi c domains, which may or may not depend on 
the formation of 2BC homomultimers. Disruption of either the 2BC protein structure or the ability to 
form homomultimers by mutations in the 2B moiety may thereby account for the disturbance of the 
interaction with the 2B protein. The possibility that the 2BC:2B heteromultimerization reaction is not 
simply provided by 2B:2B interaction is consistent with the differential results obtained with mutant 
HR2.6 (see above). 
Further experiments are required to dissect the molecular determinants that underlie the 
heteromultimerization reactions between the 2B, 2C and 2BC proteins. An important step herein are 
investigations to assay possible interactions between the 2B and 2C proteins. In the mammalian two-
hybrid system, we found no evidence for a 2B:2C interaction. In contrast, Cuconati et al. [99] observed 
a strong PV 2B:2C interaction in the yeast system. These authors, however, found no evidence for a 
2B:2C interaction in the GST pull-down assay. Further investigations are required to shed light on the 
reason for the discrepancies observed in the yeast system and the mammalian system. 
IMPLICATIONS FOR THE VIRAL LIFE CYCLE
Enteroviruses gradually modify the permeability of the ER membrane and the plasma membrane 
of the host cell . The 2B protein has been identifi ed as the membrane-active protein responsible for 
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these modifi cations, and both the amphipathic α-helix and the second hydrophobic domain have been 
recognized as major determinants for its membrane-active function [42; 46-48; 79]. The membrane 
alterations induced by protein 2B (or its precursor 2BC) are of major importance for creating the 
microenvironment required to replicate the vRNA, since mutations in the hydrophobic domains of 
the 2B protein cause early defects in vRNA replication [83; 84]. The molecular mechanism by which 
the 2B protein modifi es membrane permeability is at yet unknown. One possible mechanism that 
may explain the membrane-active function of the 2B protein is the formation of membrane-integral 
multimers of protein 2B (or 2BC), which may build aqueous pores by exposing the hydrophilic sides 
of the amphipathic α-helices towards each other. The fi nding that both the 2B protein and the 2BC 
protein formed homomultimers in the mammalian two-hybrid system lends support to this hypothesis. 
Each of the hydrophobic domains was found to be required for the 2B and 2BC homomultimerization 
reaction. This suggests that the formation of these membrane-integral pore structures may involve 
(sequence-specifi c) synergistic contacts between the two hydrophobic domains, rather than that they 
act as autonomous entities. This idea is consistent with previous observations that (i) mutations in 
each of the hydrophobic domains can interfere with the membrane-active function of the 2B protein 
[47], and (ii) neither the amphipathic α-helix nor the second hydrophobic domain of the CBV3 2B 
protein can be functionally exchanged with its PV counterpart [107]. All mutations that disturbed 
the homomultimerization reaction of the 2B protein (mutations I[64]S/V[66]S, A[71]E/I[73]E, and 
L[46]N/V[47]N/I[49]N/I[50]N)  abolish the membrane-active function of the 2B protein (de Jong et 
al., manuscript in preparation), providing evidence that there is a fi rm correlation between the ability 
of the 2B protein to form homomultimers and to permeabilize membranes. Consistent with our results, 
Cuconati et al. [99] also identifi ed hydrophobic determinants (PV aa I[53] and I[54]) as being important 
for the formation of PV 2B homomultimers.  
Further biochemical and genetic experimentation is required for a better understanding of the 
complex interplay of homomultimerization and heteromultimerization reactions that mediate regulation 
and execution of protein functions in the viral life cycle. 
EXPERIMENTAL PROCEDURES
CELLS
COS-1 cells were grown in Dulbecco’s modifi ed Eagle’s medium (Gibco) supplemented with 10% fetal bovine serum, 
100 units penicillin per ml, and 25 µg streptomycin per ml. Cells were grown at 37°C in a 5% CO2 incubator. 
PLASMIDS
The CheckmateTM Mammalian Two-Hybrid System (Promega) includes plasmids pACT, pBIND, and pG5luc. The 
pACT and pBIND plasmids contain the herpes simplex virus type 1 VP16 activation domain and the yeast GAL4 DNA binding 
domain, respectively, followed by a multiple cloning site (which in both plasmids is the same). In addition, the pBIND plasmid 
includes the Renilla luciferase gene driven by the SV40 early promoter and enhancer, which allows monitoring of the transfection 
effi ciency. The pG5luc plasmid is a reporter plasmid containing fi ve GAL4 binding sites upstream of a minimal TATA box that 
precedes the fi rely luciferase gene. 
The coding sequences of the CBV3 2BC, 2B, and 2C proteins (wild-type or mutant) were amplifi ed by PCR, using 
pCB3/T7 plasmids (van Kuppeveld et al., 1995, 1996) as template, and introduced in the expression plasmid pBIND as described 
below. The nucleotide sequence of the pBIND inserts was verifi ed by sequence analysis. The inserts were excised from the 
pBIND plasmids and directly cloned in the pACT plasmids (benefi ting from the fact that both plasmids contain the same multiple 
cloning site). 
The 2BC coding sequence was amplifi ed with primers that introduced a BamHI site (italics) at the upstream end (forward 
primer p115-14; 5’-gatgcaaggatccagggagtgaaggactatgtg-3’) and a stop codon (underlined) plus a SalI site at the downstream 
end (reverse primer p115-3; 5’-tttgatctctctgtatacgtcgacttactggaacagtgcctc-3’). The 2BC products were cloned into pBIND cut 
with BamHI and SalI. The 2B coding sequence was amplifi ed by PCR with forward primer p115-14 and a reverse primer that 
introduced a stop codon (underlined) plus a SmaI site at the downstream end (p115-7; 5’-aagccacccgggctattggcgttcagccatagg-3’). 
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The 2B products were cloned into pBIND cut with BamHI and EcoRV. The 2C coding sequence was amplifi ed by PCR with 
primers that introduced a BamHI site at the upstream end (forward primer p115-15: 5’-atggctgggatccaaaacaatagctggcttaag-3’) 
and reverse primer p115-3. The 2C product was cloned in pBIND cut with BamHI and SalI.
For the construction of pBIND-2BC∆HR1 and pBIND-2BC∆HR2, we made use of pCB3/T7-2B∆HR1 and pCB3/T7-
2B∆HR2 constructs, which contain in frame deletions of 2B aa 34-56 (HR1) or aa 64-80 (HR2), respectively  (van Kuppeveld 
et al., unpublished data). For the construction of pBIND-2BC∆30N and pBIND-2BC∆30N constructs, forward primer p115-22 
(5’-gtcaaccggatccaagaatcactagtgggtcaa-3’) was used.
TRANSFECTION
COS-1 cells were grown in 24 well tissue culture plates to 70% confl uency. Cells were tranfected with a total of 0.75 
µg plasmid DNA (1:1:1 mix of the pBIND:pACT:pG5luc plasmids) using the FuGENE 6 transfection reagent according to the 
instructions of the manufacturer (Roche). For each transfection, 3 µl of FuGENE 6 reagent was added to 100 µl of serum-free 
medium and incubated for 5 min at room temperature. This mix was added dropwise to the 0.75 µg plasmid DNA preparation 
described above and incubated at room temperature for 15 min. After this incubation, the FuGENE 6 reagent / DNA mixture was 
added drop wise to the cells. The cells were grown at 37ºC until further analysis. 
ANALYSIS OF LUCIFERASE ACTIVITIES
At 48 h posttransfection, cells were lysed and both the fi refl y luciferase and Renilla luciferase enzyme activities were 
measured from the same cell lysate sample using the Dual-LuciferaseTM Reporter Assay System, according to the instructions of 
the manufacturer  (Promega). Luciferase activities were measured in a Bio-Orbit 1251 luminometer. Measurement of the Renilla 
luciferase production revealed only small differences among different samples from the same experiment. Because these small 
differences merely refl ected variations in the luciferase measurement, we did not normalize for transfection effi ciency. 
WESTERN BLOT ANALYSIS
Cell lysates were prepared at 48 h posttransfection. Proteins were separated by SDS-PAGE, transferred to nitrocellulose 
membranes and immunodetected using a monoclonal antibody against the GAL4 DNA binding protein (Clontech). Proteins were 
visualized using a chemoluminescent detection system (Amersham Pharmacia Biotech).

Determinants for Membrane Association and Permeabilization of the Coxsackievirus 
2B Protein and the Identifi cation of the Golgi Complex as the Target Organelle
Arjan S. de Jong1, Els Wessels1, Henri B.P.M. Dijkman2, Jochem M.D. Galama1,
Willem J.G. Melchers1, Peter H.G.M. Willems3 and Frank J.M. van Kuppeveld1*
Departments of Medical Microbiology1 and Biochemistry3, Nijmegen Center for Molecular Life Sciences, 
University Medical Center Nijmegen, Department of Pathology2,
University Medical Center Nijmegen, The Netherlands
Journal of Biological Chemistry, 278(2): 1012-21 (2003)
CHAPTER 3
CHAPTER 334
3
DETERMINANTS FOR MEMBRANE ASSOCIATION AND PERMEABILIZATION OF THE COXSACKIEVIRUS 2B 
PROTEIN AND THE IDENTIFICATION OF THE GOLGI COMPLEX AS THE TARGET ORGANELLE
35
3
The 2B protein of enterovirus is responsible for the alterations in the permeability 
of secretory membranes and the plasma membrane in infected cells. The structural 
requirements for the membrane association and the subcellular localization of this 
essential virus protein, however, have not been defi ned. Here, we provide evidence that 
the 2B protein is an integral membrane protein in vivo that is predominantly localized at 
the Golgi complex upon individual expression. Addition of organelle-specifi c targeting 
signals to the 2B protein revealed that the Golgi localization is an absolute prerequisite 
for the ability of the protein to modify plasma membrane permeability.  Expression 
of deletion mutants and heterologous proteins containing specifi c domains of the 2B 
protein demonstrated that each of the two hydrophobic regions could mediate membrane 
binding individually. However, the presence of both hydrophobic regions was required 
for the correct membrane association, effi cient Golgi targeting, and the membrane-
permeabilizing activity of the 2B protein, suggesting that the two hydrophobic regions 
are cooperatively involved in the formation of a membrane-integral complex. The 
formation of membrane-integral pores by the 2B protein in the Golgi complex, and 
the possible mechanism by which a Golgi-localized virus protein modifi es plasma 
membrane permeability are discussed. 
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INTRODUCTION
Enteroviruses (e.g., poliovirus, coxsackievirus, ECHOvirus) belong to the family of 
Picornaviridae, a group of nonenveloped, cytolytic viruses that have a positive stranded RNA genome 
of 7.5 kb. The enterovirus genome contains one large open reading frame that is translated into a single, 
220-kDa polyprotein. Processing of the polyprotein by virus-encoded proteases yields the structural P1 
region proteins that encapsidate the viral RNA, and the non-structural P2 and P3 region proteins that are 
involved in replication of the viral RNA. Processing of the P2 and P3 regions yields the 2Apro, 2B, 2C, 
3A, 3B, 3Cpro and 3Dpol proteins and the more stable cleavage intermediates 2BC, 3AB and 3CDpro, 
which have functions distinct from their cleavage products. Although multiple functions have been 
attributed to the mature viral proteins and the cleavage intermediates, the exact function of most of the 
viral proteins in the replication cycle is still largely unknown. 
Host cell membranes are subject to a number of profound alterations upon enterovirus infection. 
Enteroviruses gradually modify host cell membrane permeability and rearrange intracellular membranes 
during infection. The modifi cation of the plasma membrane permeability is most likely important for 
the lysis of the cell and the release of virus progeny. Modifi cations of secretory pathway membranes 
are connected to viral functions such as genome replication. The modifi cation of host cell membrane 
permeability is such that initially calcium is released from intracellular stores [42]. Ionic gradients 
maintained by the plasma membrane are also disrupted [41]. Also, later in infection, small compounds 
like hygromycin B, a small non-permeative translation inhibitor, can effi ciently enter the cell. The 
2B protein has been identifi ed as the viral protein that is responsible for the alterations in host cell 
membrane permeability that take place in enterovirus-infected cells. Individual expression of the 2B 
protein was shown to be suffi cient for the release of calcium from intracellular stores and the increase 
in plasma membrane permeability to both calcium and hygromycin B [42; 46-49].
Another important membrane modifi cation that can be observed in enterovirus-infected cells is 
the massive proliferation and accumulation of membrane vesicles in the cytoplasm. These vesicles are 
derived from the secretory pathway [61] and were shown to be the site at which viral RNA replication 
takes place [54; 57]. Individual expression of the viral proteins has shown that the 2BC protein is 
responsible for the induction of the vesicle formation [55-57; 80], possibly together with the 3A protein 
[62]. The virus-induced inhibition of protein secretion is another important modifi cation, affecting 
traffi cking of host cell membranes. This inhibition may be advantageous for the virus by preventing 
anti-viral host cell responses like major histocompatibility complex expression and secretion of 
interferon and interleukines [63; 64]. Individual expression of the enterovirus non-structural proteins 
has shown that both the 2B protein and the 3A protein are endowed with the ability to inhibit protein 
secretion [46; 47]. The 3A protein was shown to inhibit ER-to-Golgi transport [66]. The step blocked 
by the 2B protein is still unknown. 
The mechanism by which the enterovirus 2B protein exerts its effects on membranes is as yet 
unknown. Moreover, it remains to be established whether the different activities of the 2B protein (i.e., 
membrane permeabilization, membrane rearrangement, and secretion inhibition) represent different 
functions or whether these activities are the result of a general membrane-disturbing activity of the 2B 
protein. Our aim is to gain more insight into the structure and function of the coxsackievirus 2B protein. 
The coxsackievirus 2B protein is a small protein of 99 amino acids that, in the infected cell, is present 
at the virus-induced, secretory pathway derived membrane vesicles at which the viral replication takes 
place [51]. The protein contains two hydrophobic regions (Fig. 1), of which one is predicted to form a 
cationic amphipathic α-helix with characteristics typical for the group of the so-called membrane-lytic 
peptides [84]. Mutations in the amphipathic α-helix or the second hydrophobic region were shown to 
have deleterious effects on viral RNA replication and virus growth, indicating that the integrity of these 
regions is essential for an early function in the viral life cycle [83; 84]. Mutations in these domains 
were also found to interfere with the ability of the 2B protein to increase membrane permeability and to 
inhibit protein secretion [47]. This strongly suggests that the membrane modifying activities of the 2B 
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Figure 1. The 2B protein contains two hydrophobic regions, HR1 and HR2. (A) Hydropathy plot of the 2B protein of CVB3, 
according to Kyte and Doolittle (98), using a window size of 9 residues. (B) Amino acid sequence of the two hydrophobic regions 
shown in the hydropathy plot. (C) Helical wheel diagram of the putative amphipathic α-helix formed by HR1. The hydrophobic 
residues (boxed) are positioned at one face of the α-helix, the charged and polar residues are positioned at the other face of the 
α-helix.
protein are in some way required for the accumulation of the membrane vesicles at which viral RNA 
replication takes place.  
At present, the determinants for the membrane interaction and the subcellular localization of the 
2B protein have not been defi ned. In this study, we have investigated the mode of membrane association 
in vivo and the subcellular localization of the 2B protein. Furthermore, by testing 2B deletion mutants, 
we have analyzed the importance of specifi c domains for the mode of membrane interaction, the 
subcellular localization, and the ability to increase membrane permeability. Moreover, the correlation 
between the subcellular localization and the membrane-active character of the 2B protein was 
determined.
RESULTS
CONSTRUCTION AND CHARACTERISATION OF N- AND C-TERMINAL FUSIONS OF EGFP TO THE 2B PROTEIN
Tagged 2B proteins were used because (i) an anti-2B antiserum might not recognize all 2B 
deletion mutants due to possible loss of epitopes, and (ii) the deletion mutants may become too small 
(<10 kDa) to be effi ciently detected. Fusion proteins of wild-type and mutant 2B to EGFP were used 
because they may be used in subcellular localization studies in living cells and the resulting 36 kDa 
fusion protein is effi ciently recognized and detectable by an anti-EGFP serum. 
The fusion of a fl uorescent protein at the N terminus or C terminus of a protein may affect 
its biological properties. Therefore, the possible effects of the EGFP fusion on the membrane-active 
character and the subcellular localization of the 2B protein were studied. The ability of 2B-EGFP and 
EGFP-2B to increase plasma membrane permeability of transfected cells was studied by analysing 
the entry of hygromycin B, a small inhibitor of translation that under physiological conditions poorly 
passes the plasma membrane. Cells were transfected in duplicate wells with the indicated constructs 
and pulse-labeled in the absence or presence of hygromycin B. The radiolabeled EGFP fusion proteins 
were immunoprecipitated and analyzed by SDS-PAGE to measure the entry of hygromycin B (Fig. 
2A). In EGFP expressing cells, the amount of protein synthesis was similar in the absence or presence 
of hygromycin B, indicating that the EGFP protein does not increase plasma membrane permeability 
to hygromycin B. Expression of the 2B-EGFP protein resulted in the increased entry of hygromycin B, 
as was refl ected by the almost complete inhibition of protein synthesis in the presence of hygromycin 
B. The increase in plasma membrane permeability induced by the 2B-EGFP protein was similar to that 
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Figure 2. Characterisation of fusion proteins of EGFP and the 2B protein. (A) Effect of the 2B fusion proteins on plasma 
membrane permeability. BGM cells were transfected with EGFP, 2B-EGFP or EGFP-2B, or co-transfected with EGFP and 
2B. At 48 h posttransfection, duplicate wells were pulse-labeled in the absence or the presence of 500 µg/ml of the translation 
inhibitor hygromycin B (HB), and then subjected to immunoprecipitation with anti-EGFP. Increased plasma membrane 
permeability to hygromycin B resulted in the reduction of protein synthesis in cells incubated in the presence of hygromycin B 
compared to cells incubated in the absence of hygromycin B. The 2B-EGFP protein increases plasma membrane permeability 
to similar levels as the untagged 2B protein. The ability of the EGFP-2B protein to increase plasma membrane permeability is 
severely impaired. (B) Subcellular localization of the 2B fusion proteins. Cells were transfected with the indicated constructs, 
fi xed at 24 h posttransfection and analyzed using CLSM. The 2B-EGFP protein is predominantly present in the juxtanuclear 
Golgi region, similar to the untagged anti-2B-stained 2B protein. Additional staining of an ER-like network is more apparent for 
the 2B-EGFP protein than for the untagged 2B protein. Subcellular localization of the EGFP-2B protein is different and closely 
resembles the ER. (bar = 10µm) 
A EGFP 2B-EGFP EGFP-2B
– + – + – +HB
2BEGFP-2B
– +
EGFP + 2B
2B-EGFPB
induced by the untagged 2B protein. The EGFP-2B protein showed a reduced ability to increase plasma 
membrane permeability compared to the untagged 2B protein. 
The subcellular localization of the 2B-EGFP and EGFP-2B fusion proteins was compared to that 
of the untagged 2B protein, which was stained with the anti-2B antiserum (Fig. 2B). The 2B-EGFP 
fusion protein was predominantly present in the juxtanuclear Golgi region, similar to the untagged 2B 
protein. In contrast, a small portion of the 2B-EGFP was observed in a reticular, ER-like pattern. The 
subcellular localization of the EGFP-2B protein differed substantially from that of the untagged 2B 
protein and showed resemblance to the ER. Based on these results, it was decided to use the 2B-EGFP 
protein in the subsequent experiments. 
IN VIVO MEMBRANE ASSOCIATION OF 2B-EGFP
The membrane association properties of the 2B protein were studied using an in vivo system, 
in which cytosolic and membrane fractions of EGFP or 2B-EGFP expressing cells were collected 
and analyzed on western blot. As expected, the cytosolic EGFP protein was found exclusively in the 
supernatant fraction (Fig. 3A). The 2B-EGFP fusion protein was found exclusively in the pellet fraction, 
indicating that the 2B protein is associated with membranes. The mode of membrane association was 
further investigated by extracting the membrane fractions with buffers that discriminate between 
peripheral membrane proteins (which are attached to membranes by ionic interactions with membrane 
integral proteins or phospholipid head groups) and integral membrane proteins (which are embedded 
in the phospholipid bilayer). Figure 3B shows the supernatant and pellet fractions of the membrane 
fractions following extraction with the indicated buffers. The 2B-EGFP protein remained attached to 
membranes upon extraction with PBS (control) and buffers that extract peripheral membrane proteins 
either by increasing the ionic strength of the buffer (1M NaCl), creating mild chaotropic salt conditions 
(4 M urea), or chelating divalent cations (0.5 M EDTA). Moreover, the protein was still detected in the 
pellet fraction when membranes were extracted using alkaline conditions (0.1 M Na2CO3 pH 11.5), 
one of the most potent methods to discriminate between peripheral and membrane-integral proteins 
[110]. In addition, alkaline conditions convert membranes to sheets (but do not solubilize membranes) 
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Figure 3. Membrane association of 
the wild-type and mutant 2B-EGFP 
proteins. Cells were transfected with 
the indicated constructs. At 40 h 
posttransfection, cells were harvested 
and broken in a Dounce homogenizer. 
Cytosolic (supernatant, S) and membrane 
(pellet, P) fractions were prepared and 
analyzed by western blot using the 
anti-EGFP polyclonal antiserum. (A) 
Analysis of cytosolic and membrane 
fractions of cells expressing either 
EGFP or 2B-EGFP. The EGFP protein is 
present in the cytosolic fraction, the 2B-
EGFP protein in the membrane fraction. 
(B) Mode of membrane association of the 
2B-EGFP protein. Membrane fractions 
were extracted with the indicated 
buffers. The 2B-EGFP protein is only 
released using Triton X-100 (TX-100). 
(C) Schematic representation and 
membrane association characteristics 
of the 2B-EGFP protein and 2B-EGFP 
deletion mutants. Lines indicate the 
deleted regions of the protein. All 
proteins, except 2B(∆59C)-EGFP, are 
present in the membrane fractions. 
(D) Mode of membrane association 
of 2B-EGFP deletion mutants. The 
2B(∆HR1)-EGFP and 2B(∆HR2)-EGFP 
proteins behave differently from the wild-
type 2B-EGFP protein and are partially 
present in the supernant fractions upon 
Na2CO3 extractions. All proteins, except 
the 2B(∆HR1)-EGFP protein, are 
predominantly present in the supernatant 
fraction upon TX-100 extraction. For 
each panel, one of three representative 
experiments is shown.
and release soluble proteins that are trapped inside membranous vesicles. The resistance of 2B-EGFP 
to alkaline extraction therefore argues against a peripheral association of the 2B-EGFP protein at the 
lumenal side of endo-membranes. The 2B-EGFP protein was found in the supernatant fraction only 
upon solubilization of membranes using 1% Triton X-100, a non-ionic detergent that releases integral 
membrane proteins. Taken together, these fi ndings provide evidence that the 2B protein is embedded in 
the phospholipid bilayer, rather than that it is peripherally associated with membranes.
IN VIVO MEMBRANE ASSOCIATION OF 2B-EGFP DELETION MUTANTS
Deletion mutants of the 2B protein were designed to identify the regions that are important for its 
mode of membrane association. Wild-type 2B (99 aa) and deletion mutants of 2B are depicted in Figure 
3C. Protein 2B(∆59C) contains only the N-terminal 40 amino acids of 2B, protein 2B(∆14C) lacks the 
C-terminal 14 amino acid residues and protein 2B(∆20N) has a deletion of the N-terminal 20 amino 
acids. In addition, deletion mutants were generated that lacked either the amphipathic α-helix (aa 34-
56), which will further be referred to as the fi rst hydrophobic region HR1, or the second hydrophobic 
region (aa 64-80), which will further be referred to as HR2. 
Cytosolic and membrane fractions of cells transfected with 2B-EGFP deletion mutants were 
prepared and analyzed as described above for the wild-type 2B-EGFP protein. Figure 3C shows that 
protein 2B(∆59C)-EGFP is predominantly present in the cytosolic fraction, indicating that the N-
terminal 40 amino acids of the 2B protein are not suffi cient to mediate membrane association. The 
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2B(∆14C)-EGFP and 2B(∆20N)-EGFP proteins were found predominantly in the pellet fraction, 
demonstrating that the N and the C terminus of the protein do not contribute to the membrane 
association of the 2B protein. Also, remarkably, the 2B(∆HR1)-EGFP and 2B(∆HR2)-EGFP proteins 
were found predominantly in the membrane fraction, indicating that the presence of either one of the 
hydrophobic regions of the 2B protein was suffi cient to mediate membrane binding. 
The membrane associated 2B-EGFP deletion mutants were further investigated to determine their 
mode of membrane association. Membrane fractions were extracted using PBS, 0.1 M Na2CO3, pH 
11.5, and 1% Triton X-100 (Fig. 3D). The 2B(∆14C)-EGFP and 2B(∆20N)-EGFP proteins behaved like 
the wild-type 2B protein and were found predominantly in the membrane fraction after the extraction 
with 0.1 M Na2CO3, suggesting that the N and C terminus of the 2B protein have little infl uence 
on its mode of membrane association. Both protein 2B(∆HR1)-EGFP and protein 2B(∆HR2)-EGFP 
behaved differently upon Na2CO3 extraction. Substantial amounts of these proteins were found in the 
supernatant fraction upon Na2CO3 extraction, whereas both proteins were almost exclusively detected 
in the pellet fraction upon PBS extraction. These results indicate that both hydrophobic regions are 
required for the correct membrane association of the 2B protein. When the membranes were solubilized 
using 1% Triton X-100, the wild-type 2B-EGFP protein as well as 2B(∆14C)-EGFP, 2B(∆20N)-EGFP 
and 2B(∆HR2)-EGFP were predominantly present in the supernatant fraction. In contrast, the majority 
of the 2B(∆HR1)-EGFP protein remained present in the pellet fraction upon Triton X-100 extraction, 
indicating that 2B(∆HR1)-EGFP was pelleted in a membrane-independent manner upon solubilization 
of membranes. This result suggests that the 2B(∆HR1)-EGFP protein is prone to form aggregates in the 
absence of membranes (due to the Triton X-100 extraction). It cannot be excluded that the 2B(∆HR1)-
EGFP protein also (partially) formed aggregates in the Na2CO3 extraction experiment. It is therefore 
diffi cult to draw conclusions regarding the membrane association properties of 2B(∆HR1), other than 
that it behaves differently from the wild-type 2B protein, suggesting that this region is an important 
determinant for the membrane association properties of the 2B protein. In the subcellular localization 
experiments documented below, however, evidence will be provided that the 2B(∆HR1)-EGFP protein 
is present as a membrane associated protein in vivo. The results of the in vivo membrane association 
experiments are summarized in Table 1.
SUBCELLULAR LOCALIZATION OF PROTEIN 2B DELETION MUTANTS
The importance of specifi c domains of the 2B protein for its subcellular localization was 
investigated in living cells expressing 2B-EGFP deletion mutants (Fig. 4). The wild-type 2B-EGFP 
protein was predominantly present in the juxtanuclear Golgi region and was additionally found in an 
ER-like reticular pattern, similar to what was observed in fi xed cells (Fig. 2B). The 2B(∆59C)-EGFP 
was present throughout the cell, staining both the cytoplasm and the nucleus, consistent with the 
observation that the protein is not membrane-associated (Fig. 3C). Localization of the 2B(∆14C)-EGFP 
2B-EGFP
2B( HR1)-EGFP 2B( HR2)-EGFP
2B( 59C)-EGFPFigure 4. Subcellular localization of the wild-type and mutant 2B-EGFP 
proteins in living cells. Cells were transfected with the indicated constructs. 
At 24 h posttransfection, living cells were analyzed by CLSM. Wild-type 
2B-EGFP is predominantly present in the juxtanuclear Golgi region and 
additionally in a reticular, ER-like pattern. 2B(∆59C)-EGFP is present in 
the cytoplasm and the nucleus, 2B(∆HR1)-EGFP in a reticular pattern, and 
2B(∆HR2)-EGFP in the Golgi region and in a reticular pattern. (bar = 10 
µm)
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and 2B(∆20N)-EGFP proteins was essentially the same as that of the wild-type 2B-EGFP protein 
(data not shown). The 2B(∆HR1)-EGFP and 2B(∆HR2)-EGFP proteins showed an altered localization 
compared to the wild-type 2B-EGFP protein. The 2B(∆HR1)-EGFP protein was present in an ER-like 
network and staining of the juxtanuclear Golgi region was virtually absent. The 2B(∆HR2)-EGFP 
protein was observed in the juxtanuclear Golgi region, however, staining of the ER-like network was 
more apparent than for wild-type 2B-EGFP.
A more detailed examination of the subcellular localization was undertaken in fi xed cells 
by investigating colocalization of the 2B protein with markers for the Golgi and the ER. In these 
experiments, the 2B deletion mutants were analyzed as myc-tagged proteins. This procedure was 
followed because the subcellular localization of the myc-tagged 2B protein better resembled that 
of the untagged 2B protein (compare Figs. 2B and 5A). Colocalization experiments with the Golgi 
complex were performed using the EGFP-Golgi fusion protein, in which EGFP is targeted to the 
trans-medial region of the Golgi complex by fusion to the N-terminal 81 amino acids of human 
β-1,4-galactosyltransferase. Colocalization experiments with the ER were performed using the anti-
calreticulin antiserum. The 2B-myc, 2B(∆14C)-myc and 2B(∆20N)-myc proteins colocalized with 
the EGFP-Golgi marker and were virtually absent outside of the Golgi region (Figs. 5A, 5B and 5C, 
respectively), indicating that the N and the C terminus of the 2B protein have little or no infl uence on 
its subcellular localization. Interestingly, 2B(∆HR1)-myc staining was completely different from the 
wild-type 2B-myc protein. The 2B(∆HR1)-myc protein did not colocalize with EGFP-Golgi (Fig. 5D), 
but was exclusively present in a network-like pattern that was identical to the anti-calreticulin stained 
ER (Fig. 5F). Also the 2B(∆HR2)-myc staining differed from that of the wild-type 2B-myc protein. 
The 2B(∆HR2)-myc protein was present in the Golgi complex (Fig. 5E), but also a substantial part was 
observed in a network-like pattern that was identifi ed as the ER (Fig. 5G). 
A
B
C
2B-myc EGFP-Golgi merged
EGFP-Golgi merged2B( 14C)-myc
EGFP-Golgi merged2B( 20N)-myc
D 2B( HR1)-myc EGFP-Golgi merged
2B( HR2)-myc EGFP-Golgi mergedE
F
G
2B( HR1)-myc calreticulin merged
merged2B( HR2)-myc calreticulin
Figure 5. Subcellular localization of the wild-type and mutant 2B-EGFP proteins.  (A-E) Cells were cotransfected with 
EGFP-Golgi and the indicated 2B-myc constructs, fi xed at 24 h posttransfection and stained with the anti-C-myc antiserum. (F-
G) Cells were transfected with the indicated 2B-myc constructs, fi xed at 24 h posttransfection and stained with the anti-C-myc 
and the anti-calreticulin (ER-marker) antisera. Cells were analyzed by CLSM. The wild-type 2B-myc protein (A), the 2B(∆14C)-
myc protein (B), and the 2B(∆20N)-myc protein (C) show clear colocalization with EGFP-Golgi. The 2B(∆HR1)-myc protein 
does not colocalize with the Golgi marker (D), but is present in the ER (F). The 2B(∆HR2)-myc protein partially colocalizes with 
the Golgi marker (E) and with the ER marker (G). (bar = 10µm) For full color fi gure, see page 153.
CHAPTER 340
3
DETERMINANTS FOR MEMBRANE ASSOCIATION AND PERMEABILIZATION OF THE COXSACKIEVIRUS 2B 
PROTEIN AND THE IDENTIFICATION OF THE GOLGI COMPLEX AS THE TARGET ORGANELLE
41
3
A
B
C
p58 HR1-EGFP merged
mergedHR2-EGFPp58
merged(HR1+HR2)-EGFPp58
Figure 6. Subcellular localization of the HR1-EGFP, 
HR2-EGFP and (HR1+HR2)-EGFP proteins. Cells 
were transfected with the indicated constructs, fi xed at 
24 h posttransfection, stained using the anti-Golgi 58K 
antiserum and analyzed using CLSM. (A) HR1-EGFP is 
partially present in the Golgi complex. (B) HR2-EGFP 
is absent from the Golgi comlpex, and stains a reticular, 
ER-like pattern. (C) (HR1+HR2)-EGFP is predominantly 
present in the Golgi complex. (bar = 10 µm) For full color 
fi gure, see page 153.
To further investigate the role of HR1 and HR2 in the Golgi localization, the ability of these 
domains to provide Golgi localization in the absence of other determinants of the 2B protein was 
analyzed. Initially, myc-tagged HR1 and HR2 constructs were generated. However, it was found that 
HR1-myc and HR2-myc proteins were too small to be preserved during fi xation (data not shown). 
Therefore, heterologous proteins were constructed in which regions of the 2B protein encompassing 
either HR1 or HR2, or both HR1 and HR2, were fused to the N terminus of the EGFP protein. The 
Golgi complex was stained using the anti-Golgi 58K marker. Colocalization studies of these proteins 
with this endogenously expressed Golgi marker showed that the presence of HR1 could indeed partially 
target the EGFP protein to the juxtanuclear Golgi region (Fig. 6A), indicating that HR1 acts as a 
Golgi targeting signal in the absence of other domains of the 2B protein. The HR2-EGFP protein was 
present in a reticular network that showed close resemblance to the ER (Fig. 6B). Its absence from 
the Golgi complex suggests that HR2 does not contain any Golgi targeting signals. In contrast to the 
HR1-EGFP protein, which was partially localized in the ER, the (HR1+HR2)-EGFP fusion protein was 
predominantly present in the Golgi complex (Fig. 6C), giving support for an additional role of HR2 
in Golgi localization. Taken together, these fi ndings indicate that, although the amphipathic α-helix is 
the Golgi targeting signal, the second hydrophobic region is an important additional determinant for 
the Golgi localization of both the 2B protein and the heterologous EGFP protein. The results of the 
subcellular localization experiments are summarized in Table 1.
MEMBRANE-PERMEABILIZING ACTIVITY OF 2B-EGFP DELETION MUTANTS
In the experiments described above, we have shown that the 2B protein is an integral membrane 
protein that is predominantly localized at the Golgi complex and that these properties are largely 
dependent on the presence of both hydrophobic regions of the protein. To investigate the importance 
of different regions of the 2B protein for its membrane-active character, we also tested the 2B-EGFP 
deletion mutants for their ability to increase membrane permeability to hygromycin B. 
First, a time-course experiment was performed to defi ne the time point at which plasma membrane 
permeability induced by the 2B-EGFP protein was maximal (Fig. 7A). From 24 h posttransfection to 
40 h posttransfection, an increased infl ux of hygromycin B was observed, resulting in almost complete 
inhibition of protein synthesis in its presence at 40 h posttransfection. When cells were analyzed at 48 h 
posttransfection no further increase in plasma membrane permeability to hygromycin B was observed. 
Therefore, all subsequent experiments were performed at 40 h posttransfection.
Figure 7B shows the results of the hygromycin B assay for the 2B-EGFP deletion mutants. All 
mutants were tested in three independent assays, the amount of protein synthesized was determined 
by phosphor-imaging and the ratio of protein synthesis in the presence and absence of hygromycin B 
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Figure 7. Modifi cation of plasma membrane permeability by the wild-type and mutant 2B-EGFP proteins. (A) Time course 
experiment of plasma membrane permeability to hygromycin B in 2B-EGFP expressing cells. The experimental setup is described 
in the legend of Figure 1. The 2B-induced entry of hygromycin B was maximal at 40 h posttransfection. (B) Analysis of plasma 
membrane permeability in cells expressing 2B-EGFP and deletion mutants of 2B-EGFP at 40 h posttransfection. The amount of 
anti-EGFP precipitated fusion protein was quantifi ed by means of phosphor-imaging. Plasma membrane permeability is depicted 
as the ratio of the amount of radiolabeled protein synthesized in the presence and absence of hygromycin B. Values represent 
means ± standard errors of measurements of three independent experiments. Deletion of the N-terminal 20 aa reduced the plasma 
membrane permeabilizing activity of protein 2B. Deletion of either HR1 or HR2, or HR1 and HR2 completely abolished the 2B-
induced increase in plasma membrane permeability.
was calculated. Cells expressing wild-type protein 2B-EGFP showed an increased entry of hygromycin 
B, refl ected by the reduction in protein synthesis to 10% of protein synthesis in cells expressing the 
wild-type 2B-EGFP protein in the absence of hygromycin B. Cells expressing protein 2B(∆59C)-EGFP 
showed no infl ux of hygromycin B, indicating that the N-terminal 40 amino acids of the 2B protein are 
not suffi cient to increase plasma membrane permeability. Hygromycin B entry in cells expressing the 
2B(∆14C)-EGFP protein was approximately equal to that of cells expressing the wild-type 2B protein. In 
cells expressing 2B(∆20N)-EGFP, protein synthesis in the presence of hygromycin B was approximately 
45% of that in the absence of hygromycin B, refl ecting that plasma membrane permeability was 
reduced compared to that of cells expressing the wild-type 2B-EGFP protein. Cells expressing either 
the 2B(∆HR1)-EGFP or 2B(∆HR2)-EGFP fusion protein showed no entry of hygromycin B, indicating 
that the ability of these proteins to increase plasma membrane permeability was completely disrupted. 
Thus, the combined presence of both hydrophobic regions is not only required for the membrane-
integral character of the 2B protein, but also for its membrane-active function, suggesting that the 
membrane integral topology is essential for its ability to modify membrane permeability. The results of 
the membrane-permeabilization experiments are summarized in Table 1.
FUNCTIONAL CHARACTERIZATION OF ORGANELLE-TARGETED 2B PROTEINS
The 2B protein is predominantly present in the Golgi complex of transfected cells. We investigated 
the importance of the Golgi localization for the ability to increase plasma membrane permeability. For 
this purpose, the 2B-EGFP protein was targeted exclusively to the ER or to the Golgi complex by fusion 
of specifi c targeting signals. It was shown previously that membrane proteins acquired ER localization 
by the addition of a tag sequence containing the KKAA dilysine motif (AAAAAAKKAA), which acts 
as an ER retention signal in mammalian cells [111]. The fusion of the KKAA motif to the 2B-EGFP 
protein indeed abolished the Golgi localization and resulted in a typical ER localization pattern (Fig. 
8A). The presence of a control tag of 10 alanine residues, containing no additional localization signals, 
did not affect the subcellular localization of the 2B-EGFP protein (Fig. 8A). To confer complete Golgi 
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Figure 8. Functional characterization of organelle-targeted 2B-EGFP proteins. The 2B-EGFP-KKAA construct encodes the 
wild-type 2B-EGFP protein carrying the AAAAAAKKAA sequence (containing the KKAA ER retention signal) at its C terminus. 
The control 2B-EGFP-AAAA construct contains the AAAAAAAAAA sequence (lacking targeting information) at its C terminus. 
The 2B-Golgi-EGFP construct contains the N-terminal 103 aa of NGAT-I between the 2B and EGFP coding sequences. (A) 
Subcellular localization of the targeted 2B-EGFP proteins. Cells were transfected with the indicated constructs, fi xed at 24 
h posttransfection, and analyzed by CLSM. The 2B-EGFP protein is predominantly present in the juxtanuclear Golgi region 
and additionally in a reticular pattern. The 2B-EGFP-KKAA protein is exclusively present in the ER, while the subcellular 
localization of 2B-EGFP and 2B-EGFP-AAAA are identical. The 2B-Golgi-EGFP is exclusively present in the Golgi complex. (B) 
Analysis of plasma membrane permeability to hygromycin B of cells expressing the targeted 2B-EGFP proteins. The experimental 
setup is described in the legend of Figure 1. Values represent means ± standard errors of measurements of three independent 
experiments. The 2B-EGFP-AAAA and 2B-Golgi-EGFP proteins increased plasma membrane permeability to a level that is 
similar to that of the untagged 2B-EGFP protein. The 2B-EGFP-KKAA protein is severely impaired in its ability to increase 
plasma membrane permeability. 
localization to the 2B-EGFP protein, a construct was generated in which the 2B protein was fused at 
the N terminus of the NGAT-I-GFP construct (which contains the targeting information of the β-1,2 
N-acetylglucosaminyl-transferase I, a type I med-trans Golgi membrane protein) [112]. The resulting 
2B-Golgi-EGFP protein was exclusively present in the Golgi complex (Fig. 8A). 
To analyze the importance of the subcellular localization of the 2B protein for its membrane-
active function, the entry of hygromycin B was analyzed in cells expressing the targeted 2B proteins. 
Figure 8B shows that the ER-targeted 2B-EGFP-KKAA protein was severely impaired in its ability 
to increase plasma membrane permeability to hygromycin B. The 2B-EGFP-AAAA protein behaved 
like the untagged protein, indicating that the decrease in hygromycin B entry was not the result of the 
fusion of a tag to the C terminus of 2B-EGFP. Rather, the altered subcellular localization of the protein 
was responsible for this result, suggesting that the Golgi localization of the 2B protein is important for 
its effect on plasma membrane permeability. This fi nding was further substantiated by the observation 
that the 2B-Golgi-EGFP protein increases plasma membrane permeability to hygromycin B to the same 
extend as the untagged 2B-EGFP protein. These data indicate that the Golgi localization is a critical 
determinant for the ability of the 2B protein to modify permeability of the plasma membrane.
DISCUSSION
The enterovirus 2B protein is responsible for the alterations in the permeability of secretory 
membranes and the plasma membrane that are observed in infected cells [42; 46; 47; 49]. The molecular 
mechanism by which the 2B protein disturbs host cell membranes is largely unknown. In this study, we 
have investigated the structural and functional requirements for the in vivo membrane association and 
the membrane-active function of this important virus protein. 
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The membrane association of the 2B protein was resistant against extraction with buffers that 
release peripherally associated membrane proteins, indicating that one or more domains of the protein 
are embedded in the phospholipid bilayer rather than that the protein associates with membranes 
through electrostatic interactions with membrane proteins or polar lipid head groups. Expression of 
deletion mutants and heterologous proteins showed that each of the hydrophobic regions HR1 and 
HR2 alone could mediate membrane binding. However, in contrast to the wild-type 2B protein, a 
substantial amount of the 2B proteins lacking either HR1 or HR2 was released upon Na2CO3 extraction, 
indicating that both hydrophobic regions are required for the correct membrane association. Moreover, 
the presence of both HR1 and HR2 was absolutely required for the membrane-active function of the 
2B protein, consistent with previous reports [47; 79]. Together, these fi ndings suggest that the two 
hydrophobic regions are cooperatively involved in the formation of a membrane-integral complex, 
and that the formation of this complex is required for the membrane association and membrane-active 
function of the 2B protein.  
These fi ndings provide important new insights into the molecular architecture of the 2B protein 
in the membrane. The fi rst hydrophobic region of the 2B protein has been predicted to form a cationic 
amphipathic α-helix that shows similarities with the group of lytic polypeptides [84]. Amphipathic 
α-helical lytic polypeptides may form multimers that build membrane-integral pores by exposing 
their hydrophobic sides to the lipid bilayer, while their hydrophilic faces form an aqueous interior 
[85-87]. The 2B protein has been shown to form homomultimers by yeast two-hybrid analysis [99], 
mammalian two-hybrid analysis [109], and in living mammalian cells using FRET microscopy [113]. 
The behavior of the 2B protein as an integral membrane protein and the observation that each of the 
hydrophobic regions HR1 and HR2 can independently mediate membrane binding lend support to the 
idea that multimers of protein 2B build membrane-integral pores and that each of these hydrophobic 
regions is involved in the formation of these pore complexes. Figure 9 shows a model of a multimeric 
pore complex formed by 2B proteins. According to this model, HR1 and HR2 interact with each other 
to form a ‘helix-loop-helix’ hairpin motif that traverses the lipid bilayer. The hydrophobic regions are 
separated by a hydrophilic loop sequence (RNHDD in the CVB3 2B protein). Presumably both the 
N- and C terminus of the 2B protein reside at the cytosolic side of the membrane. This suggestion is 
supported by the observation that a cytosolic ER retention signal (KKAA) [111; 114] at the C terminus 
of the 2B protein is functional in conferring ER retention to the 2B protein. Furthermore, the lack of 
glycosylation at NX(S/T) glycosylation signals introduced at different positions in the region upstream 
HR1 argues that the N terminus is localized at the cytosolic side of the membrane (unpublished results). 
Finally, localization of the N and C terminus at the cytosolic side of the membrane is consistent with the 
Table 1. Membrane-binding and membrane-active properties of the wild type and mutant 2B proteins.
(a) The resistance to Na2CO3 extraction is scored ++++ when 80-100% of the protein was present in the pellet fraction upon 
extraction, +++ when 60-80% was present in the pellet fraction, ++ when 40-60% was present in the pellet fraction, + when 
20-40% was present in the pellet fraction, and – when less than 20% was present in the pellet fraction.
(b) The membrane-active character is scored ++++ when protein synthesis in the presence of hygromycin B was reduced by 80-
100% compared to protein synthesis in the absence of hygromycin B, +++ when protein synthesis was reduced by 60-80%, ++ 
when protein synthesis was reduced by 40-60%, + when protein synthesis was reduced by 20-40%, and – when protein synthesis 
was reduced by less than 20%, n.t. = not tested
membrane
association 2CO3Na
resistance to
extractiona
subcellular
localization
membrane-active
character b
2B(wt) + ++++ Golgi ++++
2B(59C) – n.t. cytosol + nucleus –
2B(15C) + ++++ Golgi +++
2B(20N) + ++++ Golgi ++
2B(HR1) + ++ ER –
2B(HR2) + +++ Golgi + ER –
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Figure 9. Pore forming model for the membrane-active 2B 
protein. A multimeric complex of four 2B monomers is shown in a 
helix-loop-helix conformation. Of each monomer, the hydrophobic 
regions span the lipid bilayer and are spaced by a short loop 
sequence. The N and C terminus of the 2B monomers are facing the 
same side of the membrane. The hydrophilic faces of the amphipatic 
α-helix of the monomers are facing each other, thereby creating an 
aqueous interior or pore. This structural model is consistent with 
the ability of the 2B protein to modify membrane permeability and 
the observation that both hydrophobic regions are involved in the 
function and the topological architecture of the 2B protein. 
need of proteolytic liberation of the 2B protein from the viral polyprotein by the viral protein 3Cpro, a 
cytosolic protease. Both the membrane association and the membrane-active function were independent 
of the C-terminal 15 amino acids. Although dispensable for the membrane association, the N-terminal 
20 amino acids were found to be of importance for the membrane-active function of the 2B protein, 
indicating that the molecular structure and function of the 2B protein depends on more than just the 
presence of HR1 and HR2, and therefore requires further investigation.   
Upon expression in the absence of other viral proteins, the CVB3 2B protein was localising in 
the Golgi complex, consistent with the Golgi localization described for the 2B protein of the closely 
related PV [103]. Retention of the 2B protein in the ER by fusion of an ER retention signal severely 
inhibited the ability to increase plasma membrane permeability. This activity, however, was unaffected 
when the 2B protein was exclusively targeted to the Golgi complex by fusion of a Golgi targeting 
signal. This strongly suggests that the Golgi complex is the target organelle of the 2B protein to exert 
its effect on the plasma membrane. It is remarkable that a virus protein that is localized at the Golgi 
complex can modify plasma membrane permeability. The mechanism underlying this activity is as yet 
unknown. We predict that this activity is somehow linked to the ability of the 2B protein to increase 
Golgi membrane permeability. Previously, we have shown that expression of the 2B protein resulted 
in a decrease in the amount of calcium that could be released from thapsigargin-sensitive stores [42]. 
Because at that time only the ER was recognized as a thapsigargin-sensitive store [115], we concluded 
that the 2B protein modifi ed ER membrane permeability. Recently, however, also the Golgi complex 
was identifi ed as a thapsigargin-sensitive intracellular calcium store [116]. This fi nding, together with 
the identifi cation of the Golgi complex as the main target organelle of the 2B protein, suggests that 
the 2B protein causes an increased Golgi membrane permeability and a general disruption of the ionic 
gradients maintained by the Golgi membrane. Alterations in ionic gradients maintained by membranes 
of the Golgi complex have been demonstrated to result in functional disturbances of the Golgi complex. 
Disruption of cationic gradients by monensin, a H+/Na+ ionophore that mediates cation diffusion over 
Golgi membranes, results in the inhibition of complex glycosylation in the Golgi complex (refl ected 
by the inability of secretory proteins to acquire resistance to endo-ß-N-acetylglucosaminidase H 
treatment) and inhibition of protein secretion [117]. Analogous to the effects of monensin, expression 
of the 2B protein also results in the inhibition of complex glycosylation (as demonstrated by the endo-
ß-N-acetylglucosaminidase H sensitivity of glycoproteins in 2B-expressing cells) and inhibition of 
protein secretion [46]. We propose that the disruption of the ionic content of the Golgi complex by 2B 
is responsible for this effect. How the disturbance of the Golgi milieu leads to an increase in plasma 
membrane permeability remains to be established. Possibly, the 2B-induced defect in transport of 
membrane proteins or lipids beyond the Golgi complex result in destabilization and permeabilization of 
the plasma membrane. However, it cannot be excluded that the effect on the plasma membrane is caused 
by the disturbance of another Golgi function(s). 
Having identifi ed the Golgi complex as the main target organelle of the 2B protein, the question 
arises what determines the Golgi localization of the 2B protein. In this study, the amphipathic α-helix 
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was identifi ed as a Golgi targeting signal that could confer partial Golgi localization to the heterologous 
EGFP protein in the absence of other domains of the 2B protein. However, the presence of both the 
amphipathic α-helix and the second hydrophobic domain was found to be required for effi cient Golgi 
targeting. The Golgi localization of the 2B protein might depend on the length of the transmembrane 
domain(s), as suggested by the ‘bilayer-thickness model’ [35-40]. HR1 and HR2 are predicted to 
consist of 20 aa and 18 aa respectively, which is similar to the transmembrane domain of some Golgi 
resident proteins, but shorter than the transmembrane domain of plasma membrane proteins [118-
120]. Alternatively, the ‘kin-recognition’ model suggests that Golgi residents form large, oligomeric 
complexes that become too large to be transported as they reach the correct Golgi compartment [121; 
122]. It is unlikely that homomultimerization reactions of the 2B protein [99; 109; 113] are involved 
in determining its Golgi localization, as 2B deletion mutants that lacked either HR1 or HR2 were not 
transported beyond the Golgi complex, although they were unable to form homomultimers [109]. 
Another possible explanation is that the 2B protein is not transported further along the secretory pathway 
because of the lack of specifi c signals, as was suggested for some trans-Golgi network markers [118]. 
The possibility that traffi cking of the 2B protein out of the Golgi complex is blocked as a consequence 
of the inhibition of protein secretion that is induced by the 2B protein itself [46; 47] is unlikely, as 2B 
deletion mutants lacking either HR1 or HR2 are not transported beyond the Golgi complex, although 
their function was severely impaired.  
How do our fi ndings relate to the situation in virus-infected cells, where the 2B protein is present 
at the virus-induced membrane vesicles that build the viral RNA replication complex? Initially, these 
membrane vesicles are derived from the ER [57]. Later in infection, however, the Golgi complex 
has disappeared [50; 55; 103] and Golgi membranes contribute to the vesicle population [50; 61], 
suggesting that the Golgi complex is gradually used up to produce the membrane vesicles that build the 
viral replication complex. Therefore, our fi ndings that identifi ed Golgi membranes as the main target of 
the 2B protein are in agreement with the localization of the 2B and 2BC proteins at the ER- and Golgi-
derived membrane vesicles in infected cells. 
The exact function of the 2B protein in the early steps in viral RNA replication remains to be 
established. The viability of viruses that carry mutations in the 2B protein closely correlates with the 
ability of the 2B protein to increase membrane permeability and inhibit protein secretion [47; 83; 84], 
suggesting that the destabilization and/or permeabilization of secretory pathway membranes by the 
2B protein is somehow required for the accumulation of membrane vesicles or the formation of the 
membranous replication complex. Additional studies are needed to gain better insight in the membrane-
active functions of the 2B and 2BC proteins, and how these functions might aid in the processes that are 
required to facilitate the formation of membrane-associated replication complexes.
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EXPERIMENTAL PROCEDURES
CELLS AND MEDIA
Buffalo green monkey (BGM) cells were grown in minimal essential medium (MEM) (Invitrogen), supplemented with 
10% fetal bovine serum (FBS), 100 units penicillin per ml and 100 mg streptomycin per ml. Cells were grown at 37°C in a 5% 
CO2 incubator. 
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ANTIBODIES AND CONJUGATES
Rabbit polyclonal anti-EGFP antiserum was a kind gift from Dr. J. Fransen, Department of Cell Biology and Histology, 
UMC Nijmegen, The Netherlands. Rabbit polyclonal anti-2B antiserum was obtained by immunizing specifi c pathogen free 
rabbits with a recombinant MBP-2B fusion protein produced in Escherichia coli. Western blot analysis showed that the immune 
sera specifi cally recognized the MBP-2B and 2B-EGFP fusion proteins, while no reactivity of the pre-immune sera was 
detected (data not shown). Mouse monoclonal anti-C-myc (clone 9E10) and mouse monoclonal anti-Golgi 58K protein (clone 
58K-9) antisera were obtained from Sigma. Rabbit polyclonal anti-calreticulin was obtained from Affi nity Bioreagents, Inc. 
FITC-conjugated goat-anti-rabbit polyclonal antibody, Texas Red-conjugated goat-anti-mouse polyclonal antibody and Texas 
Red-conjugated goat-anti-rabbit polyclonal antibody were obtained from Jackson ImmunoResearch Laboratories. Peroxidase-
conjugated goat anti-rabbit immunoglobulin was obtained form Dako Diagnostika.
PLASMIDS
The coding sequences of the wild-type 2B protein or 2B deletion mutants were amplifi ed by PCR and cloned in the 
pEGFP fusion vectors described below (Clontech). The plasmid pCB3/T7 [108], which contains the full-length cDNA of CBV3, 
was used as a template in the PCR reactions for the amplifi cation of the sequence encoding wild-type 2B, 2B(∆59C), 2B(∆14C) 
and 2B(∆20N) proteins, lacking amino acids (aa) 41-99, aa 86-99 and aa 1-20, respectively. The pCB3/T7-2B∆HR1 and pCB3/
T7-2B∆HR2 deletion constructs [109] were used as templates in the PCR reactions for the amplifi cation of the sequences 
encoding the 2B(∆HR1) and 2B(∆HR2) proteins, lacking the amphipathic α-helix (aa 34-56) or the second hydrophobic region 
(aa 64-80), respectively.
2B-EGFP and EGFP-2B fusion proteins. For the construction of the p2B-EGFP plasmid, the 2B coding sequence 
was amplifi ed using a forward primer that introduced a SalI restriction site (restriction sites are in italics) and a start codon 
(underlined) preceded by a Kozak sequence (p115-16; 5’-ctcctgtggctggctagcgtcgacgccaccatgggagtgaaggactatgtggaa-3’), and a 
reverse primer that introduced a BamHI restriction site (p115-20; 5’-ccagctggatccttggcgttcagccatagg-3’). The PCR product was 
cloned into pEGFP-N3 digested with SalI and BamHI to yield p2B-EGFP.  For the construction of the pEGFP-2B plasmid, the 2B 
coding sequence was amplifi ed by PCR using primer p115-16 and a reverse primer that introduced a stop codon (underlined) and 
a SmaI restriction site (p115-7; 5’-aagccacccgggctattggcgttcagccatagg-3’). The PCR product was cloned into pEGFP-C1 digested 
with SmaI and SalI to yield pEGFP-2B.
2B-EGFP deletion mutants. For the construction of the p2B(∆59C)-EGFP plasmid, the coding sequence of the N-
terminal 40 amino acids (aa) of the 2B protein was amplifi ed using p115-16, and a reverse primer that introduced an EcoICRI 
restriction site (p169-3; 5’-taaggcttttagagagagctcaagtgggtc-3’). The PCR product was cloned into pEGFP-N2 digested with NheI 
and SmaI to yield p2B(∆59C)-EGFP. 
For the construction of the 2B(∆14C)-EGFP plasmid, the coding sequence of aa 1-85 of the 2B protein was amplifi ed 
using forward primer p115-16 and a reverse primer that introduced a BamHI restriction site (p115-29; 5’-ggggggggggaccggtgc
cccggggaccggcggatcctgtttgagccaccgccacgg-3’) The PCR product was cloned into pEGFP-N3 digested with SalI and BamHI to 
yield p2B(∆14C)-EGFP. 
For the construction of the p2B(∆20N)-EGFP plasmid, the coding sequence of aa 21-99 of the 2B protein was amplifi ed 
using a forward primer that introduced a SalI restriction site and a start codon (underlined) preceded by a Kozak sequence (p115-
30; 5’-ggggggggggtcgacgccatcatggtatgtgagcaagtcaacctc-3’) and a reverse primer p115-20. The PCR product was cloned into 
pEGFP-N3 digested with SalI and BamHI to yield p2B(∆20N)-EGFP. 
For the construction of the p2B(∆HR1)-EGFP and p2B(∆HR2)-EGFP plasmids, the coding sequences of proteins 
2B(∆HR1) and 2B(∆HR2) were amplifi ed using primers p115-16 and p115-20. The PCR products were cloned into p2B-EGFP 
digested with SalI and BamHI to yield p2B(∆HR1)-EGFP and p2B(∆HR2)-EGFP, respectively. 
For the construction of the plasmids pHR1-EGFP and pHR2-EGFP, the coding sequences of the regions encompassing 
these regions (aa 30–62 and aa 56-85, respectively) were amplifi ed using primers that introduced a SalI restriction site and a 
start codon (underlined) preceded by a Kozak sequence at the 5’end and a BamHI restriction site at the 3’end. The HR1 coding 
sequence was amplifi ed using p115-47 (5’-aacctcgtcgacgccaccatgtcactagtgggtcaagactcc-3’) and p115-49 (5’-agtcacggattcgtca
tcgtggttcctcaccac-3’), the HR2 coding region was amplifi ed using p115-48 (5’-tcagccgtcgacgccaccatggtggtgaggaaccacgat-3’) 
and p115-50 (5’-atattgggatccctgtttgagccaccgccacgg-3’). The region encompassing both HR1 and HR2 (aa 30-85) was amplifi ed 
using p115-47 and p115-50. The pHR1-EGFP, pHR2-EGFP and p(HR1+HR2)-EGFP plasmids were made by cloning the PCR 
products digested with SalI and BamHI into the pEGFP-N3 vector, digested with the same enzymes. All sequences that were 
amplifi ed by PCR were checked by sequence analysis.
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2B-myc constructs. Plasmids p2B-myc, p2B(∆20N)-myc, p2B(∆14C)-myc, p2B(∆HR1)-myc, and p2B(∆HR2)-myc, 
were constructed by deleting the EGFP sequence (using BamHI and NotI) from the corresponding 2B-EGFP plasmids, and 
replacing it with a PCR product encoding the C-myc tag (aa EQKLISEEDL), followed by a stop codon.  
ER-targeted 2B construct. For the construction of the plasmids p2B-EGFP-KKAA and p2B-EGFP-AAAA, the EGFP 
coding region was amplifi ed using a forward primer containing a BamHI restriction site (p318-17; 5’-ggggggggatccatcgccaccgtc
agcaagggcgaggag-3’) and a reverse primer containing a stop codon (underlined), a NotI restriction site and a sequence encoding 
either the AAAAAAKKAA or the AAAAAAAAAA tag (p382-3; 5’-ggggggggcggccgcttacgccgctttcttagctgcggctgccgcgcccttgtac
agctcgtccatgcc-3’ and p382-4; 5’-ggggggggcggccgcttacgccgcagcagcagctgcggctgccgcgcccttgtacagctcgtccatgcc-3’, respectively). 
The PCR product was cloned into p2B-EGFP digested with BamHI and NotI to yield p2B-EGFP-KKAA and 2B-EGFP-AAAA, 
respectively.
Golgi-targeted 2B construct. For the construction of Golgi-targeted 2B-EGFP, a construct was generated that contained 
an additional SmaI restriction site between the 2B and the EGFP coding regions. The coding sequence of the 2B protein was 
amplifi ed using p115-16 and a reverse primer that introduced a SmaI restriction site to the 5’ end of the BamHI restriction site 
(p318-25; 5’-gggggggggggatcccccgggttggcgttcagccatagg-3’). The PCR product was cloned into p2B-EGFP digested with SalI 
and BamHI to yield p2B-EGFP(+SmaI). The coding sequence of the N-terminal 103 amino acids of ß-1,2-N-acetylglucosaminyl-
transferase I (NGAT-I) was amplifi ed from pNGAT-I-GFP (a kind gift from Dr. Graham Warren, Cell Biology Laboratory, 
Imperial Cancer Research Fund, London, UK) using a forward primer that introduced a EcoRV restriction site (p318-14: 5’-
gggggggatatcctgaagaagcagtctgcagg-3’) and a reverse primer that introduced a BamHI restriction site (p381-13: 5’-ggggggggatc
ccgccggcgcgggggtcacagg-3’). The PCR product was cloned into p2B-EGFP(+SmaI) that was digested with SmaI and BamHI to 
yield p2B-Golgi-EGFP
EGFP-Golgi. The plasmid pEGFP-Golgi was constructed by replacing the ECFP coding region of pECFP-Golgi 
(Clontech) by the EGFP coding region of pEGFP-N1 using BamHI and NotI restriction sites. In this construct, EGFP is fused to 
the N-terminal 81 amino acids of human β-1,4-galactosyltransferase, which targets the EGFP protein to the trans-medial region 
of the Golgi apparatus.
TRANSFECTIONS
BGM cell monolayers were grown to 70% confl uency in 6-well plates or on coverslips in 24-well plates and transfected 
with 5 µg of plasmid DNA per well of a 6-well plate or with 1 µg of plasmid DNA per well of a 24-well plate. Transfections were 
carried out using FuGENE 6 reagent (Roche) according to the instructions of the manufacturer. For each transfection reaction, 
the FuGENE reagent was mixed with serum-free medium and incubated for 5 min at room temperature. This mixture was added 
drop-wise to the plasmid DNA preparation and incubated for 15 min at room temperature. The DNA/FuGENE mixture was added 
drop-wise to the cells. Cells were grown at 37°C until further analysis.
MEMBRANE ASSOCIATION
BGM cells grown in 6-well plates were transfected with plasmids encoding the proteins EGFP, wild-type 2B-EGFP or 
the 2B-EGFP deletion mutants. At 40 h posttransfection, cells were washed twice with ice cold TES (20 mM Tris (pH 7.4), 1 
mM EDTA, 100 mM NaCl). Samples were kept on ice during the entire procedure. Cells were scraped in 0.5 ml ice-cold 1:10 
TES, collected by centrifugation for 10 min at 4,500 × g and resuspended in 250 µl 1:10 TES. Cells were incubated for 15 min 
and broken by 30 strokes in a Dounce homogenizer. Nuclei and cell debris were removed by centrifugation for 10 min at 4,500 
× g. Membrane and cytoplasmic fractions were separated by centrifugation for 1 hour at 150,000 × g at 4°C. Supernatants were 
removed and stored at –80°C until further analysis. Pellet fractions were either resuspended in one supernatant volume of buffer 
(50 mM Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA, 0.1 M phenylmethylsulfonyl fl uoride, 1% Nonidet P- 40, 0.05% SDS) and 
stored at –80°C until further analysis, or resuspended in 200 µl of either PBS, 0.1 M Na2CO3 (pH 11.5), 0.5 M EDTA, 1 M NaCl, 
4 M urea or 1% Triton X-100. Resuspended pellet fractions were incubated on ice for 1 hour and centrifuged for 1 hour at 150,000 
× g and 4°C. The supernatant fractions and the pellet fractions, which were resuspended in 200 µl of lysis buffer, were analyzed 
by Western blot. 
WESTERN BLOT ANALYSIS
Supernatant and pellet fractions of each sample were run on a 12.5% SDS-polyacrylamide gel and transferred to a nitro-
cellulose membrane (BioRad). EGFP fusion proteins were stained with the anti-EGFP polyclonal antiserum (dilution 1:10,000) 
and peroxidase-conjugated goat-anti-rabbit immunoglobulins (dilution 1:1,000) and visualised using Lumi-Lightplus Western 
CHAPTER 348
3
DETERMINANTS FOR MEMBRANE ASSOCIATION AND PERMEABILIZATION OF THE COXSACKIEVIRUS 2B 
PROTEIN AND THE IDENTIFICATION OF THE GOLGI COMPLEX AS THE TARGET ORGANELLE
49
3
Blotting Substrate (Roche) according to the instructions of the manufacturer.
IMMUNOFLUORESCENCE AND CONFOCAL LASER SCANNING MICROSCOPY
At 24 h posttransfection BGM cells grown on coverslips were fi xed with 4% paraformaldehyde in PBS (pH 7.4). Cells 
were permeabilized using PBS, 0.1% Triton X-100. Antibodies and conjugates were diluted with PBS, 0.1 % Triton X-100, 2 % 
normal goat serum (NGS). Primary antibodies were diluted 1:200 (anti-2B), 1:200 (anti-C-myc), 1:75 (anti-Golgi 58K), or 1:150 
(anti-calreticulin). Conjugates were diluted 1:75. Incubations with the primary antibody were carried out overnight at 4°C and 
incubations with the secondary antibody were carried out for 1 hour at 4°C. Cells were washed with PBS, 0.1 % Triton X-100 
between incubation steps and mounted in mowiol (Sigma-Aldrich). Cells were analyzed by confocal laser scanning microscopy 
(CLSM) (Leica TCS NT, Leica Lasertechnik GmbH, Heidelberg, Germany).
HYGROMYCIN B ASSAY
BGM cells grown in 6-well plates were transfected in duplicate with plasmids encoding the proteins EGFP, wild-type 
2B-EGFP or the 2B-EGFP deletion mutants. At 40 h posttransfection, one of the duplicate wells was starved of methionine for 
15 min in the presence of 500 µg/ml hygromycin B, whereas the other well was starved of methionine for 15 min in the absence 
of hygromycin B. The cells were then pulse-labeled for 1 hour with [35S-]methionine (50 µCi/well) in the presence or absence of 
hygromycin B, washed with ice-cold PBS and lysed in 1 ml of lysisbuffer (50 mM Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA, 0.1 
M phenylmethylsulfonyl fl uoride, 1% Nonidet P- 40, 0.05% SDS). Anti-EGFP rabbit polyclonal antiserum (1:1000) was added 
to the cell lysate and the lysate/antiserum solution was incubated at 4°C for 18 h. To collect the antibody-protein complexes, the 
samples were incubated for 2 h with Protein A Sepharose (Amersham Pharmacia Biotech), washed two times with dilution buffer 
(0.01 M Tris (pH 8.0), 0.14 M NaCl, 0.1% BSA, 0.1% Triton X-100), once with TSA (0.01 M Tris (pH 8.0), 0.14 M NaCl), 
once with 0.05 M Tris (pH 6.8) and precipitated. Samples were resuspended in 35 µl of SDS-sample buffer, boiled for 5 min and 
analyzed by SDS-PAGE. The amount of radiolabeled anti-EGFP precipitated protein was quantifi ed using a phosphorimaging 
device (Bio-Rad Multi-Analyst version 1.0.1) and the ratios of the amount of protein synthesized in the presence and absence of 
hygromycin B was determined.
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The coxsackievirus 2B protein is a small hydrophobic protein (99 aa) that 
increases host cell membrane permeability, possibly by forming homomultimers 
that build membrane-integral pores. Previously, we defi ned the functional role of 
the two hydrophobic regions HR1 and HR2. Here, we investigated the importance of 
regions outside HR1 and HR2 for multimerization, increasing membrane permeability, 
subcellular localization, and virus replication through analysis of linker insertion and 
substitution mutants. From these studies the following conclusions could be extracted. 
(i) The hydrophilic region (58RNHDD62) between HR1 and HR2 is critical for 
multimerization and increasing membrane permeability. Substitution analysis of Asn61
and Asn62 demonstrated the preference for short polar side chains (Asp, Asn), residues 
that are often present in turns, over long polar side chains (Glu, Gln). This supports 
the idea that the hydrophilic region is involved in pore formation by facilitating a 
turn between HR1 and HR2 to reverse chain direction. (ii) Studies undertaken to 
defi ne the downstream boundary of HR2 demonstrated that the aromatic residues 
Trp80 and Trp82, but not the positively charged residues Arg81, Lys84 and Lys86, are 
important for increasing membrane permeability. (iii) The N terminus is not required 
for multimerization but contributes to the membrane-active character of 2B. (iv) The 
subcellular localization of 2B does not rely on regions outside HR1 and HR2, and does 
not require multimerization. (v) Virus replication requires both the membrane-active 
character and an additional function of 2B that is not connected to this activity. 
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INTRODUCTION
Enteroviruses (e.g., poliovirus, coxsackievirus, ECHOvirus) belong to the family of 
Picornaviridae, a large family of nonenveloped, cytolytic viruses. The enterovirus genome consists of 
a 7.5 kb RNA molecule of positive polarity that is translated into one single 220 kDa polyprotein in a 
cap-independent manner. Proteolytic processing of the polyprotein by virus-encoded proteases yields 
the P1, P2 and P3 region proteins. The P1 region is further processed to generate the capsid proteins, the 
P2 and P3 regions are cleaved to yield the replication proteins 2Apro, 2B, 2C, 3A, 3B, 3Cpro and 3Dpol 
and the more stable cleavage intermediates 2BC, 3AB and 3CDpro, which have functions distinct from 
their cleavage products (reviewed in [11; 12]). 
Enteroviruses induce a number of profound functional and morphological alterations in host cell 
membranes. An important membrane modifi cation that can be observed in infected cells is the increase 
in membrane permeability, affecting both intracellular membranes and the plasma membrane [41; 
42; 44]. The gradual modifi cation of membrane permeability starts with the release of calcium from 
intracellular stores, followed (or accompanied) by the disruption of ionic gradients over the plasma 
membrane. Later in infection, also low-molecular-weight compounds like hygromycin B (hygB), a 
small non-permeative inhibitor of translation, can effi ciently pass the plasma membrane. At the end of 
the virus replication cycle, cells are lysed to release virus progeny. Of the morphological modifi cations, 
the massive accumulation of small, cytoplasmic membrane vesicles with which the viral replication 
complexes are associated is the most prominent [54; 61]. Both biochemical and microscopical evidence 
indicates that these vesicles are derived from the secretory pathway [61] and that the 2BC precursor 
protein plays an important role in the accumulation of these vesicles [51; 55-57].
The enterovirus 2B protein plays a major role in these virus-induced membrane modifi cations. 
Expression of the 2B protein, or its precursor 2BC, is suffi cient to release calcium from intracellular 
stores (i.e., ER and Golgi) [42] and to increase plasma membrane permeability to calcium and low-
molecular-weight compounds [42; 46-49; 123]. How the 2B protein modifi es membrane permeability 
is at present largely unknown. In infected cells, the 2B protein is present at the secretory pathway-
derived membranes of the replication complex [51; 57; 61]. Upon individual expression, the 2B protein 
localizes at membranes of the ER and Golgi complex [103; 124]. This localization pattern suggests 
that the 2B protein increases membrane permeability of ER and Golgi membranes directly, whereas 
the permeability of the plasma membrane is increased indirectly, via an as yet unknown mechanism. 
Recently, we demonstrated that mutations that disrupt the ability of 2B to increase ER and Golgi 
membrane permeability also disrupt the 2B-induced increase in plasma membrane permeability, 
suggesting that these two phenomena are coupled [125]. Mutations in 2B that affect its ability to 
increase membrane permeability interfere with an early step in viral RNA replication [47]. Possibly, 
the membrane-active character of 2B is involved in the accumulation of replication vesicles by the 2BC 
protein. Virus replication is also affected by mutations in 2B that do not affect its ability to increase 
membrane permeability [47], arguing for an additional role of 2B in RNA replication.  
The enterovirus 2B protein is a small, hydrophobic protein (97-99 amino acids) that was recently 
classifi ed as a viroporin, a group of virus proteins that modify host cell membrane permeability and 
share a number of common features (reviewed in [126]). The 2B protein contains two hydrophobic 
regions, designated HR1 (aa 37-54) and HR2 (aa 63-80), of which the fi rst is predicted to form a 
cationic amphipathic α-helix [83; 84]. The amphipathic α-helix displays characteristics typical for 
the group of lytic polypeptides, which may build membrane-integral pores upon the formation of 
multimeric transmembrane complexes [85-87]. Accordingly, the 2B protein was suggested to form 
multimeric pores in which both HR1 and HR2 span the phospholipid bilayer. Several lines of evidence 
support this hypothesis. First, homomultimerization reactions of the 2B protein were demonstrated in 
vivo by yeast and mammalian two-hybrid analysis [99; 109] and fl uorescence resonance energy transfer 
microscopy [113], as well as in vitro using a biochemical approach [127]. Second, mutations in each of 
the hydrophobic regions interfere with the ability of the 2B protein to homomultimerize and to increase 
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membrane permeability [47; 79; 109]. Finally, the 2B protein was demonstrated to be an integral 
membrane protein, and the presence of each of the hydrophobic regions was shown to be required for 
this integral membrane association and the correct subcellular localization [124].
The structure-function relationship and the membrane architecture of the 2B protein are as yet 
poorly understood. Our current view is mainly based on the phenotypic characterization of mutations 
in HR1 and HR2. The functional role of domains upstream, between and downstream of HR1 and 
HR2, however, has not yet been characterized. Here, we describe the effects of linker insertion and 
substitution mutations in different regions of the 2B protein on homomultimerization, increasing 
membrane permeability, subcellular localization, and virus replication. 
RESULTS
IDENTIFICATION OF FUNCTIONAL REGIONS IN THE 2B PROTEIN
Previously, we demonstrated that both HR1 and HR2 are important determinants for 
multimerization and increasing membrane permeability [42; 47; 109]. Here, we analyzed the functional 
role of domains upstream, between and downstream HR1 and HR2 using a linker scanning analysis 
(Fig. 1A). A 9 amino acid linker was introduced in the N-terminus of the protein (linker insertion 
at position 5, ins(5)linker), immediately upstream HR1 (ins(34)linker), in the hydrophilic sequence 
between HR1 and HR2 (ins(61)linker), and in the C-terminus of the protein (ins(94)linker). In mutant 
ins(5)linker, the fi rst 4 amino acids of the 2B protein were duplicated to retain the correct environment 
for the 3C protease to cleave the 2A/2B junction in the viral polyprotein expressed by the infectious 
cDNA clone. Alternative codons were used for the duplicated amino acid sequences to minimize the 
chance of recombination events in the viral RNA. 
The ability of 2B mutants to form homomultimers was analyzed using a mammalian two-
hybrid system. BGM cells were transfected with fusion proteins containing the activation domain 
of herpes simplex virus type 1 VP16 or the DNA binding domain of the yeast GAL4 gene product, 
and synthesis of the fi refl y luciferase reporter protein was determined to measure protein:protein 
interactions. The ability of mutant 2B proteins to increase membrane permeability was studied by 
determining the increase in plasma membrane permeability to hygB, a small inhibitor of translation 
that under physiological conditions poorly passes the plasma membrane. HygB entry was determined 
by analyzing protein synthesis in cells expressing mutant 2B-EGFP fusion proteins in the absence and 
presence of the drug.
The ability of the 2B mutant containing a linker between HR1 and HR2 (ins(61)linker) to 
multimerize and increase hygB entry was drastically reduced (Figs. 1B and 1C). In contrast, the regions 
upstream of HR1 or downstream of HR2 were found to be of less importance. Mutants carrying linkers 
immediately upstream HR1 (ins(34)linker) or in the C-terminus of the 2B protein (ins(94)linker) 
showed wild-type multimerization and hygB entry. The presence of the linker in the N-terminus of the 
2B protein (ins(5)linker) did not interfere with multimerization, yet reduced the ability to increase hygB 
entry, indicating that the N-terminus somehow contributes to the membrane-active character of 2B. 
We previously demonstrated that the 2B protein is predominantly present in the Golgi complex 
and that its Golgi localization is an important prerequisite for its ability to increase plasma membrane 
permeability to hygB [124]. Therefore, it should be considered that the failure of 2B mutants to 
increase hygB entry may be due to an altered subcellular localization. We determined the subcellular 
localization of 2B mutants by confocal microscopy using markers for the Golgi and the ER. The 
linker insertions upstream, between, and downstream the hydrophobic regions had no effect on the 
subcellular localization of 2B; ins(5)linker, ins(34)linker, ins(61)linker and ins(94)linker all showed 
clear colocalization with the EGFP-Golgi marker, similar as wild-type 2B (see Fig. 5). Thus, the failure 
of the ins(5)linker and ins(61)linker mutants to increase plasma membrane permeability to hygB is not 
due to an altered localization. 
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4Figure 1. Functional characterization of linker insertion mutants. (A) Schematic representation of the 2B protein of 
coxsackievirus, the inserted linker (boxed), and the amino acid sequences fl anking the linker. Amino acids that were duplicated 
upon insertion of the linker are depicted in italics. Triangles indicate the positions at which the linker was inserted. (B) Analysis 
of the effects of mutations on homomultimerization. Multimerization reactions were analyzed in a mammalian two-hybrid 
analysis, in which wild-type and mutant 2BC proteins were fused to the yeast GAL4 DNA binding domain and to the HSV VP16 
activation domain. COS-1 cells were transfected with the indicated constructs and assayed for luciferase production at 48 h 
posttransfection. LU, light units. (C) Analysis of the effects of mutations on the membrane-active character of the 2B protein. The 
ability to increase plasma membrane permeability to hygB was analyzed. BGM cells were transfected with plasmids encoding 
wild-type or mutant 2B-EGFP. At 40 hours posttransfection, cells were pulse labeled in the absence or presence of hygB, and 
the ratio of protein synthesis in the absence and presence of was determined by phosphor imaging of the anti-EGFP precipitated 
proteins. (B and C) Values represent means ± SD of measurements of three independent experiments. *, P < 0.005 (D) Summary 
of the effects of mutations on virus viability. BGM cells were transfected with wild-type or mutant pCB3/T7 derived RNA 
transcripts and analyzed for the appearance of CPE. (E) Single cycle growth curve of mutant viruses. BGM cells were infected 
at a multiplicity of infection (MOI) of 1, incubated at 36°C, and harvested at 2, 4, 6, and 8 hours postinfection. Virus titers were 
determined by titration on BGM at 36°C. One representative of three independently performed experiments is shown. TCID50, 
50% tissue culture infective dose. 
The ability of mutant 2B proteins to support virus replication was investigated by transfection of 
cells with RNA transcripts derived from the infectious cDNA clone pCB3/T7. Consistent with previous 
observations that 2B mutants which have lost the ability to increase membrane permeability fail to 
replicate [47], both the ins(61)linker mutant and the ins(5)linker mutant were found to be nonviable 
(Fig. 1D). Mutations ins(34)linker and ins(94)linker, which had no effect on multimerization and 
the membrane-active character of 2B, caused defects in virus replication. The ins(34)linker mutation 
completely disrupted viral replication, whereas the ins(94)linker mutation gave rise to a slower growing 
virus in which the inserted linker was retained and no additional mutations were present in the 2B 
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Figure 2. Functional characterization of mutants of the hydrophilic region between HR1 and HR2. (A) Schematic 
representation of the 2B protein of coxsackievirus. The amino acids present in the region between HR1 and HR2 and the 
introduced mutations are depicted. (B) Analysis of the effects of the mutations on homomultimerization of the 2B protein. (C) 
Analysis of the effects of mutations on the membrane-active character of the 2B protein. (B and C) Values represent means ± 
SD of measurements of three independent experiments.  *, P < 0.005 (D,F) Summary of the effects of double mutations (D) and 
single mutations (F) on virus viability. (E,G,H) Single cycle growth curve of viruses containing double mutations (E) or single 
mutant (G,H). One representative of three independently performed experiments is shown. qi, quasi infectious. For details, see 
the legend of Figure 1.
protein (Fig. 1E). These latter results argue that the region immediately upstream HR1 and the C-
terminus of 2B are required for a (yet unknown) function of 2B in virus replication that is not connected 
to its membrane-active character. The results of the linker insertion mutations are summarized in Figure 
4C.
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MOLECULAR REQUIREMENTS OF THE HYDROPHILIC REGION BETWEEN HR1 AND HR2
The linker insertion mutation in the hydrophilic region between HR1 and HR2 (RNHDD, aa 
58-62) demonstrated the importance of this region for multimerization and the membrane-active 
character of 2B. The pore-forming model suggests that this region is required to facilitate a reverse 
turn between the two putative transmembrane domains. The molecular requirements of this sequence 
were investigated by introducing specifi c point mutations (Fig. 2A). In this study, we focused on the 
negatively charged amino acid residues, which are conserved among the enteroviruses and rhinoviruses. 
First, both negatively charged residues (Asp61 and Asp62) were replaced by neutral Ala and hydrophobic 
Val residues. Both the D61A/D62A and the D61V/D62V double mutations abolished multimerization 
and severely reduced the ability to increase hygB entry (Figs. 2B and 2C), suggesting a preference 
for hydrophilic residues at these positions. Analysis of the subcellular localization of the D61A/
D62Amutant (Fig. 5F) and the D61V/D62V mutant (data not shown) demonstrated that these mutations 
had no effect on the Golgi localization of the 2B protein. Analysis of the effects of the mutations on 
virus growth showed that both D61A/D62A and D61V/D62V double mutations abolished the ability of 
the 2B protein to support virus replication (Fig. 2D). 
To investigate the charge and length requirement of the amino acid side chains at positions 
61 and 62 in more detail, Asp61 and Asp62 were replaced by residues that have a short, uncharged 
side chain (Asn, D61N/D62N), residues that have a long, negatively charged side chain (Glu, D61E/
D62E), or residues that have a long, uncharged side chain (Gln, D61Q/D62Q) (Fig. 2A). Introduction 
of residues with a long side chain (mutations D61E/D62E and D61Q/D62Q) caused severe defects in 
multimerization and the ability to increase hygB entry. Mutation D61N/D62N, on the other hand, had 
little effect on the membrane-active character of 2B, although the ability to multimerize was reduced, 
yet not completely abolished (Figs. 2B and 2C). Analysis of the subcellular localization of the D61E/
D62E, D61N/D62N, and D61Q/D62Q mutants revealed that these mutations had no effect on the Golgi 
localization of the 2B protein (not shown). Analysis of the effects of the mutations on virus growth 
showed that mutations D61E/D62E and D61Q/D62Q caused a dramatic effect on virus replication. 
Mutation D61Q/D62Q completely abolished virus replication, whereas mutation D61E/D62E caused 
a quasi-infectious phenotype (which means that the mutation disrupts replication to such an extent 
that reversions can arise but that no virus progeny can be observed carrying the introduced mutation), 
yielding virus in which Gln62 was changed into the original Asp62 (Fig. 2D). This revertant virus 
(containing the D61E genotype) displayed wild-type growth kinetics (Fig. 2F). Mutation D61N/D62N 
did not abolish virus replication and gave rise to a slow growing virus in which the introduced mutations 
were retained and no additional second-site suppression mutations were present in the 2B protein (Fig. 
2E). Together, these data indicate that the presence of a shorter side chain at positions 61 and 62 is of 
greater importance than the presence of a negative charge. 
To investigate the functional importance of Asp61 and Asp62 individually, single mutants D61A 
and D62A were characterized. Figs. 2B and 2C show that the D62A mutation, but not the D61A 
mutation, severely affected multimerization and the membrane-active character of 2B. Consistent with 
this, the D62A mutation abolished virus growth, whereas the D61A mutation gave rise to viruses with 
wild-type growth kinetics (Figs. 2F and 2G). These results suggest that the identity of the amino acid at 
position 62 is of greater importance for the function(s) of 2B than that of the amino acid at position 61. 
Consistently, other Asp62 mutations (D62V, D62N, D62E, and D62Q) caused a more dramatic effect 
on virus replication than the corresponding Asp61 mutations (D61V, D61N, D61E, and D61Q) (Figs. 
2F-2H). The observation that Asp61,62 double mutations caused more severe defects in virus replication 
than the corresponding Asp62 single mutations suggests that Asp61 is of importance and argues that 
there is synergistic role of Asp61 and Asp62 in the correct structure/behavior of the hydrophilic region 
between HR1 and HR2. The results of the mutations in the hydrophilic loop are summarized in Figure 
4C.
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DEFINING THE BOUNDARY OF HR2
The second hydrophobic region of 2B was previously defi ned to be composed of the amino acids 
63-80 [83] based on the method described by Kyle and Doolittle [98]. Its C-terminus and the region 
immediately downstream contain a number of aromatic and positively charged amino acids that are 
well conserved among entero- and rhinovirus 2B proteins. In the 2B protein of coxsackievirus B3, this 
region (WRWLKQK, aa 80-86) contains (i) two tryptophan residues spaced by one amino acid, and (ii) 
three positively charged residues (Fig. 3A). The spatial distance between the positively charged residues 
varies between the different viruses. Tryptophans as well as positively charged residues have been 
implicated in membrane anchoring of transmembrane peptides [129-131]. The presence of aromatic 
and positively charged residues fl anking transmembrane domains is a common feature in the group of 
viroporins [126], suggesting that these residues are of importance for their membrane-active character. 
Specifi c point mutations were introduced at these positions to investigate whether these amino acids 
contribute to the membrane-active character of 2B and should thus be considered to be part of HR2.
Figure 3. Functional characterization of mutants at the boundary of HR2. (A) Schematic representation of the 2B protein of 
coxsackievirus. The amino acids present in and downstream HR2 and the introduced mutations are depicted. (B) Analysis of the 
effects of the mutations on homomultimerization of the 2B protein. (C) Analysis of the effects of the mutations on the membrane-
active character of the 2B protein. (B and C) Values represent means ± SD of measurements of three independent experiments.  *, 
P < 0.01; **, P < 0.005 (D) Summary of the effects of mutations on virus viability. (E and F) Single cycle growth curve of mutant 
viruses. One representative of three independently performed experiments is shown. For details, see the legend of Figure 1.
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First, Trp80 and Trp82 were replaced by neutral Ala residues (W80A/W82A). Multimerization 
was not affected by this mutation, however, the ability of the W80A/W82A mutant to increase plasma 
membrane permeability to hygB was reduced (Figs. 3B and 3C). This reduction was not due to 
alterations in the subcellular localization, as the W80A/W82A mutant was predominantly present 
in the Golgi complex (Fig. 5G). The W80A/W82A mutant failed to support virus replication (Fig. 
3D). Substitution of both Trp residues by aromatic Tyr residues (W80Y/W82Y) had no effect on 
multimerization and the ability to increase hygB entry (data not shown), supporting the idea that there 
is a preference for aromatic residues at positions 80 and 82.  
Trp80 and Trp82 were mutated individually into Ala (W80A, W82A) to investigate the functional 
importance of the individual amino acids. Both W80A and W82A single mutations had no effect on 
the ability to increase hygB entry (Fig. 3C). Surprisingly, the W80A mutation abolished virus growth, 
whereas the W82A mutation gave rise to a virus with wild-type growth characteristics (Figs. 3D and 
3E). The observation that the W80A/W82A double mutation affects the ability to increase hygB entry, 
whereas the single mutations have no effect, argues for a synergistic role of the Trp residues in the 
membrane-active character of 2B. 
Substitution of the three positively charged residues by neutral Ala residues (R81A/K84A/K86A) 
did not affect multimerization or the ability to increase hygB entry (Figs. 3B and 3C). In agreement with 
this, the mutant 2B protein was predominantly localized in the Golgi complex (Fig. 5H). However, virus 
replication was abolished by this mutation (Fig. 3D), suggesting that these amino acids are involved 
in a function of 2B in virus replication not connected to its membrane-active character. Analysis of the 
effects of the individual mutations of Arg81, Lys84 and Lys86 on virus replication identifi ed Lys84 as the 
most important of these conserved residues (Figs. 3D and 3F). 
Together, these data suggest that Trp80 and Trp82 are cooperatively involved in the membrane-
active character of 2B, possibly through the correct membrane anchoring of HR2, whereas Arg81, Lys84 
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Figure 4. Overview of 2B mutants. (A) 
Schematic representation of the 2B protein of 
coxsackievirus. Amino acid residues 37 to 86 are 
shown (HR1 and HR2 are underlined). (B) Helical 
wheel diagram of the cationic amphipathic 
α-helix formed by HR1. The hydrophobic 
residues (boxed) are positioned at one face of 
the α-helix, the polar and charged residues are 
positioned at the other face of the α-helix. (C) 
Summary of 2B mutants. The mutant genotypes 
and the corresponding phenotypes are depicted. 
a, homomultimerization is scored ++ when 75-
100% luciferase was produced compared to the 
wild-type, + when luciferase production was 
50-75%, –/+ when luciferase production was 
25-50%, and – when luciferase was 0-25%. b, 
the membrane-active character is scored ++ 
when protein synthesis in the presence of hygB 
was reduced by 80-100% compared to that in the 
absence of hygB, + when protein synthesis was 
reduced by 50-80%, –/+ when protein synthesis 
was reduced by 20-50%, and – when protein 
synthesis was reduced by less than 20%. c, virus 
replication is scored ++ when the mutant virus 
displayed wild-type growth kinetics, + when the 
mutant virus displayed delayed growth kinetics, 
and – when virus replication was abolished; qi, 
quasi infectious.  d, previously published (109). 
e, previously published (47). f, this study (data 
not shown). g, previously published (84). h, 
previously published (83).
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ins(5)linker EGFP-Golgi mergedB
D61A/D62A EGFP-Golgi mergedF
EGFP-GolgiW80A/W82A mergedG
EGFP-GolgiR81A/K84A/K86A mergedH
A wild-type EGFP-Golgi merged
C ins(34)linker EGFP-Golgi merged
D ins(61)linker EGFP-Golgi merged
ins(94)linker EGFP-Golgi mergedE
O EGFP-GolgiC75M/S77M merged
N L46N/V47N/I49N/I50N calreticulin merged
L46N/V47N/
I49N/I50N
EGFP-Golgi mergedM
K41E/K44E/K48E EGFP-Golgi mergedK
L EGFP-Golgiins(41)L merged
EGFP-GolgiA71E/I73E mergedQ
I K41L/K44L/K48L EGFP-Golgi merged
J calreticulinK41L/K44L/K48L merged
EGFP-GolgiI64S/V66S mergedP
Figure 5. Subcellular localization of 2B mutants. (A-I, K-M, O-Q) Cells were co-transfected with the indicated mutant 2B-myc 
construct and EGFP-Golgi, fi xed at 24 h posttransfection and stained with the anti-C-myc antiserum. (J,N) Cells were transfected 
with the indicated mutant 2B-myc construct, fi xed at 24 h posttransfection and stained with the anti-C-myc and anti-calreticulin 
antisera. Cells were analyzed by CLSM. (bar = 10µm) For full color fi gure, see page 154.
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or Lys86 do not contribute to this function. The results of the mutations at the boundary of HR2 are 
summarized in Figure 4C.
EFFECTS OF HR1 AND HR2 MUTATIONS ON SUBCELLULAR LOCALIZATION OF 2B
None of the mutations upstream HR1, between HR1 and HR2, or downstream HR2 had any effect 
on the subcellular localization of the 2B protein, suggesting that the major localization determinants 
reside in HR1 and HR2. Consistent with this, we previously observed that deletion of either HR1 or 
HR2 affected the correct localization of 2B in the Golgi complex [124]. The specifi c requirements 
in HR1 and HR2 for the Golgi localization of 2B, however, have not yet been determined. Here, we 
studied the localization of a number of previously described HR1 and HR2 mutants (see Fig. 4C) to 
better understand the structural requirements in HR1 and HR2 for Golgi localization. This analysis will 
also provide us important insight into whether alterations in subcellular localization may be responsible 
for the failure of these HR1 and HR2 mutants to increase plasma membrane permeability to hygB. 
The HR1 mutants contain alterations that disrupt the cationic or the amphipathic character of 
the α-helix. In mutants K41L/K44L/K48L and K41E/K44E/K48E, the three positively charged Lys 
residues in the small hydrophilic face of the helix (Fig. 4B) were replaced by negatively charged Leu 
residues or hydrophobic Glu residues, respectively. These mutations did not affect multimerization, yet 
inhibited the ability to increase hygB entry (Fig. 4C) and severely altered the subcellular localization. 
The localization of the K41L/K44L/K48L mutant closely resembled that of the 2B(∆HR1)-myc protein 
[124]: the mutant protein was virtually absent from the Golgi complex (Fig. 5I) but was predominantly 
present in a reticular pattern that was identifi ed as the ER (Fig. 5J). The K41E/K44E/K48E mutant 
was only partially present in the Golgi complex, and also showed staining of the ER (Fig. 5K). These 
data suggest that the failure of these mutants to increase plasma membrane permeability to hygB may 
indeed be (partly) due to an altered localization. Irrespective of its localization, substitution of the three 
Leu residues may also result in the formation of nonfunctional multimers that have lost the ability to 
permeabilize membranes. Mutant ins(41)L contains an insertion of a Leu residue at position 41, which 
results in the dispersion of the charged residues over the α-helix and thereby a reduced amphipathy [84]. 
This mutation, which had no effect on multimerization yet reduced the ability to increase hygB entry, 
did not affect its subcellular localization (Fig. 5L). In mutant L46N/V47N/I49N/I50N, four hydrophobic 
residues are replaced by hydrophilic Asn residues, thereby affecting the hydrophobic backbone of HR1. 
This mutation abolished multimerization and the ability to increase hygB entry, and drastically altered 
the subcellular localization of 2B. The L46N/V47N/I49N/I50N mutant was absent from both the Golgi 
complex (Fig. 5M) and the ER (Fig. 5N). Together, these results point to the importance of both the 
cationic residues and the overall hydrophobic character of HR1 for the Golgi localization of 2B. 
In the HR2 mutants, the overall hydrophobic character of this region is altered. Mutation C75M/
S77M, which increases the overall hydrophobicity of HR2 through the substitution of polar residues by 
more hydrophobic Met residues [84], did not affect multimerization and the ability to increase hygB 
entry. The C75M/S77M mutant was predominantly present in the Golgi complex (Fig. 5O). Mutation 
I64S/V66S, which reduces the overall hydrophobicity of HR2 through the introduction of polar Ser 
residues [84], abolished multimerization and the ability to increase hygB entry. The I64S/V66S 
mutant protein was predominantly present in the Golgi complex (Fig. 5P), suggesting that its failure 
to increase hygB entry is not related to its subcellular localization. Moreover, this results indicates 
that multimerization of 2B is not required for its Golgi localization. Mutation A71E/I73E, which more 
severely disturbs the overall hydrophobicity of HR2 through the introduction of negatively charged Glu 
residues [84] also abolished multimerization and the ability to increase hygB entry. The subcellular 
localization of the A71E/I73E mutant was altered, and closely resembled that of the 2B(∆HR2)-myc 
protein [124]: the protein was present in the Golgi complex, but also showed signifi cant staining of the 
ER network (Fig. 5Q). The altered subcellular localization of the A71E/I73E mutant may be (partly) 
responsible for its failure to increase hygB entry. Moreover, this fi nding indicates that, in addition to 
determinants present in the cationic amphipathic α-helix, the overall hydrophobic character of HR2 is 
required for the subcellular localization of 2B. 
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DISCUSSION
The enterovirus 2B protein was recently classifi ed as a viroporin, a group of virus proteins 
that modify membrane permeability, and is the fi rst viroporin of a non-enveloped virus (reviewed 
in [126]). Expression of the enterovirus 2B protein, a small hydrophobic protein that localizes at 
ER and Golgi membranes, results in an increased permeability of the ER and Golgi membranes, 
and (most likely as a downstream consequence) an increased permeability of the plasma membrane 
to ions and low-molecular-weight compounds like hygB. The molecular mechanism used by the 2B 
protein to increase membrane permeability is as yet poorly understood. Growing evidence suggests 
that multimers of 2B build transmembrane pores, in which each of the hydrophobic regions, HR1 and 
HR2, span the phospholipid bilayer [99; 109; 113; 127]. According to the hypothesized pore-model, 
the short hydrophilic sequence between the transmembrane domains is required to facilitate a turn to 
reverse chain direction, a common structural motif in membrane permeating structures [132; 133]. 
Reverse turns are mostly comprised of polar residues [134], and display a preference for small polar 
amino acids [135; 136]. The studies presented here showed that the negatively charged Asp residues 
in the short hydrophilic sequence between HR1 and HR2 are indeed an important determinant for 
the membrane-active character of the 2B protein. Substitution of both Asp61 and Asp62 residues by 
neutral Ala residues or hydrophobic Val residues abolished multimerization and the membrane-active 
character of 2B, suggesting the requirement for hydrophilic residues. Further analysis demonstrated the 
preference for the small polar Asp and Asn residues at amino acid positions 61 and 62 over the larger 
Glu and Gln residues. Both Asp and Asn residues, and not Glu and Gln, have been implicated in the 
formation of reverse turns, possibly because these amino acids easily form hydrogen bonds with the 
peptide backbone [137; 138]. Together, these data indicate that the hydrophilic region between HR1 
and HR2 indeed facilitates a reverse turn, and suggest that 2B adopts a helix-loop-helix structure, a 
commonly found structural feature in membrane-active proteins [127; 139].
A number of aromatic and positively charged amino acid residues are present at the C-terminus 
of HR2. These residues are highly conserved among all enterovirus and rhinovirus 2B proteins. The 
presence of aromatic and positively charged residues immediately downstream hydrophobic domains 
is a common feature of viroporins [126], suggesting that these residues may constitute an important 
functional membrane-active determinant. These amino acid residues are preferably present at the lipid-
water interface, and are suggested to play a role in the precise location of transmembrane segments 
in the lipid bilayer, to stabilize proteins in the lipid bilayer, and to play a role in proper functioning 
of membrane proteins [129; 131; 140-143]. In our studies towards the putative importance of these 
residues for multimerization and the membrane-active character of 2B, we found no evidence for a role 
of the positively charged residues Arg81, Lys84 and Lys86, suggesting that these residues do not play 
a role in the interaction of 2B with membranes. In contrast, we did observe a cooperative role for the 
aromatic Trp80 and Trp82 residues. These residues were found to contribute to the membrane-active 
character of 2B, without being required for multimerization. This suggests that the interaction of these 
residues with the phospholipid bilayer is involved in correct positioning of HR2 in the membrane, 
thereby contributing to the overall pore architecture of 2B. This fi nding defi nes the Trp residues as the 
downstream boundary of HR2.
The possible contribution of the regions upstream HR1 and downstream HR2 in pore formation 
is at present poorly understood. We found that the linker insertion in the C-terminal region of 2B 
had no effect on multimerization and the ability to increase hygB entry, consistent with the previous 
observation that the deletion of the C-terminal 15 amino acids had no adverse effect on the membrane-
active character of 2B [124]. Linker insertion at position 34 had no effect on multimerization and the 
membrane-active character of 2B, suggesting that the region immediately upstream HR1 is not involved 
in formation and functioning of the pore. Interestingly, we did observe a role for the extreme N terminus 
in the membrane-active character of 2B. Insertion of a linker at position 5 reduced the membrane-active 
character of 2B without affecting multimerization, similar as observed for an N-terminal deletion 
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mutant of 2B [109; 124]. This fi nding is the fi rst indication that regions other than HR1 and HR2 may 
be involved in pore function. How the N terminus contributes to the membrane-active character of 2B, 
a feature that is diffi cult to explain in light of the pore formation by HR1 and HR2, requires further 
investigation. 
Analysis of the subcellular localization of the different linker insertion and substitution mutants 
showed that the Golgi localization of the 2B protein does not rely on regions other than HR1 and HR2, 
yet depends on specifi c determinants within these hydrophobic regions. Some 2B mutants carrying 
alterations in HR2 (I64S/V66S) or the hydrophilic region between HR1 and HR2 (D61A/D62A) 
showed a wild-type Golgi localization, although these mutations interfered with multimerization. 
Multimerization is suggested to be involved in the subcellular localization of a number of Golgi resident 
proteins [121; 122]. Our results argue that multimerization of 2B is not required for its targeting and 
retention in the Golgi complex. The importance of the Golgi localization for the function of 2B [124] is 
demonstrated by the observation that all mutants that increased plasma membrane permeability to hygB 
were indeed localized in the Golgi complex. How the 2B protein is able to modify plasma membrane 
permeability while being localized in the Golgi complex is as yet unknown. 
How does the formation of pores by the 2B protein contribute to the virus life cycle? The data 
presented here suggest that the pore formation is required for effi cient replication. Based on their effect 
on the membrane-active character of 2B, mutations that caused a lethal phenotype can be divided into 
two groups. The largest group consists of mutations that abolished the ability to  multimerize and 
increase membrane permeability. In addition, this group contains the ins(5)linker and W80A/W82A 
mutations, which did not affect multimerization, yet reduced (but not abolished) the membrane-active 
character of 2B. Our results demonstrate that all mutations that interfered with the membrane-active 
character of 2B impaired virus replication. Previous reports demonstrated that the reduction in virus 
replication of 2B mutants was caused by defects early in RNA replication [82-84], suggesting that 
the membrane-active character of 2B is required for an early step in virus replication, presumably 
for creating the correct environment required for viral RNA replication. One possibility is that 
the  alterations in ER and Golgi membrane permeability [42; 125] contribute to the 2BC-induced 
accumulation of the anterograde membrane vesicles at which viral RNA replication takes place [55; 
57]. The accumulation of these transport vesicles may be the result of inhibition of membrane fusion. It 
is tempting to speculate that 2B-induced alterations in organelle Ca2+-homeostasis are involved in this 
process, possibly by interfering with Ca2+-dependent membrane fusion events [144]. 
The second group of mutations, containing ins(34)linker, ins(94)linker, and R81A/K84A/K86A, 
did not affect multimerization and the ability to increase membrane permeability, yet inhibited virus 
replication. These data suggest that the 2B protein is involved in more than one function in virus 
genome replication, possibly through the interaction with other viral or host cell proteins. In this view, 
it is interesting to note that it was demonstrated recently that severe replication defects of poliovirus 
genomes containing a poliovirus/human rhinovirus chimeric 3AB protein could be rescued by a 
compensating Thr33 → Ile mutation in the 2B protein [145]. This observation suggests that a functional 
interaction between 2B(C) and 3A(B) may exist and that this interaction is involved in some step of 
viral replication. Whether the 2BC:3A interaction is involved in the accumulation of membrane vesicles 
[62], or in a different function in replication, requires further investigation. 
The studies presented here provided new insights into the molecular determinants for the 
membrane-active character of the 2B protein, and lend support to the hypothesis that 2B multimers 
form transmembrane pores by adopting a helix-loop-helix conformation. Further investigations are 
required to understand how the membrane-active character of 2B is involved in viral RNA replication, 
and to gain further insight into the additional function of 2B in viral replication that is not connected to 
its membrane-active character.
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EXPERIMENTAL PROCEDURES
CELLS AND MEDIA
Buffalo green monkey (BGM) cells were grown in minimal essential medium (Gibco), supplemented with 10% fetal 
bovine serum, 100 units penicillin per ml and 25 µg streptomycin per ml. COS-1 cells were grown in Dulbecco’s modifi ed 
minimal essential medium (Gibco), supplemented with 10% FBS, 100 units penicillin per ml and 25 µg streptomycin per ml. 
Cells were grown at 37°C in a 5% CO2 incubator. 
CONSTRUCTION OF MUTANTS
Oligonucleotide-directed site-specifi c mutagenesis was performed using the subgenomic phagemid pALTCB3/2080-
4947 [83], using the Altered Sites in vitro mutagenesis system according to the instructions of the manufacturer (Promega). The 
(antisense) oligonucleotides that were used are depicted in Table 1, in which the triplets containing mutations are underlined and 
depicted in bold. The mutated fragments were cloned in the infectious cDNA clone pCB3/T7 using SpeI (nt 3837) and BssHII (nt 
4238) restriction enzymes. The mutations were confi rmed by sequence analysis.
For the linker scanning analysis, mutations were introduced by PCR and the mutated fragments were cloned in pCB3/
T7 [108]. In the sequences of the oligonucleotides described below, the restriction sites are shown in italics and the sequence 
encoding the 9 aa linker (a hemagglutinin epitope tag, YPYDVPDYA) is underlined. pCB3/T7-2B(ins(5)linker) was generated 
using a forward primer that contained a SmaI restriction site (italics) and the linker sequence (underlined) (5’-gggggggcccgg
gtcaaagattatccgtacgacgtccccgattatgccggagtgaaggactatgtggaa). The reverse primer (5’-cagagatttctcgagctaggagtcttggcccactag, nt 
3837) was chosen such that the PCR product contained the unique SpeI restriction site. The PCR product was digested with 
SmaI and SpeI and cloned in pCB3/T7-StuI(3743) [107] that was digested with StuI and SpeI. pCB3/T7-2B(ins(34)linker) was 
generated using a forward primer that contained the SpeI restriction site and introduced the linker sequence (5’-gggggactagtgt
atccgtacgacgtccccgattatgccggtcaagactccatcttagag) and a reverse primer that contained the BssHII restriction site (nt 4246) (5’-
ttgggatggcgcgctctgctc, nt 4230). The PCR product was cloned in pCB3/T7 using SpeI and BssHII. pCB3/T7-2B(ins(61)linker) 
was generated using a forward primer that contained a SpeI restriction site (5’-gtcaaccggatccaagaatcactagtgggtcaa, nt 3844) and 
a reverse primer that contained a StuI restriction site and the linker sequence (5’-ggggggaggcctggcataatcggggacgtcgtcggatacacca
caattactaaggctga). The PCR product was digested with SpeI and StuI and cloned in pCB3/T7-HpaI(3915) [107] that was digested 
with SpeI and HpaI. pCB3/T7-2B(ins(5)linker) was generated using a forward primer that contained a SpeI restriction site (5’-
gtcaaccggatccaagaatcactagtgggtcaa, nt 3844) and a reverse primer that contained a ScaI restriction site and the linker sequence 
(5’-ggggggagtactttggcgttcagccataggggcataatcggggacgtcgtacggataagggattccgtaatattgtga). The PCR product was digested with 
SpeI and ScaI and cloned in pCB3/T7-HpaI(4042), which was digested with SpeI and HpaI. By consequence, the sequence of 
the 2B/2C junction is altered from AERQ↓N to AERQ↓S, however, this sequence is effi ciently processed by 3Cpro and virus 
replication is not affected by the presence of this sequence at the 2B/2C junction [81]. All sequences that were amplifi ed by PCR 
were verifi ed by sequence analysis.
RNA TRANSFECTIONS AND VIRUS REPLICATION
The effect of the mutations on virus viability was examined by transfection of BGM cells with RNA transcripts generated 
from the mutated infectious pCB3/T7 cDNA clones, as described previously [83]. After transfection, cells were incubated at 36°C 
until cytopathic effect was observed. In case no cytopathic effect was observed after six days, the cell cultures were subjected to 
three cycles of freezing and thawing, passaged to fresh monolayers of BGM cells and incubated for another six days. If no virus 
replication was observed at six days after passage, it was concluded that the mutated proteins did not support virus replication. All 
viruses that were obtained were subjected to sequence analysis. To ensure that the observed phenotypes were not due to additional 
mutations in the plasmid DNA, all mutants were generated from two individual mutagenesis reactions and analyzed separately. 
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Single cycle growth curves were performed as described previously [83]. Briefl y, monolayers of BGM cells were infected at a 
multiplicity of infection (MOI) of 1, incubated at 36°C, and harvested at 2, 4, 6, and 8 hours postinfection. Viruses were released 
by three cycles of freezing and thawing, and virus titers were determined by titration on BGM cells at 36°C as described [128]. In 
vitro translation reactions demonstrated that defects in virus replication were not caused by alterations in polyprotein processing 
(data not shown).
MAMMALIAN TWO-HYBRID ANALYSIS
Homomultimerization reactions were studied using plasmids pACT, pBIND, and pG5luc of the CheckmateTM Mammalian 
Two-Hybrid System (Promega) [109]. From the mutant pCB3/T7 plasmids, the NsiI-to-BssHII fragments were cloned into 
pSP72-2BC [109] digested with the same enzymes. From the resulting mutant pSP72-2BC constructs, the BamHI-to-SmaI 
fragments were cloned into pACT-2BC and pBIND-2BC [109] digested with BamHI and EcoRV. Analysis was performed using 
pACT-2BC and pBIND-2BC fusion proteins, because the 2BC multimerization reactions always yielded higher luciferase signals 
and all the 2B mutants behaved identical in the 2BC multimerization reactions and the 2B multimerization reactions [109]. COS-1 
cells in 24-well plates were transfected with the indicated constructs and lysed at 48 hours posttransfection, using the FuGENE 
6 transfection reagent (Roche) as described previously [109]. The fi refl y luciferase and Renilla luciferase enzyme activities were 
measured from the same cell lysate sample using the Dual-LuciferaseTM Reporter Assay System according to the instructions of 
Table 1. Mutagenesis oligonucleotides. Nucleotide sequences of the (antisense) oligonucleotides used for site-directed 
mutagenesis. The triplets coding for the altered amino acids are underlined and bold.
Mutant Primer sequence
D61A/D62A 5’-ggcagtcacagtgatgagtgctgcgtggttcctcaccac
D61V/D62V 5’-agtcacagtgatcagcaccacgtggttcctcaccac
D61N/D62N 5’-ggcagtcacagtgatcaggttattgtggtttcgaaccacaattactaaggctga
D61E/D62E 5’-ggcagtcacagtgatgagctcttcgtggttcctcaccac
D61Q/D62Q 5’-ggcagtcacagtgatcagctgatggtggttcctcaccacaat
D61A 5’-agtcacagtgatcagatctgcgtggttcctcaccac
D61V 5’-agtcacagtgatcaggtcgacgtggttcctcaccacaat
D61N 5’-agtcacagtgatcaggtcgttgtggttcctcaccacaat
D61E 5’-agtgatcaggtcttcgtggttcct
D61Q 5’-agtcacagtgatcaggtcctggtggttcctcaccac
D62A 5’-agtcacagtgatcagggcgtcgtggttcctcaccac
D62V 5’-agtcacagtgatcaggacgtcgtggttcctcaccac
D62N 5’-ggcagtcacagtgatcaggttatcgtggtttcgaaccacaattactaaggctga
D62E 5’-agtcacagtgatgagctcatcgtggtt
D62Q 5’-ggcagtcacagtgatcagctgatcgtggttcctcaccac
W80A/W82A 5’-tgacaccttctgtttgagcgctcgagccggggacgaggtacaacc
W80Y/W82Y 5’-tgacaccttctgtttgagataccggtacggggacgaggtacaacc
W80A 5’-ctgtttgagccaccgcgccggcgacgaggtacaaccgat
W82A 5’-caccttctgtttgagggcccgccacggggacga
R81A/K84A/K86A 5’-gtaatattgtgacaccgcctgtgcgagccaggcccacggggacgaggt
R81A 5’-cttctgtttgagcacggcccacggggacgaggt
K84A 5’-ttgtgacaccttctgcgcaagccaccgccacgggga
K86A 5’-gtaatattgtgacacggcctgtttgagccaccg
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the manufacturer  (Promega). Luciferase activities were measured in a luminometer (Bio-Orbit 1251 luminometer). Measurement 
of the Renilla luciferase production revealed only small differences among different samples from the same experiment. Because 
these small differences merely refl ected variations in the luciferase measurement, we did not normalize for transfection effi ciency. 
Protein expression was confi rmed on western blots stained with anti-Gal 4 DNA binding domain (data not shown). 
HYGROMYCIN B ASSAY
The ability of 2B to increase plasma membrane permeability to hygB was studied using 2B-EGFP fusion proteins 
as described previously [124]. Mutant p2B-EGFP plasmids were constructed by amplifi cation of the 2B coding sequences 
of the mutant pCB3/T7 plasmids. A forward primer was used that contained a SalI restriction site (italics) and a start codon 
(underlined), preceded by a Kozak sequence (5’-ctcctgtggctggctagcgtcgacgccaccatgggagtgaaggactatgtggaa-3’), and a reverse 
primer that introduced a BamHI restriction site (5’-ccagctggatccttggcgttcagccatagg-3’). The PCR product was cloned into 
pEGFP-N3 (Clontech) digested with SalI and BamHI to yield mutant p2B-EGFP. All sequences that were amplifi ed by PCR were 
verifi ed by sequence analysis. BGM cells grown in 6-well plates were transfected in duplicate with plasmids encoding wild-type 
or mutant 2B-EGFP fusion proteins, using the FuGENE 6 transfection reagent (Roche) as described previously [109]. At 40 h 
posttransfection, cells were starved of methionine for 15 minutes in the presence or absence of 500 µg/ml hygB, pulse-labeled for 
1 hour with [35S-]methionine (50 µCi/well) in the presence or absence of hygB, washed with ice-cold phosphate-buffered saline 
and lysed in 1 ml of lysisbuffer (50 mM Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA, 0.1 M phenylmethylsulfonyl fl uoride, 1% 
Nonidet P-40, 0.05% SDS). Protein synthesis was analyzed by SDS-PAGE of immuno-precipitated EGFP fusion proteins. The 
amount of radiolabeled anti-EGFP precipitated protein was quantifi ed using a phosphor-imaging device (Bio-Rad Multi-Analyst 
version 1.0.1) and the ratios of the amount of protein synthesized in the presence and absence of hygB was determined. Protein 
expression was checked on western blots stained with anti-EGFP (not shown).
IMMUNOFLUORESCENCE AND CONFOCAL LASER SCANNING MICROSCOPY
The subcellular localization of wild-type and mutant 2B proteins was determined as described previously [124]. Briefl y, 
BGM cells were grown on coverslips in 24-well plates, and transfected with the indicated plasmids using the FuGene transfection 
reagent according to the instructions of the manufacturer (Roche). At 24 hours posttransfection, cells were fi xed, stained, and 
analyzed by confocal laser scanning microscopy (CLSM) (Leica TCS NT, Leica Lasertechnik GmbH, Heidelberg, Germany). 
Mouse monoclonal anti-C-myc (clone 9E10) was obtained from Sigma-Aldrich. Rabbit polyclonal anti-calreticulin was 
obtained from Affi nity Bioreagents, Inc. Fluorescein isothiocyanate-conjugated goat-anti-rabbit polyclonal antibody, Texas Red-
conjugated goat-anti-mouse polyclonal antibody and Texas Red-conjugated goat-anti-rabbit polyclonal antibody were obtained 
from Jackson ImmunoResearch Laboratories. Primary antibodies were diluted 1:200 (anti-c-Myc), or 1:150 (anti-calreticulin). 
Conjugates were diluted 1:75.
STATISTICAL ANALYSIS
Data are presented as mean values ± SD. Differences were tested for signifi cance by means of the Student’s t test.
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The coxsackievirus 2B protein predominantly localizes to the Golgi complex 
where it increases membrane permeability, possibly through formation of multimers 
that build transmembrane pores. Here, we show that the localization of an ER-retained 
2B mutant was restored by coexpression of the wild-type 2B protein. 2B proteins 
carrying mutations in the putative regions for multimerization and pore formation 
failed to restore localization of this mutant. We conclude that mixed multimers are 
formed in the ER and that these multimers are subsequently transported to the Golgi. 
The data provide in vivo evidence for 2B multimerization, which is a prerequisite for 
pore formation.
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Enteroviruses (e.g., poliovirus, coxsackievirus, ECHOvirus) belong to the Picornaviridae, a large 
family of nonenveloped, cytolytic RNA viruses. Enterovirus infection causes an early increase in Ca2+ 
permeability of ER and Golgi membranes [42]. The enterovirus 2B protein, a small integral membrane 
protein [124], has been identifi ed as the protein responsible for this change in membrane permeability 
[125]. In infected cells, the 2B protein localizes to the early secretory pathway-derived membrane 
vesicles at which viral replication takes place [26; 51]. The 2B protein contains two hydrophobic 
regions, HR1 and HR2, separated by a short hydrophilic sequence that has been proposed to form a turn 
to reverse chain direction (Fig. 1A) [83; 84; 124; 146]. The integrity of each of these regions is required 
for the ability of 2B to increase membrane permeability [79; 83; 84; 146]. HR1 contains a putative 
cationic amphipathic α-helix that displays characteristics of the so-called membrane-lytic polypeptides, 
a group of cytolytic peptides that can build membrane-integral pores upon multimerization [84]. 
Homomultimerization of the 2B protein has been demonstrated by two-hybrid methods [99; 109], 
fl uorescence resonance energy transfer microscopy [113], and biochemical approaches [127]. Together, 
these data suggest that homomultimers of 2B form transmembrane pores in which both hydrophobic 
regions span the phospholipid bilayer. 
Upon individual expression, the 2B protein is predominantly localized to Golgi membranes [103; 
124]. Previously, we described a 2B mutant of coxsackievirus B3 that is localized exclusively at the 
ER [124]. In this mutant, the three positively charged Lys residues in HR1 (Fig. 1A) are replaced with 
hydrophobic Leu residues (mutant 2B-K41L/K44L/K48L). This mutation had no effect on the formation 
of homomultimers of 2B in a mammalian two-hybrid system [99]. In the present study, we investigated 
whether the wild-type coxsackievirus 2B protein and the ER-retained 2B-K41L/K44L/K48L mutant are 
able to form mixed multimers and, if so, how this affects the localization of these proteins.  
The subcellular localization of wild-type 2B and the 2B-K41L/K44L/K48L mutant, both in the 
absence and presence of each other, was investigated by confocal laser scanning microscopy (Leica TCS 
NT, Leica, Germany) as described previously [124]. Wild-type 2B was expressed with a c-Myc tag at its 
C terminus, whereas the 2B-K41L/K44L/K48L mutant was C-terminally fused with the EGFP protein. 
Buffalo green monkey kidney cells were grown on coverslips in minimal essential medium (Gibco), 
supplemented with 10% fetal bovine serum, 100 units penicillin per ml and 25 µg streptomycin per 
ml. Cells at 70% confl uency were transfected with expression plasmids using FuGENE 6 transfection 
reagent (Roche). At 24 h posttransfection, cells were fi xed with 4% paraformaldehyde in phosphate 
buffered saline (PBS) (pH 7.4), permeabilized using PBS/0.1% Triton X-100, and stained with anti-
c-Myc (clone 9E10, Sigma) and Texas Red-conjugated goat-anti-mouse polyclonal antibody (Jackson 
ImmunoResearch Laboratories). The antibodies were diluted 1:200 with PBS/0.1% Triton X-100/2% 
normal goat serum. Figure 2A shows the Golgi localization of wild-type 2B and the ER localization 
of the 2B-K41L/K44L/K48L mutant when expressed individually. Upon coexpression with wild-type 
2B, the 2B-K41L/K44L/K48L mutant was no longer found in the ER, but now localized predominantly 
to the juxta-nuclear Golgi region, where it showed extensive colocalization with the wild-type protein 
Figure 1. (A) Amino acid sequence of 
the 2B protein of coxsackievirus B3. The 
hydrophobic regions HR1, which is predicted 
to form a cationic amphipathic α-helix, and 
HR2 are boxed. (B) Summary of genotype 
of the mutants used in this study, their 
subcellular localization (146), their ability to 
form homomultimers in the mammalian two-
hybrid system (109; 146), and their ability to 
form multimers as indicated by their ability to 
restore localization of 2B-K41L/K44L/K48L 
(this study). 
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2B wild Golgi + +
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D61V/D62V Golgi – –
I64S/V66S Golgi – –
R81A/K84A/K86A Golgi + +
B
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Figure 2. (A) Subcellular localization of the myc-tagged wild-type 2B protein (left) and the EGFP-tagged 2B-K41L/K44L/K48L 
mutant (right) upon individual expression. The wild-type 2B protein localized to Golgi membranes, whereas the 2B-K41L/K44L/
K48L mutant showed ER localization. (B) Upon coexpression with the wild-type 2B protein, the 2B-K41L/K44L/K48L mutant 
colocalized with the wild-type 2B protein to Golgi membranes. Bar = 10µm. For full color fi gure, see page 155.
(Fig. 2B). Thus, coexpression of wild-type 2B restored the mislocalization of the 2B-K41L/K44L/K48L 
mutant. From this observation, a number of conclusions can be drawn. First, it provides in vivo evidence 
that mixed multimers can be formed composed of both wild-type 2B and the mutant 2B-K41L/K44L/
K48L protein. Second, it argues that 2B forms multimers already in the ER, which are then transported 
via the secretory pathway to the Golgi complex rather than that the protein is post-translationally 
inserted into Golgi membranes. Third, it indicates that the targeting information in wild-type 2B is 
trans-dominant in the mixed multimer. 
To provide further evidence that the restored localization of the 2B-K41L/K44L/K48L mutant 
is indeed due to multimerization, a number of 2B mutants, carrying mutations in different regions of 
the protein, were assayed. The mutants were selected on their Golgi localization and their differential 
abilities to multimerize in the mammalian two-hybrid system (summarized in Fig. 1B). Three 
homomultimerization-competent mutants were used in the present study, namely the 2B-ins(5)linker 
and 2B-ins(34)linker mutants, containing linker insertions at amino acid positions 5 and 34, respectively, 
and the 2B-R81A/K84A/K86A mutant, containing three amino acid substitutions downstream HR2 
[109; 146]. In addition, two mutants were selected that failed to homomultimerize in the mammalian 
two-hybrid system (2B multimerization is not a prerequisite for its Golgi localization [124; 146]), 
namely the 2B-D61V/D62V mutant, containing two substitution mutations in the hydrophilic loop 
between HR1 and HR2, and the 2B-I64S/V66S mutant, containing two substitution mutations in 
HR2 [109; 146]. Unfortunately, no suitable HR1 mutant was available; the only HR1 mutant that 
failed to multimerize (mutant 2B-L46N/V47N/I49N/I50N) showed no Golgi localization [109; 146]. 
The mutants were expressed with a C terminal c-Myc tag and their localization was determined as 
described above. Figure 3 shows that the 2B-K41L/K44L/K48L mutant localized to the Golgi complex 
upon coexpression with either the 2B-ins(5)linker, 2B-ins(34)linker, or 2B-R81A/K84A/K86A mutant 
(Figs. 3A, 3B and 3E, respectively), indicating that each of these mutants formed mixed multimers 
with the mislocalized 2B mutant. In contrast, the 2B-D61V/D62V and 2B-I64S/V66S mutants were 
unable to restore the subcellular localization of 2B-K41L/K44L/K48L (Figs. 3C and 3D, respectively), 
indicating that these mutants were unable to form mixed multimers with the 2B-K41L/K44L/K48L 
mutant. These results (which are summarized in Fig. 1B) are in line with our mammalian two-hybrid 
results and biochemical studies, which both point to the importance of the hydrophobic regions, and the 
hydrophilic loop in between them, for multimerization and pore formation.
The formation of mixed multimers may be of relevance when cells are coinfected with wild-
type virus and a slowly growing 2B mutant virus. On the one hand, it can be hypothesized that mixed 
CHAPTER 570
5
WILD-TYPE COXSACKIEVIRUS PROTEIN 2B RESTORES LOCALIZATION OF AN ER-RETAINED 2B MUTANT: 
EVIDENCE FOR MULTIMERIZATION AND ER-TO-GOLGI TRAFFICKING OF THE 2B PROTEIN
71
5
Figure 3. Subcellular localization of the 
EGFP-tagged 2B-K41L/K44L/K48L mutant 
in the presence of the myc-tagged mutants 
2B-ins(5)linker (A), 2B-ins(34)linker (B), 
2B-D61V/D62V (C), 2B-I64S/V66S (D), and 
2B-R81A/K84A/K86A (E). The 2B-K41L/K44L/
K48L mutant localized to Golgi membranes 
upon coexpression with 2B-ins(5)linker, 2B-
ins(34)linker, or 2B-R81A/K84A/K86A. Upon 
coexpression with 2B-D61V/D62V or 2B-I64S/
V66S, the ER localization of the 2B-K41L/K44L/
K48L mutant was not restored. Bar = 10µm. For 
full color fi gure, see page 155.
multimers could rescue the function of the mutant 2B in trans. On the other hand, it should be considered 
that this could impair the function of the wild-type 2B. Indeed, it was previously reported that insertion 
mutations immediately upstream HR1 (at amino acid positions 28 or 34) in the poliovirus 2B protein 
exerted a dominant effect over the replication of wild-type virus in mixed infections [82], suggesting 
that the function of the wild-type 2B protein in viral RNA replication is affected by the defective 
mutant protein through the formation of mixed 2B multimers. Adverse effects of the formation of mixed 
multimers on the function of the wild-type 2B protein may also explain, at least partly, why defects in 
RNA replication due to mutations in the 2B protein are so poorly complemented in trans.  
In summary, we have provided new in vivo evidence for the multimerizing capacity of the 
coxsackievirus 2B protein by assaying its ability to restore the traffi cking defect of the 2B-K41L/K44L/
K48L mutant. The results obtained with the mutants are in agreement with those of the mammalian 
two-hybrid system, indicating that both methods are valuable tools to study 2B multimerization 
reactions. The method described in this study has the advantage that it allows the investigation and 
characterization of multimerization reactions in the proper environment of the 2B protein, i.e., within 
the membranes to which it is normally localized.
This work was partly supported by grants from the Netherlands Organisation for Scientifi c 
Research (NWO-917.46.305) and the European Communities (INTAS 2012).
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Enteroviruses, small cytolytic RNA viruses, confer an antiapoptotic state to 
infected cells in order to suppress infection-limiting apoptotic host cell responses. 
This antiapoptotic state also lends protection against cell death induced by metabolic 
inhibitors like actinomycin D and cycloheximide. The identity of the viral antiapoptotic 
protein and the underlying mechanism are unknown. Here, we provide evidence that 
the coxsackievirus 2B protein modulates apoptosis by manipulating intracellular Ca2+ 
homeostasis. Using fl uorescent Ca2+ indicators and organelle-targeted aequorins, we 
demonstrate that ectopic expression of 2B in HeLa cells decreases the Ca2+ content 
of both the endoplasmic reticulum and the Golgi, resulting in downregulation of 
Ca2+ signaling between these stores and the mitochondria, and increases the infl ux 
of extracellular Ca2+. In our studies towards the physiological importance of the 2B-
induced alterations in Ca2+ signalling, we found that expression of 2B suppressed 
caspase activation and apoptotic cell death induced by various stimuli, including 
actinomycin D and cycloheximide. Mutants of 2B that were defective in reducing the 
Ca2+ content of the stores failed to suppress apoptosis. These data implicate a functional 
role of the perturbation of intracellular Ca2+ compartmentalization in the enteroviral 
strategy to suppress intrinsic apoptotic host cell responses. The putative downregulation 
of an ER-dependent apoptotic pathway is discussed.  
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INTRODUCTION
Many viruses are endowed with the potential to manipulate cell death pathways in order to 
prevent premature abortion of the infectious cycle [147; 148]. The molecular mechanism by which 
enteroviruses manipulate the life span of their host cell is as yet poorly understood. Enteroviruses 
(coxsackievirus, poliovirus, ECHOvirus) are nonenveloped, cytolytic RNA viruses that replicate their 
genome at secretory pathway-derived membrane vesicles that accumulate in the cytoplasm of the 
infected cell [54]. Classically, lytic viral replication is believed to induce canonical cellular necrosis 
by destruction of the plasma membrane, causing the collapse of ionic gradients. However, evidence is 
accumulating that the issue of how enteroviruses induce cell death is much more complex. Enterovirus 
infection leads to the development of the so-called cytopathic effect (CPE), a necrosis-like type of 
cell death that is characterized by rounding up of the infected cells, distortion and displacement of the 
nuclei, condensation of chromatin, and increased plasma membrane permeability. This type of cell death 
is the result of a complex interplay between apoptosis-inducing and apoptosis-suppressing functions 
encoded by the enterovirus genome [70-72]. Early in infection, i.e., upon translation of the enterovirus 
RNA genome, suffi cient quantities of a putative pro-apoptotic function are produced to trigger an 
apoptotic response. Concomitantly with the onset of viral replication, however, the implementation of 
the virus-induced apoptotic program is abruptly interrupted, suggesting that enteroviruses also encode 
an antiapoptotic function [70]. This antiapoptotic function rendered infected cells also resistant against 
non-viral apoptotic stimuli like cycloheximide and actinomycin D [71]. The apoptosis-suppressing 
function dominates upon productive infection (i.e., conditions that allow effi cient virus replication). 
Under these conditions, only at late stages (i.e., after the development of CPE) some signs of apoptosis 
can be detected [149]. Virus replication and CPE, however, are not sensitive to caspase-inhibitors or 
overexpression of Bcl-2 [72]. The apoptosis-inducing function dominates upon non-permissive infection 
(i.e., conditions that restrict virus growth). The full-blown apoptosis that is induced under these latter 
conditions is effi ciently suppressed by caspase inhibitors as well as by Bcl-2 overexpression [72].   
Recent studies have shed some light on the identity of the putative apoptosis-inducing enterovirus 
proteins. Individual expression of the viral proteinases 2Apro, which inhibits cap-dependent translation 
of cellular mRNAs, or 3Cpro, which shuts off host cell RNA transcription, results in apoptotic cell 
death [68; 69]. Little is known about the identity of the apoptosis-suppressing factors. The 3A protein 
suppresses the extrinsic apoptotic pathway by eliminating labile receptors from the cell surface [65] 
through its ability to inhibit protein secretion [46]. The enteroviral protein that is responsible for the 
suppression of the intrinsic apoptotic host cell responses has not yet been identifi ed.  
Ca2+ is one of the most versatile and universal signaling mediators in cells and is required for 
the activation of many cellular processes. Increasing evidence indicates that alterations in the fi nely 
tuned intracellular Ca2+ homeostasis and compartmentalization can lead to cell death, either through 
apoptosis or necrosis [150]. The switch from the control of physiological functions to the death program 
most likely involves alterations in the tightly regulated spatio-temporal Ca2+ pattern or alterations at the 
level of organelles (e.g., mitochondria, ER/Golgi) or effector proteins (e.g., calpain, calcineurin) that 
are activated by Ca2+ [151]. Enteroviruses have a profound effect on intracellular Ca2+ homeostasis [42; 
45]. We have previously shown that infection of HeLa cells with coxsackievirus results in a reduction of 
the amount of Ca2+ that can be released from the intracellular stores. In parallel, a gradual increase in 
the cytosolic Ca2+ concentration ([Ca2+]cyt) as observed due to the infl ux of extracellular Ca2+ [42]. 
The enterovirus 2B protein has been implicated in the virus-induced alterations in intracellular 
Ca2+ homeostasis [42; 49]. The 2B protein is a small (97-99 aa) membrane-integral replication 
protein [124] that in infected cells is localized at the surface of the ER- and Golgi-derived membrane 
vesicles at which viral replication takes place [54; 57; 61]. All enterovirus 2B proteins contain two 
hydrophobic regions, of which one is predicted to form a cationic amphipathic α-helix [83; 84]. This 
amphipathic α-helix displays characteristics typical for the group of membrane-lytic α-helical peptides 
that can build membrane-integral pores by forming multimeric transmembrane bundles [85; 87]. 
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Homomultimerization reactions of 2B have been demonstrated by yeast and mammalian two-hybrid 
[99; 109], biochemical approaches [127], and in living cells using FRET microscopy [113]. These data 
strongly suggest that 2B is responsible for the reduction of the [Ca2+] in ER and Golgi ([Ca2+]ER and 
[Ca2+]Golgi) by building pores in the membranes of these organelles. Direct evidence that 2B indeed 
causes a reduction in [Ca2+] of the stores, however, is still lacking.  
In this study, we investigated Ca2+ homeostasis in 2B-expressing cells and evaluated the 
physiological importance of the alterations in Ca2+ signaling for the implementation or suppression of 
the different cell death programs. Using fl uorescent Ca2+ indicators and organelle-targeted aequorins, 
genetically encoded Ca2+ sensors, we demonstrate that 2B indeed reduces [Ca2+]ER and [Ca2+]Golgi  in 
HeLa cells. We show that this leads to a decrease in the amount of Ca2+ that can be released from these 
stores and, as a consequence, in the stimulus-induced rise of [Ca2+] in the mitochondria ([Ca2+]mt). 
Moreover, the infl ux of Ca2+ from the extracellular medium is increased, and thus the [Ca2+]cyt 
responses are larger. In our studies towards the functional importance of the 2B-induced manipulation 
of intracellular Ca2+ signaling, we found that expression of 2B suppressed apoptosis induced by certain 
stimuli, including actinomycin D and cycloheximide. 2B mutants that were unable to reduce the Ca2+ 
content of the stores failed to protect against apoptosis. These data implicate a functional role of the 2B-
induced perturbation of intracellular Ca2+ compartmentalization in the enteroviral strategy to suppress 
premature abortion of the viral life cycle and provide a physiological example of the regulatory role of 
Ca2+ signaling in the modulation of apoptotic cell death. 
RESULTS
CA2+ HOMEOSTASIS IN 2B-EXPRESSING CELLS
To investigate the effects of 2B on subcellular Ca2+ homeostasis, we made use of a fusion protein 
of 2B and GFP. We have previously shown that fusion of EGFP at the C terminus of the coxsackievirus 
2B protein does not interfere with its membrane-active function and localization [124]. Because 
the EGFP fl uorescence heavily contaminates that of the fl uorescent Ca2+ indicator Fura-2 (data not 
shown) [157], we made use of GFP (S65T), a non-enhanced GFP protein that exhibits 30-fold reduced 
fl uorescence intensity relative to EGFP. Figure 1A shows [Ca2+]cyt of nontransfected control cells and 
cells expressing either GFP (S65T) or 2B-GFP (S65T). The [Ca2+]cyt in GFP-expressing cells was 
slightly lower than that of control cells (suggesting that there is some minor contamination of the Fura-2 
fl uorescence by GFP). Expression of 2B-GFP, however, resulted in a signifi cant increase in [Ca2+]cyt (p 
< 0.01), previously shown to depend on extracellular Ca2+ [42]. 
Next, we addressed the relationship between the [Ca2+]cyt and the [Ca2+] of the intracellular 
stores (i.e., ER and Golgi) using thapsigargin, a specifi c inhibitor of the SERCA pump. The activity 
of the SERCA is required to compensate for the continuous leakage of Ca2+ that takes place from 
the stores under normal conditions. Upon inhibition of the SERCA, Ca2+ that leaks from the stores 
is not resequestered and accumulates in the cytosol. The size of the thapsigargin-induced transient 
increase in [Ca2+]cyt refl ects the [Ca2+] of the stores. Figure 1B shows that the amount of thapsigargin-
releasable Ca2+ in cells expressing GFP was similar to that observed in nontransfected control cells. 
Cells expressing 2B-GFP, however, exhibited a signifi cant decrease (p < 0.01) in the amount of 
thapsigargin-releasable Ca2+. Figure 1C shows representative traces of nontransfected controls cells, 
cells expressing GFP and cells expressing 2B-GFP. The amount of thapsigargin-releasable Ca2+ from 
cells expressing 2B-GFP exhibited an inverse relationship with the initial [Ca2+]cyt (as measured in the 
presence of extracellular Ca2+); i.e., the higher the initial [Ca2+]cyt the lower the amount of Ca2+ that 
can be released from the stores (Figs. 1C and 1D). Figure 1D also demonstrates that the fi lling state of 
the thapsigargin-sensitive stores of 2B-GFP expressing cells was always lower than that of control cells, 
even when the initial [Ca2+]cyt was similar. Taken together, these results show that the 2B-induced 
reduction in [Ca2+] of the stores precedes the increased infl ux of extracellular Ca2+, providing evidence 
that the stores are the primary target of 2B.
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Figure 1. Intracellular Ca2+ homeostasis in 2B-expressing cells. (A) [Ca2+]cyt of CHO cells expressing  GFP or 2B-GFP at 
48 hours posttransfection. Cells were loaded with Fura-2/AM, GFP-positive cells were identifi ed, the fl uorescence at 340 nm and 
380 nm was analysed, and the ratio 340/380 nm was calculated. (B) Amount of thapsigargin-releasable Ca2+. The average peak 
increase in the thapsigargin-induced 340/380 nm ratio is shown (i.e., the increase in the 340/380 nm ratio relative to the basal 
340/380 nm ratio in Ca2+-free medium that was recorded just before the addition of thapsigargin, see Fig. 1C). (C) Representative 
traces showing the peak increases in thapsigargin response of a control cell, a GFP expressing cell, and three 2B-GFP expressing 
cells. (D) Average peak increase in the thapsigargin-induced 340/380 nm ratio plotted against the initial 340/380 nm ratio of cells 
in the presence of extracellular Ca2+. Note that the average amount of thapsigargin-releasable Ca2+ of 2B-GFP-expressing cells 
that exhibited an initial 340/380 nm ratio of 0.6-0.9 (which is similar to that of the control cells) was signifi cantly lower than that 
of control cells. In each experiment, the 340/380 nm ratio of a large number of cells from different coverslips was analysed. The 
average ± SD of fi ve independent experiments is shown. *, P < 0.05; **, P < 0.01.
CHAPTER 678
6
THE COXSACKIEVIRUS 2B PROTEIN SUPPRESSES APOPTOTIC HOST CELL 
RESPONSES BY MANIPULATING INTRACELLULAR CA2+ HOMEOSTASIS
79
6
A
B CaCl2 CaCl2
Hist. Hist.
30 s
[C
a
]
µM
2+
G
ol
gi
,
400
300
100
0
200
CaCl2 CaCl2
Hist. Hist.
30 s
[C
a
]
µM
2+
E
R
,
400
300
100
0
200
[C
a
]
µM
2+
E
R
,
400
300
100
0
200
*
control + 2B
[C
a
]
µM
2+
G
ol
gi
,
400
300
100
0
200
*
control + 2B
Figure 2. [Ca2+]ER and [Ca2+]Golgi in 2B-expressing cells. HeLa cells were cotransfected with ER-targeted or Golgi-targeted 
aequorin (erAEQ or GoAEQ, respectively) and 2B-GFP or mt-GFP (control). At 36 h posttransfection, the organelles were 
depleted of Ca2+ to optimise AEQ reconstitution. After this, the cells were transferred to the luminometer chamber and AEQ 
luminescence was collected and calibrated into [Ca2+] values as described in Materials and Methods. Representative traces of 
[Ca2+]ER (A) and [Ca2+]Golgi (B) in 2B-expressing cells (grey line) and control cells (black line) are shown on the left. On the 
right is shown the average ± SD of ten independent experiments. *, P < 0.005.
REDUCED ER AND GOLGI LUMENAL CA2+ CONCENTRATIONS IN 2B-EXPRESSING CELLS
To investigate the effect of 2B on ER and Golgi calcium levels directly and independently, 
we used chimeras of aequorin (AEQ), a Ca2+-sensitive photoprotein. To this end, HeLa cells were 
cotransfected with erAEQ or GoAEQ and 2B-GFP or mt-GFP (which was further used as negative 
control throughout this study) and the [Ca2+]ER and [Ca2+]Golgi were compared. To effi ciently 
reconstitute the aequorin chimeras and to reliably measure [Ca2+]ER and [Ca2+]Golgi, the lumenal 
[Ca2+] of these organelles fi rst must be reduced. This was obtained by incubation of the cells in KRB 
supplemented with coelenterazine (i.e., the prosthetic group of aequorin) and ionomycin, a Ca2+ 
ionophore, in the absence of extracellular Ca2+. Aequorin luminescence signals were collected using 
a luminometer and calibrated into [Ca2+] values. Under these conditions, the [Ca2+] was < 10 mM in 
both organelles. Upon switching the perfusion medium to KRB buffer supplemented with 1 mM Ca2+, 
[Ca2+]ER and [Ca2+]Golgi gradually increased, reaching in control cells plateau levels of ~365 mM in 
the ER and ~345 mM in the Golgi (Fig. 2). In 2B-GFP-expressing cells, lower steady state levels (~30-
40% reduction) were observed in both compartments (~255 mM and ~215 mM in the ER and Golgi, 
respectively). Addition of histamine to the cells resulted in a rapid decrease in [Ca2+] in both organelles, 
confi rming that sensitivity to agonists of the two Ca2+ stores was retained, although a smaller amount of 
Ca2+ could be released in 2B-expressing cells. Taken together these data indicate that 2B is responsible 
for a reduction of the lumenal [Ca2+] in both ER and Golgi. 
MITOCHONDRIAL AND CYTOSOLIC CA2+ HANDLING IN 2B-EXPRESSING CELLS
Mitochondria play an important role in intracellular Ca2+ homeostasis. The mitochondria are 
localized in close proximity of inositol 1,4,5 trisphosphate (IP3)-gated channels and are capable of 
taking up Ca2+ that is released by IP3-generating agonists, thereby buffering the [Ca2+]cyt [158]. We 
hypothesized that the 2B-induced reduction in the steady state [Ca2+]ER and [Ca2+]Golgi levels and the 
ensuing reduction of IP3-induced Ca2+ release should decrease the uptake of Ca2+ by the mitochondria. 
To test this hypothesis, HeLa cells were transfected with mtAEQ and either 2B-GFP or mt-GFP and 
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Figure 3. Stimulus-induced increases in [Ca2+]mt and [Ca2+]cyt in 2B-expressing cells. HeLa cells were cotransfected with 
mitochondrially-targeted or cytosolic aequorin (mt AEQ or AEQ, respectively) and 2B-GFP or mt-GFP (control), incubated 
in medium containing extracellular Ca2+, and then challenged with 100 µM histamine (hist.). (C) HeLa cells transfected 
with cytAEQ and 2B-GFP or mt-GFP (control) were incubated in Ca2+-free medium (+ 100 µM EGTA) and challenged with 
histamine, followed by the addition of Ca2+-containing medium. Representative traces in [Ca2+]mt (A) and [Ca2+]cyt (B) in 
2B-expressing cells (grey line) and control cells (black line) are shown on the left. On the right is shown the average ± SD of six 
independent experiments. *, P < 0.005.
then challenged with histamine (in the presence of extracellular Ca2+). Fig. 3A shows that the peak 
mitochondrial response is markedly reduced (almost ~35%) in 2B-GFP-expressing cells compared to 
the control cells. Similar results were obtained when cells were challenged with ATP, an agonist that 
drives production of IP3 through its action on a Gq-coupled P2Y receptor, or when CHO cells were used 
as model system (data not shown). Taken together, these data indicate that the 2B-induced reduction of 
[Ca2+] in the stores leads to a reduction in the stimulus-induced mitochondrial Ca2+ uptake.   
The 2B-induced reduction in the steady state [Ca2+]ER and [Ca2+]Golgi levels should also 
be refl ected in a decrease in the rise of the [Ca2+]cyt upon stimulation with IP3-generating agonists. 
To investigate this supposition, HeLa cells were cotransfected with cytAEQ and 2B-GFP or mt-GFP 
and then challenged with histamine (in the presence of extracellular Ca2+). Surprisingly, we found no 
difference in the amplitude of [Ca2+]cyt between 2B-GFP-expressing cells and control cells (Fig. 3B). 
On the contrary, upon releasing Ca2+ from the stores by a passive process (i.e., ionomycin treatment 
in Ca2+-free conditions) a signifi cant reduction in 2B-GFP-expressing cells was observed (data not 
shown). A likely explanation for the results shown in Fig. 3B is that in 2B-GFP-expressing cells a 
reduced amount of Ca2+ is released by histamine, but that this effect is masked by an increased infl ux 
of Ca2+ from the extracellular medium due to an additional effect of 2B. To fi nd support for this 
hypothesis, we evaluated in HeLa and CHO cells the relative effi ciency of the two pathways for Ca2+ 
increase in the cytosol: the Ca2+ released from stores and Ca2+ infl ux from the extracellular medium. In 
these experiments, the cells were fi rst challenged with histamine in HeLa (or ATP in CHO) in Ca2+-free 
medium, under those conditions the increase of the [Ca2+]cyt will be due only to the release of Ca2+ 
from the stores. The following readdition of Ca2+ to the extracellular medium causes a second [Ca2+]cyt 
rise due to the infl ux through the plasma membrane channels. Fig. 3C demonstrates that an increased 
infl ux of Ca2+ in 2B-expressing cells indeed equilibrates the reduced amount of Ca2+ that is released 
from the stores in these cells compared to control cells.
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Figure 4. Coxsackieviruses confer an antiapoptotic state to infected cells.  (A) Coxsackievirus-induced cell death upon 
permissive and nonpermissive infection. HeLa cells were either mock-infected (left) or infected with coxsackievirus at an MOI 
of 50 in the absence (middle) or presence (right) of 2 mM GuHCl and then incubated at 37°C. At 14 h postinfection, cells were 
fi xed and the nuclei were stained with DAPI. Addition of 2 mM GuHCl to noninfected cells had no toxic effect on the cells (data 
not shown). (B) Coxsackievirus infection protects against actinomycin D and cycloheximide-induced apoptosis. HeLa cells were 
mock-infected (upper row) or infected with coxsackievirus (bottom row), grown at 37°C, and after 4 h either mock-treated (left) 
or treated with actinomycin D (0.5 mg/ml, middle) or cycloheximide (100 mg/ml, right) for 4 h. At the end of the experiment, cells 
were fi xed and the nuclei were stained with DAPI. One representative experiment of three independent experiments is shown.
COXSACKIEVIRUS INFECTION PROTECTS AGAINST CYCLOHEXIMIDE AND ACTINOMYCIN D-INDUCED APOPTOSIS
Poliovirus infection of HeLa cells under permissive conditions results in the cytopathic 
effect (CPE) whereas infection under nonpermissive conditions (e.g., in the presence of guanidine 
hydrochloride GuHCl, an inhibitor of viral replication) results in apoptotic cell death [71]. Moreover, 
productive poliovirus infection has been shown to confer an antiapoptotic state to HeLa cells that 
protects them against apoptosis induced by actinomycin D and cycloheximide (at concentrations 
of 0.5 mg/ml and 100 mg/ml, respectively) [71]. We tested whether these features are conserved in 
coxsackievirus. HeLa cells were infected with coxsackievirus in the absence or presence of GuHCl 
and the type of cell death that was induced was assayed by examining the nuclear morphology. Fig. 4A 
shows that productive coxsackievirus infection of HeLa cells (i.e., in the absence of GuHCl) resulted 
in the canonical CPE (crescent-shaped nuclei with condensed chromatin), whereas upon nonpermissive 
conditions (i.e., in the presence of absence of GuHCl) a typical nuclear apoptotic response, i.e., 
condensation of chromatin and fragmentation into apoptotic bodies, was observed in a large portion 
of the cells, similar as described for poliovirus [71]. To test whether coxsackievirus also initiates 
an antiapoptotic program, mock-infected and coxsackievirus-infected cells were challenged with 
actinomycin D and cycloheximide in the concentrations described above. Fig. 4B shows that treatment 
of mock-infected cells with these drugs resulted in a typical nuclear apoptotic response. Upon addition 
of these drugs to coxsackievirus-infected cells, however, no signs of apoptosis were observed, but 
instead signs typical of CPE were manifested. Together, these fi ndings suggest that the antiapoptotic 
function is conserved in coxsackievirus. 
To further demonstrate the existence of a viral antiapoptotic function, we monitored the ability 
of coxsackievirus to suppress caspase activation. To this end, HeLa cells that were either mock-infected 
or coxsackievirus-infected were treated with actinomycin D. Caspase activation was monitored both by 
incubating HeLa cell lysates with a caspase-3 fl uorescent substrate and by analysing internucleosomal 
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DNA degradation (“laddering”). Fig. 5 shows that both caspase activation and DNA laddering are 
strongly reduced in coxsackievirus-infected cells. These fi ndings provide further evidence for the 
existence of an antiapoptotic function in coxsackievirus. 
EXPRESSION OF 2B PROTECTS AGAINST CYCLOHEXIMIDE AND ACTINOMYCIN D-INDUCED APOPTOSIS
Next, the possible role of the coxsackievirus 2B-induced alterations in Ca2+ homeostasis in 
the suppression of apoptosis was investigated. For this, the following protocol was used. Cells were 
transfected with 2B-GFP and the number of fl uorescent cells was counted at the microscope before and 
after a challenge with an apoptotic drug. The rationale, as previously reported for other proteins, such 
as Bcl-2 [159] and VDAC [160], is that if the transfected protein increases the sensitivity to apoptotic 
agents, the number of fl uorescent cells will be lower after the apoptotic challenge (because more 
transfected cells die), while the opposite will happen if the protein has antiapoptotic activity. 
To investigate whether 2B is involved in conferring an antiapoptotic state to infected cells, 
2B-GFP-expressing cells and mt-GFP-expressing cells were challenged with actinomycin D and 
cycloheximide at 36 h posttransfection. The results obtained with actinomycin D are shown in Fig. 
6A. When mt-GFP was transfected, ~40-45% of the cells showed GFP fl uorescence. 16 hours after 
the addition of actinomycin D, the number of viable cells was drastically reduced, but the fraction of 
fl uorescent cells remained the same. Conversely, when 2B-GFP was transfected, the same fraction of 
fl uorescent cells was identifi ed before actinomycin D treatment, but it markedly increased 16 hours 
after the addition of the apoptotic agent (~70%). These data indicate that the 2B-induced alterations in 
Ca2+ homeostasis confer protection against actinomycin D-induced apoptotic cell death (P < 0.005). 
Enhanced survival was also observed upon treatment with cycloheximide (P < 0.01)(Fig. 6B).
To test whether expression of 2B also protects against other apoptotic stimuli, we tested the 
possible suppressive effect against apoptosis induced by 10 mM ceramide, a lipid signaling mediator 
that releases Ca2+ from intracellular stores and induces apoptosis via a Bcl-2 sensitive pathway [161], 
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Figure 6. Protein 2B protects against apoptotic cell death induced by actinomycin D, cycloheximide and ceramide, but 
not etoposide. HeLa cells were transfected with 2B-GFP or mt-GFP (control). At 36 h posttransfection, cells were either mock-
treated (dark grey) or treated (light grey) with actinomycin D (0.5 mg/ml) (A), cycloheximide (100 mg/ml) (B), ceramide (10 mM) 
(C), or etoposide (20 mM) (D) for 16 h. The percentage of fl uorescent cells before and after the challenge with the apoptotic 
drugs was determined de visu by counting at the microscope. The average ± SD of four independent experiments is shown. *, P 
< 0.01; **, P < 0.005.
and 20 mM etoposide, a drug that causes DNA damage by inhibiting topoisomerase II, leading to 
apoptosis through p53 via a Bcl-2-sensitive, Bax-dependent pathway. Again the number of fl uorescent 
cells before and after a treatment with the apoptotic drugs was determined. No change in the percentage 
of living fl uorescent cells was observed in HeLa cells transfected with mt-GFP. Cells expressing 2B-
GFP were effi ciently protected against apoptosis induced by ceramide (P < 0.005) (Fig. 6C) but not by 
etoposide (Fig. 6D). The failure of 2B to suppress etoposide-induced apoptosis was not due to a lower 
apoptotic effi cacy of this drug (etoposide induced apoptosis in ~60% of the cells, similar as observed for 
actinomycin D and cycloheximide, data not shown). Taken together, these data indicate that 2B protects 
against some, but not all, Bcl-2-sensitive apoptotic pathways. 
To demonstrate that the cytoprotective effect of 2B is indeed due to a reduced activation 
of caspases, cells expressing either 2B-GFP or mt-GFP were treated either with actinomycin D, 
cycloheximide, or etoposide and then stained with an antibody that specifi cally recognizes the active 
form of caspase-3 but not its inactive zymogen (Fig. 7). In control cells, the vast majority of cells 
showed extensive caspase-3 activation upon addition of each of these apoptotic drugs (similar as in 
nontransfected cells, data not shown). In 2B-expressing cells, however, caspase-3 activation induced by 
actinomycin D and cycloheximide, but not by etoposide, was potently suppressed. These fi ndings are in 
agreement with the results described in Fig. 6 and provide evidence that the enhanced survival observed 
in 2B-expressing cells is due to the suppression of caspase-3 activation. 
EFFECTS ON INTRACELLULAR CA2+ HOMEOSTASIS AND APOPTOSIS OF 2B MUTANTS
Our data strongly suggest that the 2B protein lends protection against apoptosis through its 
ability to manipulate intracellular Ca2+ homeostasis. However, it cannot be excluded that the effects 
of 2B on Ca2+ homeostasis and its anti-apoptotic ability represent two distinct, unrelated functions. To 
investigate whether the antiapoptotic activity of 2B is functionally related to its ability to manipulate 
intracellular Ca2+ fl uxes, we characterized two 2B-GFP mutants with mutations in the hydrophobic 
regions that are implicated in pore formation [124]. In the fi rst mutant, the amphipathic character of the 
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Figure 7. Protein 2B suppresses caspase-3 activation 
induced by actinomycin D and cycloheximide. HeLa 
cells were transfected with 2B-GFP or mt-GFP (control). 
At 36 h posttransfection, cells were either mock-treated 
(dark grey) or treated (light grey) with actinomycin D 
(0.5 mg/ml) (A), cycloheximide (100 mg/ml) (B), ceramide 
(10 mM) (C), or etoposide (20 mM) (D) for 4 h. Cells 
were fi xed and stained with an anti-active caspase-3 
antibody. The percentage of caspase-3-positive GFP-
expressing cells was determined de visu by counting at 
the microscope. The average ± SD of three independent 
experiments is shown. *, P < 0.005.
α-helix formed by the fi rst hydrophobic region (aa 37-54) is disturbed by substitution of lysine residues 
41, 44 and 48 by hydrophobic leucine residues (mutation K41L/K44L/K48L) [109]. In the second 
mutant, the hydrophobic nature of the second hydrophobic region (aa 63-80) is disturbed by substitution 
of two hydrophobic residues (isoleucine-64 and valine-66) by polar serine residues (mutation I64S/
V66S) [83]. 
HeLa cells were cotransfected with erAEQ and the indicated 2B-GFP mutants or mt-GFP and the 
[Ca2+]ER was compared. Fig. 8A shows that both mutant 2B-K41L/K44L/K48L and 2B-I64S/V66S 
failed to reduce the lumenal [Ca2+] in the ER. Consistent with this, measurement of the [Ca2+]mt upon 
challenge with histamine in cells transfected with mtAEQ showed that the peak mitochondrial Ca2+ 
response in cells expressing the mutants was similar as in control cells (Fig. 8B). These data provide 
evidence that both mutants are defective in manipulating intracellular Ca2+ fl uxes. To investigate the 
antiapoptotic activity of these mutants, HeLa cells expressing the 2B-GFP mutants were challenged with 
either actinomycin D or cycloheximide and caspase-3 activation was analysed as described above.
Fig. 9 shows that mutants 2B-K41L/K44L/K48L and 2B-I64S/V66S were unable to suppress 
either actinomycin D-induced or cylcoheximide-induced caspase-3 activation. Consistent with this, 
both mutants also failed to increase cell survival after treatment with these apoptotic drugs (data not 
shown). Together, these fi ndings demonstrate that the antiapoptotic activity of 2B is functionally linked 
to its ability to manipulate intracellular Ca2+ homeostasis. 
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Figure 8. Mutants 2B-K41L/K44L/K48L and 2B-I64S/V66S do not alter intracellular Ca2+ homeostasis.  Measurement of 
the steady-state [Ca2+]ER (A) and the histamine-induced increase in [Ca2+]mt (B) were performed as described in the legends 
of Fig. 2 and 3, respectively. 
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Figure 9. Mutants 2B-K41L/K44L/K48L and 2B-
I64S/V66S fail to suppress actinomycin D-induced 
and cycloheximide-induced apoptosis. Analysis of the 
caspase-3 activation induced by actinomycin D (A) or 
cycloheximide (B) was performed as described in the 
legend of Fig. 7.  
DISCUSSION
Viruses induce a number of alterations in metabolism and structure of their host cell in order to 
ensure effi cient reproduction. Some of these alterations can be sensed by the host cell and turn on a 
defensive apoptotic reaction that is aimed at curtailing virus replication. Many viruses have developed 
countermeasures to prevent premature abortion of the viral life cycle. Enteroviruses are small cytolytic 
RNA viruses that cause a necrosis-like type of cell death, called CPE, which is the ultimate result 
of a complex interplay between apoptosis-inducing and apoptosis-suppressing functions encoded 
by the enterovirus genome [71]. In this report, we provide evidence that the enterovirus 2B protein 
plays a major role in suppressing apoptotic host cell responses by manipulating intracellular Ca2+ 
homeostasis. 
Using both chemical and genetically-encoded Ca2+ indicators, we demonstrated that expression 
of 2B results in (i) a reduction in the lumenal [Ca2+] in both ER and Golgi, (ii) a decrease in the amount 
of Ca2+ that can be released from these organelles using either thapsigargin or physiological, IP3-
generating stimuli like histamine and ATP, (iii) a reduction in the stimulus-induced amount of Ca2+ that 
is taken up by mitochondria, and (iv) an increase in the infl ux of extracellular Ca2+, leading to a rise 
in [Ca2+]cyt. The reduction in the Ca2+ fi lling state of the stores preceded the increase in the infl ux of 
extracellular Ca2+, indicating that the stores are the primary target of 2B. Similar results were obtained 
in HeLa cells and CHO cells arguing that it is unlikely that the effects of 2B are cell-type specifi c. 
These data are consistent with the idea that 2B decreases [Ca2+]ER and [Ca2+]Golgi by increasing the 
passive leakage of Ca2+ ions from these stores, most likely through the formation of membrane-integral 
pores, and thereby accounts for a reduction in the amount of releasable Ca2+ and the downregulation 
of Ca2+ fl uxes between stores and the mitochondria. The increased infl ux of Ca2+ is most likely due to 
the increased plasma membrane permeability that is observed in 2B-expressing cells and that allows the 
passage of ions and normally nonpermeant low-molecular-weight compounds [46-48]. 
The 2B-induced perturbation of intracellular Ca2+ distribution and signaling was identifi ed as 
an important component of the enteroviral strategy to suppress infection-limiting apoptotic host cell 
responses. These apoptotic responses are most likely triggered by the action of viral proteinases 3Cpro 
and 2Apro, which inhibit cellular transcription and cap-dependent translation, respectively [68; 69]. 
Enteroviruses interrupt this apoptotic program by encoding functions that implement an antiapoptotic 
program [71]. The antiapoptotic state that is conferred to infected cells can even suppress nonviral 
apoptotic stimuli such as cycloheximide and actinomycin D (whose effects resemble those of 3Cpro and 
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2Apro, respectively). In our studies towards the physiological relevance of the 2B-induced alterations in 
intracellular Ca2+ homeostasis, we observed a role for 2B in suppressing apoptosis. Expression of 2B 
suppressed caspase-3 activation and apoptotic cell death induced by actinomycin D and cycloheximide. 
Mutants of 2B that were defective in manipulating intracellular Ca2+ fl uxes failed to protect against 
apoptosis. Together, these fi ndings strongly suggest that 2B, by modulating intracellular Ca2+ 
homeostasis, plays a major role in conferring the antiapoptotic state to infected cells and, thereby, in 
extending the life span of the host cell.  
The enterovirus 2B protein represents one of the fi rst antiapoptotic proteins of small genome RNA 
viruses. Most of our knowledge about viral apoptosis-suppressing functions comes from the group of 
large genome DNA viruses (herpesviruses, adenoviruses, and poxviruses), which often encode multiple 
antiapoptotic proteins, including Bcl-2 homologs, caspase suppressors, and cell cycle and transcription 
mediators [147; 148]. Relatively little is known about apoptosis-suppressing functions in small genome 
RNA viruses that exhibit a relatively fast replication cycle and which have little, if any, genetic capacity 
to develop individual antiapoptotic functions. It has been suggested that antiapoptotic activities of RNA 
viruses may be byproducts of the cellular alterations that are induced by the viral replication proteins 
to effi ciently replicate their RNA genome. Obviously, the ability of 2B to suppress apoptotic host cell 
responses is not its sole and primary function. Mutations in the hydrophobic domains of 2B, which 
most likely interfere with pore formation (as shown in this study for mutations K41L/K44L/K48L and 
I64S/V66S), cause primary defects in viral RNA replication [83; 84]. The exact function of 2B is as 
yet unknown. The ability of 2B to form pore-like structures in secretory pathway membranes may be 
required for the ability of the 2BC precursor to cause the accumulation of secretory pathway-derived 
membrane vesicles at which viral RNA replication takes place [54; 55]. Thus, the ability of 2B to reduce 
the Ca2+ fi lling state of the stores most likely serves two different functions; formation of the viral 
replication complex and suppression of apoptotic host cell responses. 
How can the 2B-induced alterations in intracellular Ca2+ signaling lend protection against 
certain apoptotic stimuli? The fi nding that 2B failed to suppress etoposide-induced apoptosis indicates 
that the alterations in Ca2+ homeostasis suppress a specifi c apoptotic pathway rather than conferring 
a general blockage of apoptosis. Recent studies on the Bcl-2 oncogene have provided evidence for 
the coexistence of spatially different apoptotic pathways in the same cell, one ER-dependent and 
one mitochondrium-dependent, which eventually converge at the mitochondria [162; 163]. Bcl-2 is 
localized at the outer mitochondrial membrane, the nuclear envelope, and the ER membrane. Most 
of the results published so far have emphasized the importance of Bcl-2 at the mitochondria, where it 
antagonizes the ability of pro-apoptotic Bcl-2 family members to induce cytochrome C release [164]. 
The function of Bcl-2 at the ER membrane is less clear. An ER-restricted Bcl-2 mutant suppressed 
apoptosis induced by various stimuli (including ceramide) but failed to protect against etoposide, a 
drug that acts directly at the mitochondria by causing membrane translocation of Bax [148; 162]. The 
antiapopotic activity of ER-restricted Bcl-2 argues for the existence of a signaling mechanism between 
the ER and the mitochondria. Growing evidence indicates that alterations in Ca2+ fl uxes between these 
organelles have a modulatory effect on apoptosis [151]. Key events occurring in the mitochondrial 
matrix such as ATP production, an important source of reactive oxygen species production, and possibly 
also the opening of the permeability transition pore, leading to swelling of the outer mitochondrial 
membrane and the release of proapoptotic proteins like cytochrome C, are sensitive to increases in 
[Ca2+]mt [151; 165]. Accordingly, downregulation of Ca2+ fl uxes between the ER and the mitochondria 
can protect the mitochondria from cytotoxic rises in [Ca2+]mt. Increasing evidence indicates that Bcl-2 
exerts some of its antiapoptotic effects from the ER by reducing [Ca2+]ER and downregulating Ca2+ 
fl uxes between the ER and mitochondria [159; 166; 167], possibly through the ability of Bcl-2 to form 
ion channels in the ER membrane [168]. Moreover, conditions that lowered [Ca2+]ER protected HeLa 
cells from ceramide-induced apoptosis whereas conditions that increased [Ca2+]ER had the opposite 
effect [161]. The fi ndings that 2B downregulated Ca2+ fl uxes between the stores and the mitochondria 
and suppressed apoptosis induced by ceramide, but not etoposide, strongly suggest that 2B specifi cally 
targets a Ca2+-sensitive, ER-dependent apoptotic pathway.
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Is the ability of 2B to decrease Ca2+ signaling between the ER and mitochondria suffi cient for 
conferring an antiapoptotic state to enterovirus-infected cells? Both in poliovirus-infected cells [70; 71] 
and in coxsackievirus-infected cells (this study), the antiapoptotic function is expressed already early 
in infection (i.e., at about 2 h postinfection). Previously, we demonstrated that coxsackievirus infection 
results in a ~50% reduction of the Ca2+ content of the thapsigargin-sensitive stores within the fi rst 2 h 
of infection [42]. Thus, the virus-induced alterations in intracellular Ca2+ signaling coincide with the 
implementation of the antiapoptotic state, lending support to the idea that these events are causally 
linked. It cannot be excluded that the rise in [Ca2+]cyt also somehow contributes to the suppression of 
apoptosis in infected cells. A rise in [Ca2+]cyt may lead to the activation of calpains, Ca2+-sensitive 
proteases that can exert antiapoptotic effects by cleaving caspases, including key caspases 8 and 9 [169; 
170]. Interestingly, aberrant processing of caspase-9 (albeit at a low level) was observed in HeLa cells 
upon productive poliovirus infection but not upon abortive infection [171]. However, aberrant processing 
of caspase-9 was not reported upon productive coxsackievirus infection [172]. Our observation that the 
2B-induced alterations in Ca2+ homeostasis failed to protect against etoposide-induced caspase-9-
dependent apoptosis suggests that it is unlikely that aberrant processing of caspase-9 can completely 
account for the antiapoptotic activity of 2B. Moreover, signifi cant rises in [Ca2+]cyt of coxsackievirus-
infected cells take place only after 5 h. Therefore, we propose that the 2B-induced reduction of the Ca2+ 
content of the ER and Golgi, and the resulting downregulation of  Ca2+ fl uxes between these stores and 
the mitochondria is the major component of the viral antiapoptotic program. It should be kept in mind, 
however, that later in infection signs of apoptosis (cytochrome C release and caspase activation) become 
apparent in enterovirus-infected cells [149; 171; 172], and it has been suggested that this may contribute 
to the killing of the host cell and the release of virus progeny [172]. Thus, the antiapoptotic activity 
of the 2B protein most likely serves to delay apoptotic responses, thereby providing the virus the time 
required for genome replication, rather than to completely prevent all signs of apoptosis. 
Further research is required to defi ne the antiapoptotic mechanism of 2B and the role of Ca2+ 
herein. A better understanding of the molecular mechanism used by enteroviruses to manipulate cell 
death may lead to a better insight into the pathogenesis of viral disease and may contribute to our 
understanding of the critical role of Ca2+ signaling in the modulation of apoptosis. 
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EXPERIMENTAL PROCEDURES
REAGENTS AND SOLUTIONS
Fura-2/AM and coelenterazine were purchased from Molecular probes (The Netherlands). Thapsigargin, histamine, 
actinomycin D, cycloheximide, N-acetyl-D-sphingosine (C2 Ceramide), and etoposide were purchased from Sigma. DAPI was 
obtained from Merck. HT buffer contained 132.6 mM NaCl, 5.5 mM glucose-monohydrate, 10 mM HEPES, 4.2 mM MgCl2, and 
(1x) MEM Eagle amino acids (Gibco). Krebs Ringer Buffer (KRB) contained: 20 mM HEPES pH 7.4, 125 mM NaCl, 5 mM KCl, 
1 mM MgSO4, 1 mM Ha2HPO4, 20 mM NaHCO3, 5.5 mM glucose, 2 mM L-glutamine. 
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CELL CULTURE, VIRUSES, PLASMIDS, AND TRANSFECTION
HeLa cells were grown in DMEM (Gibco) supplemented with 10% FBS, 100 units penicillin per ml and 25 mg 
streptomycin per ml. CHO cells were grown in DMEM supplemented with 10% FBS and 100 mg gentamycin per ml. Cells were 
grown at 37°C in a 5% CO2 incubator.
The coxsackievirus B3 used in this study was derived from plasmid pCB3/T7, which contains a cDNA of coxsackievirus 
B3 (strain Nancy) behind a T7 RNA polymerase promoter. Virus titers were determined by endpoint titration as described [83]. 
Plasmid GFP (S65T) was from Clontech. Plasmid 2B-GFP (S65T) was constructed by replacing the ECFP coding region 
from 2B-ECFP [113] by the GFP (S65T) coding region using AgeI and BfrI. Plasmid 2B-EGFP has been described [124]. Plasmid 
mt-GFP encodes an EGFP protein that is targeted to the mitochondria through fusion with the signal sequence of cytochrome 
oxidase subunit VIII [152]. ER-targed aequorin (erAEQ), Golgi-targeted aequorin (GoAEQ), mitochondrially-targeted aequorin 
(mtAEQ) and cytosolic aequorin (cytAEQ) have been described [116; 153-155]. 
For the Fura-2/AM measurements, 3 x 105 CHO cells were transfected with 2 mg of either GFP (S65T) or 2B-GFP 
(S65T) using Lipofectin (Invitrogen). After 24 hours, 5 x 104 cells were seeded onto 24 mm coverslips and grown for another 
16 hours before [Ca2+ ]cyt measurements. For the aequorin measurements, HeLa cells were seeded onto 13 mm coverslips 
and cotransfected using the Ca2+ phosphate technique with 1mg of erAEQ, GoAEQ, cytAEQ, or mtAEQ, together with 3 mg 
of 2B-EGFP or in combination with the same amount 3 mg of mt-GFP (which served as negative control). For the cell death 
experiments, HeLa cells were seeded onto 24 mm coverslips and transfected with 4 mg of 2B-EGFP or mt-GFP.  
FURA-2/AM MEASUREMENTS
The fl uorescent Ca2+ indicator Fura-2 was used to measure [Ca2+]cyt at the single cell level essentially as described [42]. 
Briefl y, cells were incubated in medium supplemented with 2.5 mM Fura-2/AM for 30 min, washed with HT buffer to remove 
extracellular probe, supplied with preheated HT buffer (supplemented with 1 mM CaCl2) and placed in a thermostated (37°C) 
incubation chamber on the stage of an inverted fl uorescence microscope (Nikon). Dynamic video imaging was performed using 
the MagiCal hardware and TARDIS software (Joyce Loebl, UK). Fluorescence was measured every 2 sec with the exitation 
wavelength being altered between 340 and 380 nm and the emission fl uorescence being recorded at 492 nm. At the end of the 
experiment, a region free of cells was selected and one averaged background frame was collected at each excitation wavelength 
for background correction. To measure [Ca2+] of the stores, the amount of thapsigargin-releasable Ca2+ was determined. After 
recording the cells in Ca2+-containing HT buffer, the medium was replaced with Ca2+-free HT buffer supplemented with 0.5 mM 
EGTA. After 10 min, the cells were challenged with 1 mM thapsigargin and [Ca2+]cyt was measured as described above.
AEQUORIN MEASUREMENTS
Organelle-targeted aequorin constructs were used to measure the [Ca2+] in the cytosol and different organelles at the 
cell population level (at 36 h posttransfection). For the mtAEQ and cytAEQ measurements, the cells were incubated with 5 µM 
coelenterazine for 1-2 h in DMEM supplemented with 1% FBS and then transferred to the perfusion chamber. For reconstituting 
with high effi ciency the erAEQ and GoAEQ, the lumenal [Ca2+] of the ER and Golgi fi rst must be reduced. This was achieved 
by incubating the cells for 1 h at 4°C in KRB supplemented with 5 µM coelenterazine, the Ca2+ ionophore ionomycin and 600 
µM EGTA. After this incubation, cells were extensively washed with KRB supplemented with 2% BSA. The coverslip with 
transfected cells was placed in a perfused, thermostatted chamber located in the close proximity of a low-noise photomultiplier, 
with built-in amplifi er-discriminator. All aequorin measurements were carried out in KRB, supplemented with either 1 mM 
Ca2+ or the indicated [Ca2+]. Agonists and other drugs were added to the same medium, as specifi ed in the Figure legends. The 
experiments were terminated by lysing the cells with 100 µM digitonin in a hypotonic Ca2+-containing solution (10 mM CaCl2 
in H2O), thus discharging the remaining aequorin pool. The output of the discriminator was captured by a Thorn-EMI photon 
counting board and stored in an IBM-compatible computer for further analyses. The aequorin luminescence data were calibrated 
off-line into [Ca2+] values, using a computer algorithm based on the Ca2+ response curve of wild-type and mutant aequorins [154; 
156]. 
CELL DEATH ANALYSIS
To assay the antiapoptotic effects in coxsackievirus-infected cells, cells grown on coverslips were either mock-infected or 
infected with coxsackievirus (30 min at room temperature) at a multiplicity of infection (MOI) of 50. At the indicated times (see 
legends to the fi gures), cells were challenged with GuHCl (2 mM), cycloheximide (100 mg/ml) or actinomycin D (0.5 mg/ml) 
for the indicated times. For the analysis of the nuclear morphology, cells were fi xed with 4% paraformaldehyde, stained with 
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DAPI (10 mg/ml), viewed under an Axiovert epifl uorescence inverted microscope (Carl-Zeiss Gmbh), and imaged with a Nikon 
Coolpix 995 digital camera equipped with a MDC lens. Caspase activation was analysed using the Apo-ONETM homogeneous 
caspase-3/7 assay according to the instructions of the manufacturer (Promega). Analysis of DNA fragmentation was performed as 
described by Tolskaya et al. [71]. Incubations were performed in serum-free DMEM except for the experiments in which caspase-
3 activation was assayed (because of the high caspase-3 background in serum-free DMEM in control cells and infected cells).   
To investigate the antiapoptotic effects in 2B-expressing cells, cells grown on coverslips were transfected either with 2B-
GFP or mt-GFP. At 36 h posttransfection, cells were treated with the apoptosis-inducing drugs for 4 h (for analysis of caspase-3 
activation) or 16 h (for analysis of cell survival). Incubation with cycloheximide, actinomycin D and etoposide was performed 
in DMEM containing 10% FBS. Incubation with ceramide was performed in KRB buffer supplemented with 1 mM CaCl2. To 
assay caspase-3 activation, cells were fi xed and stained as described [124] with an anti-cleaved caspase-3 (Asp175) antibody (Cell 
Signaling Technology), which specifi cally recognizes active caspase-3 but not its inactive zymogen, and a Texas Red-conjugated 
goat anti-rabbit antibody. The percentage of caspase-3-positive GFP-expressing cells was determined de visu by counting at the 
microscope. To assay cell survival, cells were washed thoroughly to eliminate apoptotic cells after incubation with the apoptotic 
drugs. The percentage of fl uorescent cells before and after a challenge with the apoptotic drugs was determined de visu by 
counting at the microscope.
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Coxsackievirus infection leads to a rapid reduction of the fi lling state of the 
intracellular Ca2+ stores. It is yet unknown whether this effect is due to a decreased 
Ca2+ uptake in the stores or an increased Ca2+ effl ux. The coxsackievirus 2B protein, a 
small membrane protein that localizes to ER and Golgi membranes, has been suggested 
to be responsible for this effect by forming membrane-integral pores, but fi rm evidence 
for this idea is lacking. Here we provide evidence that 2B reduces the Ca2+ fi lling 
state of both ER and Golgi without affecting the uptake of Ca2+. Bioluminescence 
measurement of intra-organelle free Ca2+ in permeabilized cells revealed that the 2B 
effect was preserved at steady ATP. Moreover, biochemical analysis of the SERCA 
activity in a cell-free system showed that 2B had no adverse activity on this Ca2+
ATPase. To investigate whether the effect of 2B is specifi c for Ca2+ or also allows 
the diffusion of other ions, we measured the pH in the lumen of the Golgi complex. 
Expression of 2B resulted in an increased Golgi pH, indicative for the effl ux of H+ from 
the Golgi lumen. Together, these data support a model that 2B increases ER and Golgi 
membrane ion permeability by forming membrane-integral pores. We demonstrate that 
a major consequence of this activity is the blockage of protein traffi cking through the 
Golgi complex. 
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INTRODUCTION
Enteroviruses (e.g., poliovirus, coxsackievirus, ECHOvirus) belong to the family of 
Picornaviridae, a large family of nonenveloped, cytolytic viruses that contain a single-stranded RNA 
genome of positive polarity. Upon infection, enteroviruses induce a number of dramatic alterations 
in their host cell, which serve to create the appropriate conditions for viral RNA replication and/or 
prevent antiviral host cell responses. One of these alterations is the modifi cation of intracellular Ca2+ 
homeostasis. We have previously shown that infection of HeLa cells with coxsackievirus results in a 
reduction of the amount of Ca2+ that can be released from the intracellular stores using thapsigargin, 
an inhibitor of the SERCA (the Ca2+-ATPase that transports Ca2+ from the cytosol into the stores). In 
addition, a gradual increase in the cytosolic Ca2+ concentration ([Ca2+]cyt) was observed due to the 
infl ux of extracellular Ca2+ [42]. 
The enterovirus 2B protein, one of the nonstructural proteins involved in viral RNA replication, 
plays a major role in the alterations in intracellular Ca2+ homeostasis that take place in enterovirus-
infected cells [42; 125]. The mechanism by which 2B exerts its effects is largely unknown. Ca2+ 
homeostasis in the intracellular stores (i.e., ER and Golgi) is the net result of the activity of the SERCA 
on the one hand and the continuous passive Ca2+ leak from these organelles that exists under normal 
conditions on the other hand [173]. Thus, the reductions in the Ca2+ fi lling state of the stores in 2B-
expressing cells may result from a decrease in Ca2+ uptake (through reduced SERCA action) or from 
an increase in Ca2+ effl ux.
The enterovirus 2B protein is a small (97-99 aa) membrane-integral protein [124] that upon 
individual expression is present at ER and Golgi membranes [103; 124]. The enterovirus 2B protein 
contains two hydrophobic regions (HR1 and HR2), of which the fi rst is predicted to form a cationic 
amphipathic α-helix [84]. The α-helix displays characteristics typical for the group of the so-called 
lytic polypeptides, which may build membrane-integral pores by forming transmembrane multimers 
[85; 87]. Accumulating evidence indicates that 2B forms homomultimers, in which both hydrophobic 
regions span the phospholipid bilayer suggesting that 2B increases the effl ux of Ca2+ from the stores by 
forming transmembrane pores [109; 113; 127]. However, fi rm evidence that 2B forms pores in ER and 
Golgi membranes is still lacking. 
In this study, we investigated ER and Golgi ion homeostasis in 2B-expressing cells. Using 
organelle-targeted aequorins, we provide evidence that 2B decreases the Ca2+ content of both the ER 
and Golgi complex. We show that the reduction in Ca2+ fi lling state of these organelles is not due to a 
reduced Ca2+ uptake, indicating that the effl ux of Ca2+ is increased. Measurement of the Golgi pH with 
a Golgi-targeted pH-sensitive GFP variant revealed that expression of 2B results in an increased Golgi 
pH, indicative for the effl ux of H+ from the lumen of the Golgi. Finally, we show that the 2B-induced 
modifi cation of ER and/or Golgi membrane permeability results in the inhibition of protein secretion 
through the Golgi complex. 
RESULTS
THE 2B PROTEIN DISTURBS ER AND GOLGI CA2+ HOMEOSTASIS
Previously, we demonstrated that 2B expression resulted in a reduced fi lling state of the 
intracellular Ca2+ stores in intact HeLa cells [125]. Here, we investigated the effect of 2B on ER and 
Golgi Ca2+ levels in BGM kidney cells. 
Measurements of organelle [Ca2+] were performed in cells that were permeabilized with 
saponin and then incubated in an intracellular medium containing a high ATP concentration (saponin 
specifi cally permeabilizes the plasma membrane without affecting endomembranes). By following 
this approach, it can be excluded that possible effects on organelle [Ca2+] are due to reduced SERCA 
activity due to ATP depletion. The [Ca2+]ER and  [Ca2+]Golgi were determined by bioluminometric 
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Figure 1. The 2B protein modifi es ER and 
Golgi Ca2+ homeostasis. Ca2+ levels were 
determined in (A) the ER, (B) the Golgi complex, 
and (C) the cytosol of 2B-expressing cells 
and control cells. BGM cells were transfected 
with the the indicated aequorin and 2B-EGFP 
and processed for luminometric analysis of 
populations of cells. At the indicated times, 
the organelles were depleted of Ca2+ and the 
aequorins were reconstituted with coelenterazine. 
Cells were subsequently transferred to the 
luminometer chamber. For the ER and Golgi 
measurements, cells were perfused with 10 µg/ml 
saponin for 4 minutes at 37°C to permeabilize the 
plasma membrane, and subsequently perfused 
with 0.7 µM Ca2+ and 5 mM ATP. Cytosolic 
measurements were performed with non-
permeabilized cells, which were perfused with 1 
mM Ca2+. Aequorin luminescence was collected 
and calibrated into [Ca2+] values as described 
in Experimental Procedures. Representative 
traces are shown of control cells (black) and 2B-
expressing cells (grey), the arrow indicates when 
Ca2+ was added. The mean [Ca2+] ± SD of four 
individual experiments is shown. *, P< 0.05; **, 
P <  0.005.
analysis of cell populations using the Ca2+-sensitive photoprotein aequorin that was targeted to these 
organelles by fusion to specifi c targeting signals [174]. BGM cells were cotransfected with expression 
constructs of 2B-EGFP and either ER- or Golgi-targeted aequorin. The 2B-EGFP fusion protein was 
used because it allowed sorting of transfected cells for measurement of the SERCA activity (see 
below). We have previously shown that fusion of EGFP to the C terminus of 2B has no effect on the 
subcellular localization and function of the latter protein [124]. Upon perfusion of the permeabilized 
cells with intracellular medium containing 0.7 µM free Ca2+ and 5 mM ATP, the organelle [Ca2+] 
increased rapidly by the action of the SERCA (Figs. 1A and 1B, left panel). No increase in organelle 
[Ca2+] was observed under these conditions in the absence of saponin, indicating that the cells were 
effi ciently permeabilized (data not shown). Moreover, the increase in luminescence observed upon 
addition of ATP and Ca2+ was virtually completely blocked by the SERCA inhibitor CPA, indicating 
that Ca2+ is actively stored in the ER and Golgi compartment. After approximately 40 s a steady-state 
[Ca2+] was reached at which the amount of Ca2+ pumped into the organelle by the SERCA was equal 
to the Ca2+ leak. In control cells, the mean steady-state [Ca2+]ER was 235 µM (Fig. 1A, right panel). 
In 2B-expressing cells, however, this value was signifi cantly (P < 0.005) decreased to 110 µM and 95 
µM at 18 h and 40 h posttransfection, respectively. The effect of 2B-expresion was even more profound 
on [Ca2+]Golgi (Fig. 1B, right panel). In control cells, the mean steady-state [Ca2+]Golgi was 410 
µM, whereas in 2B-expressing cells this value was signifi cantly (P < 0.005) decreased to 125 µM and 
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130 µM at 18 h and 40 h posttransfection, respectively. These results demonstrate that 2B expression 
reduces the Ca2+ content of both the ER and Golgi complex in BGM kidney cells, and that this effect 
is not caused by ATP depletion.
We also investigated whether 2B expression affects the cytosolic free Ca2+ concentration 
([Ca2+]cyt). Upon perfusion of intact cells with extracellular medium containing 1 mM CaCl2, 
[Ca2+]cyt gradually increased to a plateau (Fig. 1C, left panel). At 18 h posttransfection, no difference 
was observed in plateau [Ca2+]cyt between control cells and 2B-expressing cells (Fig. 1C, right panel). 
At 40 h posttransfection, however, the plateau [Ca2+]cyt was signifi cantly higher in 2B-expressing cells 
(P < 0.05). These data indicate that the cytosolic Ca2+ level was not affected by 2B expression at a 
time point, 18 h posttransfection, when the 2B-induced increase in Ca2+ permeability of ER and Golgi 
membranes was already maximal. The same order of events was previously reported in coxsackievirus-
infected cells [42]. It is therefore unlikely that the observed reduction in [Ca2+]ER and [Ca2+]Golgi are 
somehow due to the 2B-induced alterations in the cytosolic Ca2+ levels or any downstream consequence 
thereof. 
To address the possibility that the 2B protein reduced [Ca2+]ER and [Ca2+]Golgi by inhibiting 
the SERCA pump, we performed an in vitro radiochemical analysis of SERCA activity [178]. BGM 
cells were transfected with EGFP (control) or 2B-EGFP. At 40 h posttransfection, fl uorescent cells 
were sorted by FACS analysis and subsequently homogenized. ATPase activity of the homogenate 
was determined by analyzing γ-(32P)-ATP hydrolysis, counting the amount of liberated radiolabeled 
inorganic phosphate (32Pi). Homogenates were assayed in the absence and presence of 10 µM 
thapsigargin and at an ambient free [Ca2+] of 5 µM. In each experiment, the total ATPase activity 
was set at 100%, to which the activity measured in the presence of thapsigargin was related. Figure 2 
shows that the thapsigargin-sensitive ATPase activity was not different between control cells and 2B-
expressing cells and amounted to approximately 45% of the total activity. This indicates that the 2B 
protein does not inhibit the SERCA pump. Together with the observation that reduced Ca2+ fi lling of 
the ER and Golgi complex occurs also when ATP is not rate-limiting, this argues against an effect of 
2B on Ca2+ uptake. 
THE 2B PROTEIN DISTURBS THE PH OF THE GOLGI COMPLEX
We next investigated whether the 2B-induced increase in ER and Golgi membrane permeability 
is Ca2+-specifi c, or also applies to other ions. Therefore, we analyzed the effect of 2B expression on 
the pH of the Golgi complex, reasoning that non-selective alterations in membrane permeability would 
result in a disturbance of the proton gradient that exists over the Golgi membranes. This proton gradient 
is the consequence of the gradual acidifi cation of secretory pathway organelles by the activity of the 
vacuolar H+-ATPase (V-ATPase) [180]. Intra-organelle pH measurements were performed by digital 
imaging microscopy of individual cells expressing targeted ratiometric pHluorin constructs. pHluorin 
+ 2Bcontrol
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+ thapsigargin- thapsigargin Figure 2. The 2B protein does not inhibit SERCA activity. 
BGM cells were transfected with EGFP (control) or 2B-EGFP 
expression plasmids. At 40 h posttransfection, SERCA activity 
was determined using an in vitro radiochemical ATPase 
assay. Fluorescent cells were sorted using FACS analysis and 
homogenized. The ATPase activity of the homogenates (2.5 
x 106 cells) were determined by analyzing the hydrolysis of 
radiolabeled ATP in the absence and presence of the 10 µM 
of the SERCA-inhibitor thapsigargin. The ATPase activity in 
the absence of thapsigargin was calculated relative to the 
ATPase activity in the presence of thapsigargin, which was 
set at 100%. The difference between these two measurements 
represents SERCA ATPase activity and is indicated by an 
arrow. The mean ATPase activity of three independently 
performed experiments is shown. No difference is observed in 
the thapsigargin-sensitive ATPase activity in control cells and 
2B-expressing cells.
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Figure 3. The 2B protein increases the pH of the Golgi complex. (A and C) BGM cells were transfected with the indicated 
constructs, fi xed at 18 h posttransfection, stained with the anti-C-myc antiserum and processed for CLSM analysis. (B and D) 
BGM cells were transfected with the indicated constructs, and processed for digital imaging microscopy of individual cells. At 
the indicated times posttransfection, the 395/470-nm excitation ratio of individual cells, which is indicative for the pH value, 
was determined as described under Experimental Procedures. The mean value ± SD of two  experiments is shown. R395/470, 
395/470-nm excitation ratio. *, P<0.05; **, P<0.005. For full color fi gure, see page 156.
is a variant of wild-type (non-enhanced) GFP which displays a pH-dependent fl uorescence excitation 
spectrum due to specifi c substitution mutations [175]. The excitation spectrum of pHluorin displays two 
excitation peaks, one at 395 nm and one at 470 nm. At low pH-values, emission intensity is low at 395 
nm and high at 470 nm, resulting in a low 395/470-nm fl uorescence emission ratio at 510 nm (R395/
470). At high pH-values, emission intensity is high at 395 nm and low at 470 nm, resulting in a higher 
R395/470 value. Thus, the R395/470 increases as a function of the pH and can be used to determine pH 
differences [175].
To investigate whether the use of ratiometric pHluorins allowed us to sensitively detect in vivo 
pH differences in BGM cells, we determined the R395/470 emission ratio of the cytosol (pHcyt ≈ 7.2), 
the med-trans region of the Golgi complex (pHGolgi ≈ 6.4), and the trans-Golgi network (pHTGN ≈ 5.9) 
(pH values described in [180]). Cells were transfected with pHluorein expression constructs targeted 
either to the cytosol (pHluorin-cyt), the med-trans region of the Golgi complex (pHluorin-Golgi), or the 
trans-Golgi network (pHluorin-TGN). Figure 3A shows the localization of the targeted pHluorins. At 40 
h posttransfection, the R395/470 fl uorescence emission ratio of the different subcellular compartments 
was determined. The mean R395/470 of pHluorin-cyt was 1.04 ± 0.02 (Fig. 3B), indicative of the 
neutral pH that exists in the cytosol. The mean R395/470 values obtained with pHluorin-Golgi (0.59 ± 
0.10) and pHluorin-TGN (0.44 ± 0.07) were signifi cantly lower (P < 0.005), refl ecting the lower pH in 
these compartments.
We next investigated the effect of 2B expression on the pH of the Golgi complex. Previous work 
showed that the 2B protein predominantly localizes to the med-trans region of the Golgi complex [124]. 
Therefore, we used the med-trans Golgi-targeted pHluorin (pHluorin-Golgi) to investigate the effect 
of 2B expression on the pH in this compartment. In this part of the study we used the 2B-myc protein 
because fl uorescence derived from 2B-EGFP would contaminate the pHluorin signals. Colocalization 
of 2B-myc and pHluorin-Golgi was confi rmed by CLSM analysis (Fig. 3C). Figure 3D shows that in 
2B-expressing cells the Golgi pH was already increased at 18 h posttransfection. Because the increase 
in Golgi pH was not (yet) observed in all cells, the difference with control did not reach statistical 
signifi cance. At 40 h posttransfection, however, the pH of the Golgi complex was increased in all 2B-
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expressing cells, resulting in a mean R395/470(Golgi) that was signifi cantly higher (0.85 ± 0.13) than 
that of control cells (0.59 ± 0.10) (P < 0.005). This indicates that 2B expression results in an increase 
in Golgi membrane permeability to protons. The 2B-induced increase in R395/470(Golgi) was even 
higher than that observed upon treatment of cells with monensin, a well-known Na+/H+ ionophore 
that increases the Golgi pH by transporting H+ out of the Golgi lumen [117]. An increase in Golgi 
pH was also observed in coxsackievirus-infected BGM cells at 5 h postinfection (data not shown). In 
conclusion, these data show that the 2B-induced increase in endomembrane permeability applies not 
only for calcium ions, but also for protons.
THE 2B PROTEIN INHIBITS PROTEIN SECRETION THROUGH THE GOLGI COMPLEX
Alterations in lumenal ion concentrations of secretory pathway organelles may have deleterious 
effects on vesicular transport. For instance, the monensin-induced increase in pH of the Golgi complex 
has been shown to result in the inhibition of protein traffi cking through the Golgi complex [117]. Recent 
evidence suggests that there may also be a role for Ca2+ in vesicular traffi c. The release of Ca2+ from 
the lumen of transport vesicles is involved in many SNARE-dependent fusion events [144]. Here, we 
investigated whether the 2B-induced disturbances of ion homeostasis in the lumen of the ER and Golgi 
complex affects protein traffi cking. As a marker for protein traffi cking, we used the temperature-sensitive 
mutant of the envelope glycoprotein of vesicular stomatitis virus (VSV-G-ts045, hereafter referred to 
as VSV-G), fused to the N terminus of GFP. At 40°C, the temperature-sensitive fusion protein (VSV-
G-GFP) is misfolded and accumulates in the ER (Fig. 4A). Upon shifting the temperature to 32°C, the 
protein is correctly refolded and transported via the secretory pathway to the plasma membrane (Fig. 
4B) [181]. Figure 4C shows that treatment of BGM cells with monensin resulted in accumulation of 
VSV-G-GFP in the Golgi region, consistent with earlier observations reported in the literature [117]. 
To test the effect of 2B on vesicular traffi cking, BGM cells were transfected with expression 
plasmids encoding VSV-G-GFP and 2B-myc. Cells were incubated at 40°C for 18 h to accumulate VSV-
G-GFP in the ER and subsequently at 32°C for 2 h to allow its transport out of the ER. Cells were fi xed, 
stained with anti-C-myc, and processed for CLSM. In 2B-expressing cells, VSV-G-GFP colocalized 
with the 2B-myc protein in the med-trans region of the Golgi complex (Figs. 4D-4F), demonstrating 
that 2B expression resulted in the inhibition of protein secretion through the Golgi complex. Inhibition 
of protein secretion by 2B was evident as early as 18 hours posttransfection (data not shown). The same 
holds true for the 2B-induced increase in ion permeability of ER and Golgi membranes, suggesting that 
this effect of 2B is the underlying cause of the inhibition of protein secretion. Consistent with this idea, 
A B C
D E F
Figure 4. The 2B protein inhibits VSV-G 
traffi cking through the Golgi complex. 
BGM cells were transfected with VSV-G-
GFP, or cotransfected with VSV-G-GFP and 
2B-myc expression constructs. Cells were 
incubated at 40°C for 18 h to accumulate 
VSV-G-GFP in the ER. Cells were 
additionally incubated for 2 h at 40°C (A), 
or at 32°C to allow VSV-G-GFP traffi cking 
along the secretory pathway (B-D). Cells 
were fi xed, stained with the anti-C-myc 
antiserum and processed for CLSM analysis. 
(A) VSV-G-GFP accumulation in the ER 
upon incubation at 40°C. (B) VSV-G-GFP 
exposure on the plasma membrane upon 
subsequent incubation at 32°C. (C) VSV-
G-GFP accumulation in the Golgi complex 
upon treatment with 5 µM monensin for 20 
h. (D-F) VSV-G-GFP accumulation in the 
Golgi complex upon co-expression with the 
2B-myc protein. (bar = 10 µm). For full 
color fi gure, see page 156.
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Figure 5. The ability of 2B to increase 
membrane permeability is responsible for 
the inhibition of VSV-G traffi cking. BGM 
cells were cotransfected with expression 
constructs of VSV-G-GFP and the indicated 
mutant 2B-myc proteins, and incubated at 
40°C for 18 h and additionally incubated for 
2 h at 32°C. Cells were fi xed, stained with 
the anti-C-myc antiserum and processed 
for CLSM analysis. The K41L/K44L/K48L 
mutant (A) and I64S/V66S mutant (B)  were 
impaired in the ability to inhibit VSV-G-GFP 
traffi cking. The ins(5)linker mutant (C), 
the ins(34)linker (D), and the ins(94)linker 
mutant (E) inhibited VSV-G-GFP traffi cking 
through the Golgi complex. (bar = 10µm). 
For full color fi gure, see page 157.
VSV-G-GFP traffi cking through the Golgi complex was also inhibited in HeLa and CHO cells (data not 
shown), two other cell types in which 2B expression results in an increase in ER and Golgi membrane 
permeability [125]. 
To provide experimental evidence for the idea that 2B inhibits protein secretion by increasing 
the ion permeability of ER and Golgi membranes, we analyzed VSV-G-GFP traffi cking in BGM cells 
expressing 2B mutants that were previously shown to defective in increasing ion permeability of these 
membranes [125]. The mutants in question, K41L/K44L/K48L and I64S/V66S, have mutations in 
the putative pore-forming hydrophobic regions HR1 and HR2, respectively [146]. BGM cells were 
transfected with expression plasmids of the fl uorescent VSV-G-GFP fusion protein and mutant 2B-
myc constructs and processed as described above. The K41L/K44L/K48L mutant, which localized to 
the ER, did not inhibit VSV-G-GFP traffi cking through the Golgi complex, resulting in VSV-G-GFP 
exposure on the plasma membrane (Fig. 5A). The same lack of inhibition was obtained with the I64S/
V66S mutant, which localized to the Golgi complex (Fig. 5B). These fi ndings are in agreement with the 
idea that the ability of 2B to increase ER and Golgi membrane permeability is required for its inhibitory 
effect on protein secretion.
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We also analyzed VSV-G-GFP traffi cking in cells expressing 2B mutants that carried linker 
insertions in regions outside the hydrophobic regions HR1 and HR2. The mutants in question, 
ins(5)linker, ins(34)linker, and ins(94)linker mutants, contain a 9 aa linker inserted at the indicated aa 
position [146]. All three mutants localized to the Golgi complex and inhibited VSV-G-GFP traffi cking 
through this complex (Figs. 5C, 5D, and 5E, respectively). These data show that regions outside the 
putative pore-forming hydrophobic regions are not involved in the secretion inhibiting function of 
2B, thus substantiating the idea that pore formation is important for secretion inhibition by this viral 
protein.
DISCUSSION
In this study, we investigated the molecular mechanism by which the coxsackievirus alters ER 
and Golgi membrane permeability and the downstream consequences of this modifi cation. Using 
organelle-targeted forms of the Ca2+-sensitive photoprotein aequorin and the pH-sensitive GFP variant 
pHluorin, we demonstrate that expression of the 2B protein results in a reduction of the free Ca2+ 
concentration in both the ER and Golgi complex and an increase of the pH in the Golgi complex. The 
2B-induced decrease in ER and Golgi Ca2+ concentration occurred under conditions that ATP is not 
rate-limiting. Therefore, the decrease in Ca2+ content of the intracellular stores is not the result of a 
decrease in cellular ATP content. In addition, measurements of maximal SERCA activity in a cell free 
system showed no difference between control and 2B-expressing cells. This indicates that SERCA 
action is not altered by expression of the 2B protein. Based on these fi ndings, we conclude that the 
2B-induced reduction of the steady state Ca2+ level in intracellular stores is due to increased Ca2+ 
leakage rather than decreased Ca2+ uptake. Together with the observation that 2B expression results in 
a reduced H+ concentration in the Golgi complex, these fi ndings lend support to the idea that the 2B 
protein increases ion permeability of ER and Golgi membranes by forming membrane-integral pores in 
these membranes. Previous work with MBP-2B fusion proteins showed an increase in permeability of 
large unilamellar vesicles to a number of different compounds [127]. The molecular mass cut off was 
estimated to be between 660 kD to 1000 KD, suggesting that, in addition to ions, also low molecular 
weight compounds may pass through the putative pores formed by 2B.
What consequences do the 2B-induced disturbances in ion homeostasis have for the host cell? 
Ca2+ is a highly versatile second messenger that is involved in many different functions of the cell. 
Ca2+ signaling events are tightly regulated and mostly function through the generation of repetitive 
brief Ca2+ pulses [182]. The reduction in organelle Ca2+ levels and the subsequent increase in cytosolic 
Ca2+ in 2B-expressing cells may therefore affect Ca2+ signaling events and thus infl uence cell death 
and cell proliferation [151]. In fact, we recently demonstrated that the 2B-induced reduction in the Ca2+ 
content of ER and Golgi stores resulted in the down-regulation of Ca2+-signaling between the ER and 
mitochondria, and that this down-regulation of Ca2+-signaling plays an important role in the protection 
of HeLa cells against certain apoptotic stimuli [125]. This apoptosis-suppressing function of 2B is 
most likely of great importance for the virus to prevent premature curtailment of the viral life cycle. 
In addition to the alterations in Ca2+-signaling, the disturbance of the pH in the Golgi complex may 
be of importance for the viral regulation of the balance between cell death and survival. For instance, 
the interaction of the papilloma virus E5 oncoprotein with the 16 kD subunit of the V-ATPase and the 
subsequent increase in the Golgi pH of E5-expressing cells was shown to be essential for the oncogenic 
transformation of the host cell [183]. 
Here, we identifi ed another important consequence of the 2B-induced disturbance in ion 
homeostasis. We found that the 2B-induced alterations in membrane permeability of the ER and Golgi 
complex are paralleled by inhibition of protein traffi cking through the Golgi complex. Mutations in 
the putative pore-forming hydrophobic regions that inhibited the ability of 2B to increase ER and 
Golgi membrane permeability also impaired its ability to inhibit protein secretion. According to our 
model this means that 2B forms pores to alter the permeability of ER and Golgi membranes, which, in 
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turn, leads to inhibition of protein secretion. Accordingly, mutations outside the putative pore-forming 
regions did not interfere with the ability of 2B to accumulate secretory proteins in the Golgi complex. 
We propose that the inhibition of protein traffi cking through the Golgi is the result of the altered ionic 
conditions in the lumen of this complex, which may inhibit the sugar-modifying enzymes of the Golgi 
complex (i.e., glycosyltransferases and glycosidases). Consistent with this, expression of poliovirus 2B 
was reported to accumulate secretory glycoproteins in an endoglycosidase H-sensitive glycosylation 
state [46]. Accumulation of improperly glycosylated proteins in the Golgi complex is in agreement 
with its role in the quality control of protein folding [184; 185]. The similarities between the inhibition 
of protein secretion by 2B and the Na+/H+-ionophore monensin, which also causes accumulation 
of glycoproteins in the Golgi complex in an endoglycosidase H-sensitive glycosylation state [117], 
suggest that 2B inhibits protein secretion in a manner analogous to monensin. Because both monensin 
and 2B expression increase the Golgi pH it is likely that this effect is responsible for the 2B-induced 
inhibition of protein secretion. On the other hand, the involvement of the 2B-induced reduction of the 
Ca2+ concentration in the lumen of the Golgi complex cannot be excluded. Ca2+ plays an important role 
in protein folding [186] and has been implicated in membrane fusion events, which require the local 
release of lumenal Ca2+ [144; 187]. 
To our knowledge, the enterovirus 2B protein is the fi rst viral protein that interferes with protein 
traffi cking through the Golgi complex by forming non-selective pores that allow the diffusion of ions 
from the Golgi lumen. Another viral protein that interferes with protein secretion is the infl uenza virus 
M2 protein, yet this protein disturbs the pH of the Golgi complex and the TGN by forming a specifi c 
proton channel [188]. Perturbation of the pH of the Golgi and TGN by infl uenza M2 was shown to slow 
traffi c of various glyocoproteins (infl uenza hemagglutinin, F glycoprotein of paramyxovirus SV5, and 
gamma-glutamyltranspeptidase) along the secretory pathway [189; 190]. 
The relevance of the 2B-induced inhibition of host cell protein secretion for the viral life cycle 
remains to be established. Enteroviruses most likely inhibit protein secretion to down-regulate innate 
(secretion of cytokines) as well as adaptive immune responses (exposure of peptide-loaded MHC-I 
molecules) and to interfere with the recycling of labile receptors (e.g., TNF receptor) to the cell surface 
[63-65]. Both the enterovirus 2B and 3A proteins have been shown to interfere with vesicular protein 
traffi cking when expressed individually [42; 46]. It is diffi cult to dissect the relative importance of 
the secretion inhibition functions of 2B and 3A for the evasion of anti-viral immune responses in 
infected cells. For this, enteroviruses must be obtained that carry mutations in the 2B or 3A protein 
which interfere with the secretion inhibition activity but that do not affect virus growth. Until now, 
only a 3A mutant has been obtained that fulfi ls these requirements. This mutant showed a reduced 
ability to inhibit cytokine secretion and MHC-I exposure, confi rming the importance of the secretion 
blockage induced by the 3A protein for the evasion of anti-viral immune responses in infected cells. 
Unfortunately, no enterovirus 2B mutants have yet been described with a reduced ability to inhibit 
protein secretion but which show a wild-type growth, most likely because the effect 2B on ER and Golgi 
membrane permeability is connected to its function in viral RNA replication (see below). It is therefore 
as yet impossible to defi ne the importance of the secretion inhibition function of the 2B protein for the 
suppression of immune responses by the host cell.     
Is the ability of 2B to increase ion permeability of ER and Golgi membranes required for its 
function in viral RNA replication? Mutations in the 2B protein cause early defects in viral RNA 
replication [82-84]. Moreover, our previous reports suggest that there is a close correlation between 
the ability of 2B mutants to alter membrane permeability and to support viral RNA replication [47; 
146]. Infected cells contain both the 2B protein and its relatively stable precursor 2BC. We found that 
expression of the 2BC protein also results in the accumulation of VSV-G-GFP in the juxtanuclear Golgi 
region (de Jong et al., unpublished data). The 2BC protein has been identifi ed as the viral protein that 
is responsible for the accumulation of the membrane vesicles at which viral RNA replication takes 
place [48; 54; 61]. These replication vesicles are anterograde transport vesicles that are suggested to 
accumulate in infected cells [57]. The 2B(C)-induced increase in membrane permeability of these 
anterograde transport vesicles might be involved in their cytoplasmic accumulation, possibly because 
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the increase in the lumenal pH, which was also observed in coxsackievirus-infected cells (data not 
shown), inhibits their traffi cking, or because the reduced lumenal Ca2+ concentrations abolish Ca2+-
dependent membrane fusion events that require the local release of lumenal Ca2+ [144; 187]. Further 
research is required to characterize the functional relevance of the pore-forming capacity of the 2B 
protein for the viral life cycle. 
ACKNOWLEDGEMENTS
We thank Henri Dijkman for advice and support with the CLSM studies, Drs. P. Keller and K. 
Simons for the kind gift of the pVSV-G(ts045)-GFP construct, and Drs G. Miesenbock and J. Rothman 
for the kind gift of the pHluorin and pHluorin-TGN constructs. This work was partly supported by 
grants from the Netherlands Organisation for Scientifi c Research (NWO-917.46.305) and the European 
Communities (INTAS 2012).
EXPERIMENTAL PROCEDURES
CELLS AND MEDIA
Buffalo green monkey kidney (BGM) cells were grown in minimal essential medium (Gibco), supplemented with 10% 
(v/v) fetal bovine serum (FBS), 100 units penicillin per ml and 25 µg streptomycin per ml. Cells were grown at 37°C in a 5% 
CO2 incubator. 
ANTIBODIES, CONJUGATES AND REAGENTS
Mouse monoclonal anti-C-myc (clone 9E10) was obtained from Sigma-Aldrich. Texas Red-conjugated goat-anti-mouse 
polyclonal antibody and Texas Red-conjugated goat-anti-rabbit polyclonal antibody were from Jackson ImmunoResearch 
Laboratories. Coelenterazine-W and coelenterazine-N were from Molecular Probes, thapsigargin from LC Services (Woburn, 
MA), and ionomycin and monensin from Sigma-Aldrich. 
PLASMIDS
Expression plasmids p2B-EGFP and p2B-myc [124], pCyt-AEQ and pER-AEQ [174] and pGolgi-AEQ [116] have 
been described. The pHluorin and pHluorin-TGN constructs [175] were a kind gift from Drs. G. Miesenbock and J. Rothman, 
Memorial Sloan-Kettering Cancer Center, New York, USA. pHluorin-Golgi was constructed by cloning the coding sequence 
of the N-terminal 81 amino acids of human β-1,4-galactosyltransferase, which contains the targeting information for the med-
trans region of the Golgi complex immediately upstream the pHluorin coding region. The coding sequence of the N-terminal 81 
amino acids of human β-1,4-galactosyltransferase was amplifi ed by PCR using the EGFP-Golgi plasmid (Clontech) as template. 
The forward primer contained an NheI restriction site (italics) and a start codon preceeded by a Kozak sequence (p318-22; 
5’-gggggggctagcgccaccatgaggcttcgggagccgc-3’), the reverse primer contained an EcoRI restriction site (italics) (p318-23; 5’-
gggggggaattcggtggcgaccggtggatcctt-3’). pVSV-G(ts045)-GFP [176] was a kind gift from Drs. P. Keller and K. Simons, Max 
Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.
PLASMID DNA TRANSFECTIONS
BGM cell monolayers were grown to 70% confl uency and transfected using FuGENE 6 reagent (Roche) as described 
previously [124]. For aequorin measurements, cells were seeded onto 13 mm coverslips in 12-wells plates and transfected with 1 
µg of aequorin construct, with or without 2 µg of 2B-EGFP DNA per well. For SERCA activity measurements, cells were grown 
in two 6-wells plates and transfected with 5 µg of 2B-EGFP DNA per well. For the pHluorin measurements, cells were seeded 
onto 22 mm coverslips in 6-wells plates and transfected with 1.5 µg of pHluorin construct, with or without 3 µg of 2B-myc DNA 
per well. For the immunofl uorescence assays, cells were seeded onto 12 mm coverslips in 24-wells plates and transfected using 1 
µg of VSV-G-GFP, with or without 2 µg of 2B-myc DNA per well. Cells were grown at 37°C until further analysis at the indicated 
times.
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AEQUORIN MEASUREMENTS
Targeted aequorin constructs were used to measure [Ca2+] in the cytosol, the ER and the Golgi complex in control 
cells and 2B-EGFP-expressing cells at the cell population level. For intra-organelle Ca2+ measurements, BGM cells expressing 
either ER-AEQ or Golgi-AEQ were incubated in Krebs-Ringer bicarbonate medium (KRB) (140 mM NaCl, 3.5 mM KCl, 0.5 
mM NaH2PO4, 0.5 mM MgSO4, 10 mM HEPES, 2 mM NaHCO3, 5.5 mM D-glucose, pH 7.4) supplemented with 2 µM of the 
Ca2+ ionophore ionomycin, 600 µM EGTA and 5 µM coelenterazine-N for 1 hr at 4°C. To remove the ionomycin, cells were 
washed with KRB supplemented with 2% (w/v) BSA. Then, cells were transferred to a luminometer. Aequorin luminescence 
(λmax = 450 nm) was monitored continuously from the cell population using a custom build setup that consisted of a perfused, 
thermostatted chamber located in close proximity of light shielded low-noise photomultiplier tube (PMT) with a built-in H7360-1 
amplifi er-discriminator (Hamamatsu Photonics K. K. Shizuoka-Ken, Japan). PMT output was monitored in time using a PCI-
6601 photon counting board (National Instruments, Austin, USA) coupled to an IBM-compatible computer using custom written 
software (Drs. S.P. Srinivas and W. van Driessche, Laboratory of Physiology, K.U. Leuven, Belgium). Cells were perfused with 
intracellular medium (120 mM KCl, 30 mM imidazole, 5 mM MgCl2, 0.44 mM EGTA, 10 mM NaN3, pH 6.8) containing 10 
µg/ml saponin for 4 min at 37°C. Intra-organelle Ca2+ measurements were carried out in intracellular medium supplemented with 
0.210 mM CaCl2 (free [Ca2+] = 0.7 µM) and 5 mM ATP. Free [Ca2+] was calculated using the WCaBuf software provided by 
G. Droogmans, Department of Physiology, KU Leuven, Belgium (available at ftp.cc.kuleuven.ac.be/pub/droogmans/cabuf.zip) 
and the stability constants given by Fabiato and Fabiato [177]. For cytosolic Ca2+ measurements, cells expressing cyt-AEQ were 
incubated in KRB supplemented with 5 µM coelenterazine-W, 2 µM ionomycin, and 600 µM EGTA for 1 hr at 4°C. After removal 
of ionomycin, cytosolic Ca2+ measurements were carried out in extracellular medium (KRB supplemented with 1 mM CaCl2). 
Experiments were terminated by lysing the cells with 100 µM digitonin in a hypertonic Ca2+-containing solution (10 mM CaCl2 
in H2O) to discharge the remaining aequorin pool. The aequorin luminescence data were calibrated off-line into [Ca2+] values, 
using a computer algorithm based on the Ca2+ response curve of wild-type and mutant aequorins [154; 156].
SERCA ACTIVITY MEASUREMENTS
SERCA activity was determined using a radiochemical method [178]. Cells transfected with either EGFP or 2B-EGFP 
were harvested in PBS supplemented with 10 mM EDTA at 40 h posttransfection. After washing with PBS, cells were sorted 
by FACS analysis using an Altra Hypersort fl owcytometer (Beckman Coulter), equipped with an Argon laser running at 20 mW. 
Forward-scatter (FS), side-scatter (SS) and cell fl uorescence were analysed and viable GFP-positive cells were high-speed sorted 
(15,000 cells/sec) using a band-pass fi lter of 525/530 nm and a dichroic mirror of 550 nm. GFP-positive cells were washed 
with homogenisation buffer (250 mM sucrose, 2 mM EDTA, 50 mM Tris-Ac, pH 7.0), and lysed by resuspension in 0.1 ml H20 
and freezing and thawing in liquid nitrogen for three times. The homogenate was diluted with 0.2 ml homogenisation buffer. 
Aliquots of 20 µl were incubated at 37°C for 40 min in a reaction medium containing 50 mM Tris-Ac (pH 7.0), 5 mM MgCl2, 1 
mM Tris-azide, 0.5 mM EGTA, 0.5 mM EDTA, 5 µM ionomycin, 150 mM KCl, 3 mM α-(32P)-ATP (specifi c activity 100-500 
mCi/mmol), and 0.5 mM CaCl2 (free [Ca2+] = 5 µM). The reactions were stopped by adding 500 µl of 10% (w/v) charcoal in 6% 
(w/v) trichloroacetic acid and the mixture was centrifuged for 30 sec at 10000g. To 200 µl of clear supernatant, containing the 
liberated inorganic phosphate (32Pi), 4 ml of OptiFluor (Canberra Packard, Tilburg, The Netherlands) was added, and the mixture 
was analyzed by liquid scintillation analysis. Blanks were prepared by incubation of the reaction medium in the absence of 
homogenate. ATPase activity was determined in the presence and absence 10 µM thapsigargin, and SERCA activity is presented 
as the difference between the mock-treated and the thapsigargin-treated homogenates.
PHLUORIN MEASUREMENTS
Targeted pHluorin construct were used to measure pH in cytosol, med-trans region of the Golgi complex and the TGN at 
the single cell level. Coverslips containing pHluorin- expressing BGM cells were mounted in a Leiden chamber [179] and placed 
on the stage of an inverted microscope (Axiovert 200 M, Carl Zeiss, Jena, Germany) equipped with a x63, 1.25 NA plan-Neofl uar 
objective. During measurement, cells were perfused with KRB. pHluorin was excited at 395 and 470 nm, respectively, using a 
monochromator (Polychrome IV, TILL Photonics, Gräfelfi ng, Germany) and fl uorescence was monitored at 508 nm. Fluorescence 
light was directed by a 505DRLPXR dichroic mirror (Omega Optical Inc., Brattleboro, USA) through a 515ALP emission fi lter 
(Omega Optical Inc.) onto a CoolSNAP HQ monochrome CCD-camera (Roper Scientifi c, Vianen, The Netherlands). Hardware 
was controlled with Metafl uor 6.0 software (Universal Imaging Corporation, Downingtown, USA) running on a PC equipped 
with 1 Gb RAM and Windows XP Professional.
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IMMUNOFLUORESCENCE AND CONFOCAL LASER SCANNING MICROSCOPY
BGM cells grown on coverslips were fi xed with 4% (w/v) paraformaldehyde in PBS (pH 7.4) at the indicated time points 
posttransfection. Cells were permeabilized using PBS / 0.1% (v/v) Triton X-100. Primary antibodies and conjugates were diluted 
1:200 with PBS / 0.1% (v/v) Triton X-100 / 2% (w/v) normal goat serum (NGS). Incubations with the primary antibody were 
carried out overnight at 4°C and incubations with the secondary antibody were carried out for 1 hr at 4°C. Cells were washed with 
PBS / 0.1% (v/v) Triton X-100 between incubation steps and mounted in mowiol (Sigma-Aldrich). Cells were analyzed using 
confocal laser scanning microscopy (Leica TCS NT, Leica Lasertechnik GmbH, Heidelberg, Germany). 
CALCULATIONS
Data are presented as mean values ± SD. Differences were tested for signifi cance by means of the Student’s t test.
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The family of Picornaviridae consists of a large group of plus-strand RNA 
viruses that share a similar genome organization. The nomenclature of the picornavirus 
proteins is based on their position in the viral RNA genome but does not necessarily 
imply a conservation of function between the proteins of the different genera. The 
enterovirus 2B protein is a small hydrophobic protein that inhibits protein secretion 
and increases plasma membrane permeability, most likely by forming pores in ER and 
Golgi membranes. As yet, little is known about the function of the other picornavirus 
2B proteins. In this study, we compared the subcellular localization and functional 
aspects of the 2B proteins of enteroviruses, rhinovirus, foot-and-mouth disease virus, 
encephalomyocarditis virus, and hepatitis A virus. The 2B protein of rhinovirus, which 
is phylogenetically closely related to that of enterovirus, showed the same localization 
pattern as the enterovirus 2B protein and also inhibited protein secretion and increased 
plasma membrane permeability. The 2B proteins of the other viruses, which show little 
homology at the amino acid level, showed different results. The foot-and-mouth disease 
virus and encephalomyocarditis virus 2B proteins did not localize at ER and Golgi, and 
did not inhibit protein secretion or alter plasma membrane permeability. The hepatitis 
A virus 2B protein increased plasma membrane permeability to some extent, but it 
localized exclusively at the ER and did not inhibit protein secretion. We conclude that 
the 2B proteins of enterovirus and rhinovirus are closely related and most likely exhibit 
the same function in the viral life cycle. 
CHAPTER 8104
8
FUNCTIONAL ANALYSIS OF PICORNAVIRUS 2B PROTEINS: 
EFFECTS ON PROTEIN SECRETION AND MEMBRANEMEABILITY
105
8
INTRODUCTION
The family of Picornaviridae is a group of small, non-enveloped cytolytic viruses that include 
a number of important human and animal pathogens. The picornavirus family consists of nine genera: 
enterovirus (e.g., coxsackievirus, CBV, and poliovirus, PV); rhinovirus (e.g., human rhinovirus, HRV); 
cardiovirus (e.g., encephalomyocarditis virus, EMCV); aphtovirus (e.g., foot-and-mouth disease virus, 
FMDV); hepatovirus (hepatitis A virus, HAV); teschovirus (e.g., porcine teschovirus, PTV); erbovirus 
(e.g., equine rhinitis B virus, ERBV); parechovirus (e.g., parechovirus 2, PaV2); and kobuvirus 
(e.g., aichivirus). In addition, the picornavirus family contains a number of unassigned viruses. All 
picornaviruses have a similar genome organization. The viral genome typically consists of a positive-
stranded RNA molecule of approximately 7,000 – 8,000 nucleotides that contains one single large open 
reading frame, preceded by a long 5’ untranslated region (UTR) and followed by a much smaller 3’ 
UTR and a genetically encoded poly(A)-tail. A small viral protein, VPg, is covalently linked to the 5’ 
end of the viral genome. Translation of the RNA genome yields a polyprotein of approximately 2,200 
amino acids that is divided into the P1, P2 and P3 region. The polyprotein is processed by virus-encoded 
proteases to generate the individual structural and nonstructural proteins. Processing of the P1 region 
yields the structural capsid proteins 1A (VP4), 1B (VP2), 1C (VP3) and 1D (VP1), whereas processing 
of the P2 and P3 regions yields the nonstructural replication proteins 2A, 2B, 2C, 3A, 3B (VPg), 3C and 
3D, as well as some cleavage intermediates (2BC, 3AB, 3CD) that are relatively stable and may serve 
other functions than their individual constituents. It should be emphasized that the nomenclature of the 
picornavirus proteins is based on their position in the viral RNA genome (1A-3D from 5’ to 3’) and does 
not necessarily imply a conservation of function between the different genera.  
The function of the nonstructural picornavirus proteins has been investigated by analysis of 
well-defi ned mutants, by expression in bacteria and eukaryotic cells, and enzymatic assays in vitro. 
Multiple functions have been attributed to the mature viral proteins and the cleavage intermediates 
but their exact role in the picornaviral replication cycle is still not fully understood (reviewed in [11; 
12; 191]). Some proteins of the different picornavirus family members exhibit a marked similarity in 
structure and function. The 2C protein is the most highly conserved protein among all picornaviruses; 
all picornavirus 2C proteins contain a functional NTPase domain [90; 192]. The relevance of the 
NTPase activity for the viral life cycle, however, is as yet unknown. All picornavirus 3AB precursor 
proteins contain a hydrophobic region in the 3A protein that mediates membrane binding and thereby 
delivers VPg, the peptide primer for RNA synthesis, to the membrane-associated replication complex 
[191]. In all picornaviruses, 3C is the protease that is responsible for the proteolytic processing of the 
viral polyprotein, and 3D is the RNA-dependent RNA polymerase responsible for genome replication 
[191]. 
There also exist some remarkable differences in the structure and function of picornavirus 
proteins that are encoded at the same position on the viral genome. Some picornaviruses contain 
an additional leader protein at their extreme N terminus, which has different functions in different 
picornavirus family members [193]; the leader of aphthovirus is a protease that shuts off host cell 
translation by cleaving eIF4G [194], whereas the leader of cardiovirus lacks protease activity and is 
involved in the suppression of IFN-α/ß gene transcription [195]. Thus, picornavirus proteins that are 
encoded on the same position of the genome can exert completely different functions. On the other 
hand, it has been described that picornavirus proteins can exert the same function although they share 
little or no structural similarity. The 2A protein of enterovirus and human rhinovirus is a protease that 
is involved in processing of the polyprotein and responsible for the shut-off of host cell translation by 
cleaving eIF4G [196; 197]. The cardiovirus 2A protein has also been implicated in the shut-off of host 
cell translation but shows no structural similarity with the enterovirus or HRV 2A protein and lacks 
protease activity [198], and therefore most likely uses another mechanism. 
Little is known about the function of the picornavirus 2B proteins. Most of our current 
understanding of the 2B protein stems from studies on enteroviruses. In enterovirus-infected cells, the 
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Figure 1. Genetic analysis of the picornavirus 2B proteins. (A) Phylogenetic tree of the 2B proteins constructed with Clustal-W 
software. The Blosum62 similarity matrix was used to perform sequence alignment analysis. The phylogenetic tree shows that the 
2B proteins of CBV3, PV1 and HRV14 are grouped together, whereas the 2B proteins of other genera are more distantly related. 
(B) Identity matrix of the 2B proteins. Identity was calculated using the BLOSUM62 similarity matrix. (C) Pairwise alignment 
of the CBV3, PV1, and HRV14 2B proteins. All three proteins contain two hydrophobic regions (HR1 and HR2), spaced by a 5 
aa hydrophilic sequence. Dots represent residues that are identical to that in the 2B protein of CBV3. Dashes indicate gaps in 
the alignment. (D) Top view of the amphipathic α-helices of the fi rst hydrophobic region of CBV3, PV1, and HRV14 2B proteins. 
Note that all three contain a hydrophobic backbone and a hydrophilic face that contains three cationic residues. Hydrophobic 
residues are boxed. CBV3, coxsackievirus B3; HRV14, human rhinovirus 14; PV1, poliovirus 1; FMDV, foot-and-mouth disease 
virus; EMCV, encephalomyocarditis virus; HpaV2, human parechovirus 2; PTV, porcine teschovirus; ERBV, equine rhinitis B 
virus; HAV, hepatitis A virus.
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2B protein is present both as mature protein and as part of the 2BC protein, a relatively stable precursor 
protein that is responsible for the cytosolic accumulation of the secretory pathway-derived membrane 
vesicles at which viral replication takes place [51; 57; 61]. Studies on both PV and CBV indicate that the 
2B protein plays an important role in the modifi cation of host cell membrane structures and functions. 
The 2B protein is a small hydrophobic membrane protein that localizes at ER and Golgi membranes 
[51; 103; 124]. Increasing evidence indicates that the homomultimers of 2B form pores in ER and 
Golgi membranes [99; 109; 113; 127; 146; 199] and thereby is responsible for the depletion of Ca2+ 
and H+ from the lumen of these organelles in infected cells [42; 125; 199]. Individual expression of the 
2B protein furthermore results in inhibition of protein secretion through the Golgi complex [46; 199] 
and an increased permeability of the plasma membrane to hygromycin B (HgB), a small translation 
inhibitor that under physiological conditions poorly passes the plasma membrane [46-48]. Both the 
ability to inhibit secretion and to increase HgB entry are most likely downstream consequences of the 
disturbance in ER and Golgi ion homeostasis [199]. Whether the ability of 2B to disturb ER and Golgi 
ion homeostasis contributes to the function of its precursor 2BC to accumulate membranous replication 
vesicles is unknown.  
In this study, we investigated whether the structural and functional aspects of the enterovirus 2B 
protein are conserved among other members of the picornavirus family. To this end, the phylogenetic 
relationship and the degree of conservation with the 2B proteins of rhinovirus, cardiovirus, aphtovirus, 
and hepatovirus 2B proteins were defi ned, the subcellular localization of these 2B proteins was 
determined, and their ability to inhibit protein secretion and modify plasma membrane permeability 
was investigated.
RESULTS
PHYLOGENETIC ANALYSIS OF PICORNAVIRUS 2B PROTEINS
A phylogenetic analysis between the 2B proteins of enterovirus, rhinovirus, cardiovirus, 
aphtovirus and hepatovirus was performed. The enterovirus genus can be divided into two subgroups 
(on basis of differences in amino acid sequence); the CBV-like subgroup and the PV-like subgroup. 
Both CBV3 2B and PV1 2B were included in this study because it allowed a direct comparison of 
these proteins in one study; i.e., in the same cell type and using the same expression constructs. The 
rhinovirus genus is also divided into two subgroups (on basis of their sensitivity towards a panel of 
antiviral compounds) [207; 208]; HRV group A and HRV group B. Sequence comparison of the 2B 
proteins of HRV group A and HRV group B showed that they were very similar (data not shown), 
therefore only HRV14 (HRV group B) was used as a representative of the rhinovirus genus. EMCV was 
used as representative of the cardiovirus genus, FMDV as representative of the apthovirus genus, and 
HAV as representative of the hepatovirus genus. 
Phylogenetic analysis showed that the 2B proteins of CBV3 (99 aa), PV1 and HRV14 (both 97 
aa) are closely related (Fig. 1A). The 2B proteins of both PV1 and HRV14 share 51% and 55% identity 
(71% and 74% similarity) with the CBV3 2B protein, respectively, and 49% identity (71% similarity) 
with each other (Fig. 1B). Like CBV3 2B, both PV1 2B and HRV14 2B contain two hydrophobic 
regions (referred to as HR1 and HR2) (Fig. 1C), of which the fi rst is predicted to form a cationic 
amphipathic α-helix that displays characteristics of membrane-lytic polypeptides (Fig. 1D) [84]. CBV3 
2B contains a hydrophilic sequence (58RNHDD62) between HR1 and HR2, which most likely serves 
to facilitate a turn to reverse chain direction between these hydrophobic regions [146]. The 2B proteins 
of PV1 and HRV14 also contain a hydrophilic sequence between HR1 and HR2, which is very similar 
(56RNYED60, PV1) or identical (HRV14) to that of CBV3 2B (Fig. 1C). 
The 2B proteins of EMCV, FMDV, and HAV share little, if any, relationship (<20% sequence 
identity) to the enterovirus and rhinovirus 2B proteins (Figs. 1A and 1B). They also share little 
sequence identity with each other or the 2B proteins of aichivirus (kobuvirus), human parechovirus-2 
(parechovirus), porcine teschovirus (teschovirus), and equine rhinitis B virus (erbovirus) (Figs. 1A 
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and 1B). The EMCV, FMDV, and HAV 2B proteins are larger than the enterovirus and rhinovirus 2B 
proteins (EMCV, 151 aa; FMDV 2B, 155 aa; HAV 2B, 251 aa). They contain one or more hydrophobic 
regions, but none of them contains a putative cationic amphipathic α-helix typical for the group of 
membrane-lytic polypeptides followed by a short hydrophilic region and a second hydrophobic region, 
as can be found in all enterovirus and rhinovirus 2B proteins.  
SUBCELLULAR LOCALIZATION OF PICORNAVIRUS 2B PROTEINS
We recently demonstrated that the CBV3 2B protein is predominantly present in the Golgi 
complex [124]. Here, we determined the subcellular localization of the other picornavirus 2B proteins. 
The coding regions of the picornavirus 2B proteins were amplifi ed and cloned in a eukaryotic 
expression vector that drives the expression of the proteins carrying a C-myc tag at their C terminus. 
The experiments were performed in BGM kidney cells, because all viruses used in this study are able 
to replicate in kidney cell lines, indicating that the 2B proteins have the ability to fulfi ll their function(s) 
in these cells [209-212]. BGM cells were transfected with the expression constructs and the subcellular 
distribution of the 2B proteins was compared with that of markers for the Golgi complex (EGFP-Golgi) 
and the ER (calreticulin) as described previously [124]. 
Like the CBV3 2B-myc protein, the PV1 2B-myc protein predominantly colocalized with the 
EGFP-Golgi protein (Fig. 2A and 2B). The closely related HRV14 2B protein showed a subcellular 
distribution that was similar to that of the enterovirus 2B proteins and also predominantly colocalized 
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Figure 2. Subcellular localization of picornavirus 2B proteins. (A-D,F,H) BGM cells were cotransfected with EGFP-Golgi 
and the indicated 2B-myc constructs, fi xed at 24 h posttransfection and stained with the anti-C-myc antiserum. (E,G,I) BGM cells 
were transfected with the indicated 2B-myc constructs, fi xed at 24 h posttransfection and stained with the anti-C-myc and the 
anti-calreticulin  antisera. Cells were analyzed by CLSM. The 2B-myc proteins of CBV3 (A), PV1 (B), HRV14 (C) colocalize with 
the Golgi marker. The 2B protein of HAV does not colocalize with the Golgi marker (D), but is predominantly colocalized with 
the ER marker (E). The 2B proteins of FMDV (F,G), and EMCV (H,I) do not colocalize with the Golgi and ER markers. (bar = 
10µm). For full color fi gure, see page 158.
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8with the Golgi marker (Fig. 2C). The more distantly related HAV, EMCV and FMDV 2B proteins showed a different subcellular localization. HAV 2B was virtually absent from the Golgi complex 
(Fig. 2D) and stained a reticular pattern that included the nuclear envelope and was largely identical to 
staining of calreticulin (Fig. 2E), indicating that HAV 2B localizes to the ER. The FMDV and EMCV 
2B proteins showed no colocalization with either EGFP-Golgi or calreticulin, indicating that these 
proteins are not present in either the Golgi complex or the ER (Figs. 2F-2I). 
EFFECTS OF PICORNAVIRUS 2B PROTEINS ON PROTEIN TRAFFICKING
We next investigated whether the picornavirus 2B proteins have the ability to inhibit protein 
secretion through the Golgi complex (analogous to the CBV3 protein [199]), or through other 
compartments of the secretory pathway. We used the temperature-sensitive mutant of the envelope 
glycoprotein of vesicular stomatitis virus (VSV-G-ts045, hereafter referred to as VSV-G) fused to the 
fl uorescent EGFP protein (VSV-G-GFP) to study protein traffi cking. The temperature-sensitive VSV-G-
GFP mutant is misfolded at 40°C, resulting in its accumulation in the ER. Upon shifting the temperature 
to 32°C, the protein is refolded correctly and transported via the secretory pathway, resulting in its 
exposure on the plasma membrane [181].
BGM cells were co-transfected with expression constructs of VSV-G-GFP and the picornavirus 
2B-myc proteins. Cells were incubated at 40°C for 18 h to accumulate the VSV-G-GFP protein in the 
ER (Fig. 3A, left image), and subsequently incubated at 32°C for 2 h to allow VSV-G-GFP transport out 
of the ER (Fig. 3A, right image). Cells were fi xed, stained with the anti-C-myc antiserum and processed 
for CLSM analysis. Similar to the CBV3 2B protein, the 2B proteins of PV1 and HRV14 effi ciently 
inhibited protein secretion through the Golgi complex Figs. 3B – 3D). Cells expressing these 2B 
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Figure 3. Analysis of protein secretion in cells expressing the picornavirus 2B proteins. BGM cells were transfected with 
the VSV-G-GFP construct (A), or cotransfected with the VSV-G-GFP and the picornavirus 2B-myc constructs (B-G). Cells were 
incubated at 40°C for 18 h to accumulate the VSV-G-GFP protein in the ER, and subsequently incubated at 32°C for 2 h (B-G). 
Cells were fi xed, stained with the anti-C-myc antiserum and processed for CLSM analysis. (A) Accumulation of VSV-G-GFP in 
the ER upon incubation at 40°C (left image) and on the plasma membrane upon additional incubation at 32°C (right image). The 
VSV-G-GFP protein accumulates in the Golgi complex upon incubation with the 2B proteins of CBV3 (B), PV1 (C), and HRV14 
(D). VSV-G-GFP is exposed on the plasma membrane in cells expressing the 2B proteins of HAV (E), FMDV (F), or EMCV (G). 
(bar = 10µm). For full color fi gure, see page 159.
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Figure 4. Analysis of hygromycin B entry in cells expressing the picornavirus 2B proteins. Plasma membrane permeability 
was determined at 40 h posttransfection by analyzing protein synthesis in the absence and presence of HgB in cells expressing 
picornavirus 2B-EGFP fusion proteins or the unfused EGFP protein (no 2B). The amount of anti-EGFP precipitated fusion 
protein was quantifi ed by means of phosphor-imaging. Plasma membrane permeability is defi ned as the ratio of the amount 
of radiolabeled protein synthesized in the presence and absence of HgB. Values represent means ± standard errors of three 
independent measurements. *, P < 0.05. 
proteins showed accumulation of VSV-G-GFP in the juxta-nuclear Golgi region, where it colocalized 
with the respective 2B proteins. This demonstrates that the ability of the 2B protein to inhibit protein 
secretion through the Golgi complex is conserved among these three closely related viruses. In contrast, 
expression of the 2B protein of HAV, FMDV or EMCV did not result in the inhibition of protein 
secretion. The VSV-G-GFP protein was predominantly localized on the plasma membrane and showed 
no colocalization with these 2B proteins (Fig. 3E – 3G).
EFFECTS OF PICORNAVIRUS 2B PROTEINS ON PLASMA MEMBRANE PERMEABILITY TO HYGROMYCIN B
Expression of the CBV3 2B protein results in an increased entry of the small translation inhibitor 
HgB [47]. Here, we analyzed the ability of the picornavirus 2B proteins to increase HgB entry, as 
described previously for CBV3 2B [124]. To this end, 2B-EGFP expression plasmids were constructed. 
BGM cells were transfected with these expression plasmids and pulse-labelled in the absence or 
presence of HgB at 40 h posttransfection. The 2B-EGFP fusion proteins were immuno-precipitated 
with anti-EGFP antiserum and the amount of 2B-EGFP produced in the absence and presence of HgB 
was determined as a measure of HgB entry. In cells that expressed EGFP (i.e., in the absence of 2B), 
protein synthesis was similar in the absence and presence of the drug, whereas in cells that expressed 
the CBV3 2B protein, protein synthesis in the presence of HgB was reduced to less than 10% of that 
in the absence of HgB (Fig. 4). Expression of the 2B proteins of both PV1 and HRV14 resulted in a 
similar increase in the entry of HgB, demonstrating that the 2B proteins of these viruses modify plasma 
membrane permeability to a similar extent as the CBV3 2B protein. 
The 2B proteins of the more distantly related HAV, EMCV and FMDV showed differential 
abilities to increase HgB entry (Fig. 4). The 2B protein of HAV increased HgB entry to such extent 
that protein synthesis in the presence of HgB was reduced to approximately 40% of that in the absence 
of the drug. This suggests that the HAV 2B protein has the ability to modify plasma membrane 
permeability, yet not as potent as the enterovirus and rhinovirus 2B proteins. In cells expressing the 
FMDV 2B protein, no differences were observed between protein synthesis in the absence and presence 
of HgB, indicating that FMDV 2B does not increase HgB entry. Cells expressing the EMCV 2B protein 
displayed a slight, yet not signifi cant, increase in HgB entry, indicating that also EMCV 2B lacks the 
ability to modify plasma membrane permeability. The 2B proteins of HAV, FMDV and EMCV were 
effi ciently synthesized (Fig. 4) arguing that it is unlikely that the reduced ability to modify membrane 
permeability is due to lower expression levels.
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DISCUSSION
This study was performed to gain more insight into the phylogenetic conservation of the structure 
and function of the picornavirus 2B proteins. Our results demonstrate that the structural and functional 
properties of the 2B proteins of enterovirus (in this study represented by CBV3 and PV1) and rhinovirus 
(represented by HRV14) are strongly conserved. Phylogenetic analysis revealed that the 2B proteins 
of CBV3, PV1 and HRV14 are closely related and share approximately 50% identity and over 70% 
similarity. Despite differences in amino acid sequence, the 2B proteins of CBV3, PV1 and HRV14 
share remarkable structural similarities. These proteins are similar in length (97 – 99 aa) and contain 
two hydrophobic regions, of which the fi rst is predicted to form a cationic amphipathic α-helix. The 
amphipathic α-helices of these 2B proteins all contain three lysine residues in the (small) hydrophilic 
face of the helix. The CBV3 2B protein is present at ER and Golgi membranes [124] and is responsible 
for the release of Ca2+ and H+ from these organelles, most likely by forming membrane-integral pores 
[125; 199]. This activity is thought to be the upstream event that is responsible for the inhibition of 
protein secretion through the Golgi and the increase in HgB entry [199]. Here, we demonstrate that also 
the PV1 and HRV14 2B proteins localize to the Golgi complex, inhibit VSV-G traffi cking through the 
Golgi and increase plasma membrane permeability to HgB in BGM cells, whereas the more distantly 
related 2B proteins of HAV, FMDV and EMCV behave differently. These fi ndings strongly suggest that 
the 2B proteins of PV1 and HRV14, and most likely of the other enteroviruses and rhinoviruses, form 
pores in membranes of the ER and Golgi complex, as has been proposed for the CBV3 2B protein. 
The 2B protein of HAV (a member of the hepatoviruses) shares little or no sequence and structural 
homology with the other picornavirus 2B proteins. We show here that the protein is also functionally 
distinct from the other 2B proteins. Analysis of the subcellular localization of HAV 2B demonstrated 
that it predominantly localized in the ER but that it is absent from the Golgi complex. Immuno-electron 
microscopy analysis of the subcellular localization of HAV 2B in transfected cells (FRhK-4 and HeLa) 
demonstrated that the protein was almost exclusively present in a tubular-vesicular network [213]. This 
tubular-vesicular network, which was not observed in control cells, closely resembled the network 
that is present in HAV-infected cells [213], suggesting that the HAV 2B protein is responsible for this 
membrane reorganization. The origin of the tubular-vesicular network (i.e., the presence of organelle-
specifi c markers) was not investigated [213]. Our fi nding that HAV 2B largely colocalizes with a maker 
for the ER suggests that the tubular-vesicular structures may be derived, at lease partly, from the ER.
The studies presented here demonstrate that the HAV 2B protein does not inhibit VSV-G 
traffi cking, suggesting that it does not have the ability to inhibit vesicular transport along the secretory 
pathway. This is consistent with the hypothesis that HAV may use the host cell secretory apparatus to 
leave the cell, as virus release of the cell culture adapted HAV strain from polarized epithelial cells 
was shown to be sensitive to secretion inhibiting drugs [214]. We did observe an increase in plasma 
membrane permeability in HAV 2B-expressing cells, albeit to a lesser extent than in cells expressing 
the enterovirus or rhinovirus 2B protein. This is consistent with a previous report that described a 
moderate increase in plasma membrane permeability (as measured by the effl ux of ß-galactosidase) 
in HAV 2B-expressing COS-1 cells [215]. The mechanism by which the HAV 2B protein increases 
plasma membrane permeability is different from that of the enterovirus and rhinovirus 2B proteins; 
HAV 2B shows no sequence or structural homology with these 2B proteins, and the HAV 2B protein 
was demonstrated to peripherally associate with membranes rather than an integral membrane protein 
[215]. Further research is required to unravel the mechanism by which HAV 2B increases plasma 
membrane permeability.
The 2B proteins of FMDV and EMCV (members of the aphthoviruses and cardioviruses, 
respectively) are not related to any of the other picornavirus 2B proteins or to each other, and are also 
functionally distinct from the other 2B proteins. Both FMDV and EMCV 2B proteins were absent from 
the ER and the Golgi complex. Instead, they showed a punctate localization pattern in the cytosol. 
Whether this pattern represents another membrane compartment remains to be established. Neither of 
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these proteins interfered with protein secretion or plasma membrane permeability. To our knowledge, 
there are no reports on alterations of membrane permeability in FMDV-infected cells. EMCV was 
reported to modify membrane permeability to ions as well as to low-molecular-weight compounds 
like HgB in HeLa cells [76]. Similarly, we observed that EMCV infection results in the increase in 
plasma membrane permeability to HgB in BGM cells (data not shown). The observation that the EMCV 
2B protein does not increase HgB entry indicates that it is not involved in the increased membrane 
permeability in EMCV-infected cells, or that it requires (co-)expression of other EMCV proteins. It is 
unlikely that the 2BC protein is responsible for the increase in membrane permeability, since 2BC is not 
a stable cleavage intermediate in EMCV-infected cells [216].
Enterovirus proteins of which the function is conserved were in some instances exchangeable, 
meaning that chimeric genomes in which one protein is replaced by the corresponding protein of a 
closely related virus have the ability to replicate [145; 217-219]. We have previously shown that a 
chimeric CBV3 genome containing the PV1 2B protein failed to replicate [107], indicating that despite 
the high degree of similarity and the functional conservation of the enterovirus and rhinovirus 2B 
proteins, they are not exchangeable. Possibly, exchange of the 2B protein results in conformational 
changes that interfere with functions of the 2BC precursor protein, and/or the interaction of 2B(C) with 
other viral proteins. It is interesting to note that replication defects due to the exchange of part of the 
hydrophobic region of PV1 3A by the corresponding region of HRV14 3A were partially restored by 
compensating mutations in 2B [145]. It is tempting to speculate that a functional 2B(C):3A interaction 
is required.
Taken together, we have demonstrated that the ability of the enterovirus 2B protein to inhibit 
protein secretion through the Golgi complex and to increase HgB entry is conserved in the closely 
related rhinovirus 2B proteins. The 2B proteins of HAV, FMDV and EMCV are structurally and 
functionally unrelated to the enterovirus and rhinovirus 2B proteins. HAV 2B was shown to increase 
plasma membrane permeability, yet the different subcellular localization and the inability to inhibit 
protein secretion suggest that it exploits a different mechanism. FMDV and EMCV 2B do not inhibit 
protein secretion and do not increase HgB entry. We conclude that the 2B proteins of enterovirus and 
rhinovirus, but not those of hepatovirus, aphthovirus and cardiovirus, are closely related and most likely 
exhibit the same function in the viral life cycle.
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EXPERIMENTAL PROCEDURES
CELLS AND MEDIA
Buffalo green monkey (BGM) cells were grown in minimal essential medium (Gibco), supplemented with 10% fetal 
bovine serum (FBS), 100 units penicillin per ml and 25 µg streptomycin per ml. Cells were grown at 37°C in a 5% CO2 
incubator. 
ANTIBODIES
Mouse monoclonal anti-C-myc (clone 9E10) was obtained from Sigma-Aldrich. Rabbit polyclonal anti-calreticulin was 
obtained from Affi nity Bioreagents, Inc. FITC-conjugated goat-anti-rabbit polyclonal antibody, Texas Red-conjugated goat-
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anti-mouse polyclonal antibody and Texas Red-conjugated goat-anti-rabbit polyclonal antibody were obtained from Jackson 
ImmunoResearch Laboratories. 
PLASMIDS
pVSV-G(ts045)-GFP [176] was a kind gift from Drs. P. Keller and K. Simons, Max Planck Institute of Molecular 
Cell Biology and Genetics, Dresden, Germany. Expression constructs p2B-EGFP and p2B-myc of CBV3 have been described 
previously [124]. For the construction of the p2B-EGFP and p2B-myc plasmids of the other picornavirus 2B proteins, the 2B-
coding sequences were amplifi ed and cloned into the p2B-EGFP and p2B-myc constructs from which the CBV3 2B region was 
removed using SalI and BamHI restriction sites. The forward primers contained the SalI restriction site (italics) and a startcodon 
preceeded by a Kozak sequence (underlined). The reverse primers contained a BamHI restriction site (italics). The PV1 2B protein 
was amplifi ed using the cDNA clone pXpA [200] and primers p374-11 (5’-gggggggtcgacgccaccatgggcatcaccaattacatagag-3’, nt 
3833) and p374-12 (5’-ccccccggatcctgcttgatgacataaggtat-3’, nt 4123). The HRV14 2B protein was amplifi ed using the cDNA 
clone pWR3.26 [201] and primers p374-1 (5’-tgggacagtgtcgacgccaccatggggctgagtgattacatcacaggt-3’, nt 3635) and p374-2 (5’-
gatccagctggatccttgtctttcaatgtaaggcac-3’, nt 3925). The HAV 2B protein was amplifi ed using the cDNA clone pHAV/7 (plasmid 
containing the cDNA of the cell culture adapted HAV175 virus) [202] and primers p374-13 (5’-tgggacagtgtcgacgccaccatggctaaaa
tttctcttttttatactgag-3’, nt 3243) and p374-4 (5’-gatccagctggatccctgagtccttaactccatcttctgga-3’, nt 3995). The FMDV 2B protein was 
amplifi ed using the cDNA clone pMR15 (FMDV type 01K) [203] and primers p374-7 (5’-tgggacagtgtcgacgccaccatggggcccttcttt
ttctccgacgttagg-3’, nt 3883) and p374-8 (5’-gatccagctggatccctgtttctctgctctctcaaggtcttcggg-3’, nt 4344). The 2B protein of EMCV 
(strain mengovirus) was amplifi ed using the cDNA clone pM16.1 [204] and primers p374-5 (5’-tgggacagtgtcgacgccaccatgcctttca
cgtttaaaccaagacaacgg-3’, nt 3966) and p374-6 (5’-gatccagctggatccctgctgttggaaaagtgagatcacagg-3’, nt 4415). 
PHYLOGENETIC ANALYSIS
Alignments were made using the BLOSUM62 similarity matrix [205]. A phylogenetic tree was constructed using Clustal 
W (1.81) multiple sequence alignments software [206].
SUBCELLULAR LOCALIZATION
Immunofl uorescence was performed as described previously [124]. Briefl y, BGM cells were grown on coverslips and 
transfected with 1 µg of picornavirus p2B-myc, or with 0.5 µg p2B-myc and 0.5 µg pEGFP-Golgi [124] per well, using the 
FuGENE 6 transfection reagent (Roche) as described previously [109]. Cells were fi xed, permeabilized and stained at 24 h 
posttransfection. Primary antibodies were diluted 1:200 (anti-c-Myc), or 1:150 (anti-calreticulin). Conjugates were diluted 1:200. 
Cells were analyzed by confocal laser scanning microscopy (Leica TCS NT, Leica Lasertechnik GmbH, Heidelberg, Germany).
PROTEIN SECRETION INHIBITION
Immunofl uorescence was performed as described above (see ‘subcellular localization’). BGM cells were transfected 
with 0.5 µg p2B-myc and 0.5 µg pVSV-G-GFP(ts045), incubated at 40°C for 18 h and additionally incubated at 32°C for 2 h. 
Cells were fi xed, permeabilized and stained. Cells were analyzed by confocal laser scanning microscopy (Leica TCS NT, Leica 
Lasertechnik GmbH, Heidelberg, Germany).
HYGROMYCIN B ASSAY
Plasma membrane permeability was studied using 2B-EGFP fusion proteins as described previously [124]. Briefl y, BGM 
cells grown in 6-well plates were transfected in duplicate with 5 µg of 2B-EGFP plasmid per well. At 40 h posttransfection, cells 
were starved for methionine for 15 minutes, pulse-labeled for 1 h with [35S]-methionine (50 µCi/well) in the presence or absence 
of HgB, washed with PBS and lysed. EGFP fusion proteins were immuno-precipitated and protein synthesis was analyzed by 
SDS-PAGE phosphor-imaging (Bio-Rad Multi-Analyst version 1.0.1). 
STATISTICAL ANALYSIS
Data are presented as mean values ± SD. Differences were tested for signifi cance by means of the Student’s t test.
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Infection with enterovirus results in a number of drastic alterations in host cell structures and 
functions, including an increased permeability of intracellular membranes and the plasma membrane 
[42-47], the inhibition of vesicular transport along the secretory pathway [46; 47; 80], and the extensive 
accumulation of membrane vesicles in the cytosol. These membrane vesicles are derived from the early 
secretory pathway and are the site at which viral RNA replication takes place [51; 53; 54; 61]. The 
enterovirus 2B protein, a small replication protein that localizes to membranes of the early secretory 
pathway [54], plays an important role in these membrane modifi cations. The 2B protein contains two 
hydrophobic regions (HR1 and HR2) of which the fi rst is predicted to form a cationic amphipathic 
α-helix with characteristics that are typical for the group of membrane-lytic polypeptides [83; 84] The 
experiments described in this thesis were performed to gain insight into the mechanism by which the 2B 
protein increases host cell membrane permeability and to investigate downstream consequences of the 
subsequent alterations in ion homeostasis for host cell functions and virus replication.
I. MECHANISM FOR MEMBRANE PERMEATION BY THE 2B PROTEIN
At the beginning of this project, the mechanism by which the 2B protein increases membrane 
permeability was largely unknown. The 2B protein was thought to increase membrane permeability 
either by covering the cell surface in a carpet-like manner (carpet-model) or by forming membrane-
integral pores (barrel-stave model) (Fig. 1), analogous to what has been proposed for membrane-lytic 
polypeptides [86]. These two alternative models have emerged from in vitro studies on the interaction of 
synthetic peptides with model membranes. The results of these studies may depend on the concentration 
and type of peptide, the lipid composition of the membrane, and the method that was applied to measure 
the membrane-binding properties of the lytic polypeptide. 
According to the carpet model, lytic peptides bind onto the surface of the target membrane with 
their hydrophobic surfaces facing the membrane and their hydrophilic surfaces facing the solvent, 
covering the membrane in a carpet-like manner. Membrane permeation via the carpet mechanism 
requires the presence of high concentrations of surface-bound peptide [220]. These peptides usually 
contain many positive charges spread over the entire peptide chain, and interact predominantly with 
membranes rich in phospholipids that contain negatively charged headgroups, i.e., bacterial membranes 
[221]. The initial interaction of these peptides with membranes is electrostatically driven [220]. In 
a second step, the peptides are reoriented to insert the hydrophobic amino acid residues into the 
hydrophobic core of the membrane [87]. As a result of the electrostatic interaction, the many positively 
charged residues remain in contact with the negatively charged phospholipid headgroups during the 
entire process of membrane permeation [87; 221]. Carpet-like peptides do not require a specifi c peptide 
structure or the assembly into (homo)multimeric structures and do not traverse the phospholipid bilayer 
[87; 220]. The presence of high peptide concentrations may disturb membrane integrity and cause 
membrane permeation by altering the bilayer curvature, leading to the formation of pores or holes in 
the membrane [221]. In these so-called toroidal (or wormhole) pores, the phospholipid headgroups are 
present in the interior of the pore. The peptides are always separated from each other due to the presence 
of these phospholipid head groups [222]. Toroidal pores may be relatively stable and allow the passage 
of solutes across the phospholipid bilayer. In addition, the formation of these pores may allow diffusion 
of peptides to the other leafl et of the membrane, and thus eventually result in the disintegration of 
membranes through the formation of micelles (Fig. 1). 
The barrel-stave model describes the formation of transmembrane channels/pores by bundles 
of amphipathic α-helical peptides, such that their hydrophobic surfaces interact with the lipid core of 
the membrane and their hydrophilic surfaces point inward, producing an aqueous interior [86; 221]. 
In the barrel-stave model, peptide monomers bind to the membrane and recognize each other already 
at low surface density of bound peptide, after which helices insert in the hydrophobic core of the 
membrane to form a multimeric pore structure [87; 221]. Hence, in contrast to peptides that act via 
the carpet mechanism, these peptides can permeate membranes already at low peptide to lipid ratios. 
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Figure 1. Schematic representation of the carpet and barrel-stave model for membrane permeation. (A) Membrane 
permeation via the carpet mechanism requires the presence of high concentrations of surface-bound peptide (top). The many 
positively charged residues present in these peptides remain in contact with the negatively charged phospholipid headgroups 
during the entire process of membrane permeation. High peptide concentrations may disturb membrane integrity and cause 
membrane permeation by altering the bilayer curvature, leading to the formation of pores or holes in the membrane (toroidal or 
wormhole pores). In these pores, the phospholipid headgroups are present in the interior of the pore (I). Toroidal pores may allow 
diffusion of peptides to the other leafl et of the membrane and may eventually result in the disintegration of membranes through 
the formation of micelles (II). (B) In the barrel-stave model, peptide monomers bind to the membrane and recognize each other 
already at low surface density of bound peptide (top). Bundles of amphipathic α-helical peptides insert in the hydrophobic core 
of the membrane to form transmembrane channels/pores. The hydrophobic surfaces of the α-helices interact with the lipid core 
of the membrane while the hydrophilic surfaces point inward, producing an aqueous interior (bottom). Adapted from (17).
Moreover, the barrel-stave model requires that peptides adopt an α-helical structure. Peptides usually 
contain few, if any, charged residues, which are present in a small hydrophilic face of the α-helix [86; 
87]. The membrane interaction of pore-forming peptides is predominantly governed by hydrophobic 
interactions, and these peptides predominantly permeate eukaryotic membranes, which are rich in 
zwitterionic phospholipids like phosphatidylcholine and sphingomyelin phospholipids [220; 221]. In 
fact, it is now being recognized that pore formation specifi cally occurs in zwitterionic membranes, 
whereas the detergent-like effect of the carpet model holds true for peptides in negatively charged 
membranes [220]. 
How can we interpret the results of the studies on the enterovirus 2B protein in view of the 
specifi c requirements for carpet-like and barrel-stave peptides? In this thesis, evidence is presented that 
the 2B protein has the ability to form homomultimers. In Chapter 2, a mammalian two-hybrid analysis 
demonstrated that the 2B protein has the ability to form homomultimers in vivo. In agreement with 
the results obtained in this study, the wild-type 2B protein was found to restore the altered subcellular 
localization of a 2B mutant [Chapter 5]. Mutant 2B proteins carrying mutations outside the putative 
multimerization regions defi ned in the mammalian two-hybrid study restored the altered subcellular 
localization of the mislocalized mutant, whereas those with mutations within these regions failed to 
do so. The evidence for multimerization presented in this thesis is consistent with results presented 
in other studies, in which the formation of 2B multimers was demonstrated using a yeast two-hybrid 
approach [99], FRET microscopy [113], and an in vitro biochemical approach [127]. The idea that 2B 
permeates membranes through the formation of pores is further supported by the results obtained from 
the analysis of 2B mutants. The results presented in this thesis show that all 2B mutants that failed to 
form multimers were impaired in their membrane-active character, indicating that the formation of 
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multimers is a prerequisite for the ability of the 2B protein to increase membrane permeability [Chapter 
4]. Thus, the results described in the fi rst chapters of this thesis lend support to the idea that the 2B 
protein homomultimerizes to form transmembrane pores. Consistently, it is demonstrated that the 2B 
protein displays characteristics of an integral membrane protein. The membrane association of the 
2B protein was resistant against extraction with buffers that release peripherally associated membrane 
proteins, which indicates that one or more domains of the protein are embedded in the phospholipid 
bilayer rather than that the protein associates with membranes through electrostatic interactions with 
membrane proteins and/or polar lipid headgroups [Chapter 3]. 
Previous work has demonstrated the importance of the organization of HR1 as an amphipathic 
α-helix for the membrane-active character of the 2B protein. Insertion mutations dispersing the 
hydrophilic residues present in the small hydrophilic face of the α-helix interfered with the ability of 
the 2B protein to permeate membranes [84]. Interestingly, the presence of the three cationic amino acids 
in HR1 is an important determinant for the membrane-active character of 2B. Substitution of these Lys 
residues by hydrophobic Leu residues (K41L/K44L/K48L) interfered with the ability of the 2B protein 
to permeate membranes [Chapters 2 and 6], while it did not affect its ability to multimerize [Chapters 
2 and 5]. The latter fi nding suggests that, in contrast to the barrel-stave model, the interaction of the 
2B protein with membranes is not solely dependent on hydrophobic interactions. How the Lys residues 
in HR1 are involved in the membrane-active character of 2B is as yet unknown. The analysis of 2B 
mutants revealed that in addition to HR1, other regions are involved in the membrane-active character 
of the 2B protein. The relevance of the second hydrophobic region, HR2, was shown previously [83], 
while the structure-function analysis described in Chapter 4 revealed that also the hydrophilic region 
between HR1 and HR2, and to a lesser extent the two Trp residues at the downstream boundary of 
HR2, are important functional determinants for membrane permeation. Mutational analysis of the 
two negatively charged residues in the hydrophilic region between HR1 and HR2 (Asp61, Asp62) 
demonstrated the preference for residues that are preferably present in turns, indicating that this 
hydrophilic region most likely facilitates a turn between HR1 and HR2 to reverse chain direction 
[Chapter 4]. The two Trp residues residues at the downstream boundary of HR2 are thought to be 
involved in the structural organization of 2B by correctly positioning HR2 [Chapter 4]. The importance 
of HR1, HR2, as well as the hydrophilic region between HR1 and HR2 for pore-formation suggests that 
Figure 2. Schematic representation of the enterovirus 2B protein. (A) Amino acid sequence of the 2B protein of coxsackievirus. 
The hydrophobic regions, HR1 and HR2, are boxed. (B) Helical wheel diagram of the putative amphipathic α-helix formed by 
HR1. The hydrophobic residues (boxed) are positioned at one face of the α-helix, the charged and polar residues are positioned 
at the other face of the α-helix. (C) Side-view and (D) top-view of the putative topology of the pores formed by 2B homomultimers 
according to the barrel-stave model. The 2B protein forms homomultimers, in which both HR1 and HR2 span the phospholipid 
bilayer, and in which the hydrophobic faces of HR1 are oriented towards each other to create an aqueous interior. The hydrophilic 
region between HR1 and HR2 facilitates a turn to reverse chain direction.
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the 2B protein adopts a helix-loop-helix conformation (Fig. 2), which is a common motif in membrane-
active proteins [127; 139]. This idea is supported by the observations that both HR1 and HR2 contribute 
to the membrane-integral character of 2B [Chapter 3], and that both multimerization and the ability to 
increase membrane permeability are (almost) exclusively dependent on determinants within the region 
encompassing HR1, the hydrophilic region between HR1 and HR2, and HR2 [Chapters 2, 3 and 4]. 
Although each of the individual observations presented above do not provide conclusive evidence to 
conclude that 2B increases membrane permeability via the barrel-stave model, collectively, these data 
favor this model over the carpet model. 
To provide fi rm evidence for the existence of transmembrane pores build by 2B multimers, other 
approaches than genetic or biochemical methods are required. Two methods that are generally used 
for structural analysis of proteins are nuclear magnetic resonance (NMR) and X-ray crystallography. 
However, structural analysis of membrane proteins using these methods has been limited by technical 
and practical diffi culties. For solution NMR studies, membrane proteins need to be solubilized in a polar 
solvent, which is achieved by the incorporation in model membrane systems. The size of the resulting 
complexes is usually too large to be examined by NMR [223]. Nevertheless, recent developments have 
made it possible to study membrane proteins in these larger structures (the total structure size may be 
up to 900 kDa) [223]. Similarly, structural analysis of membrane proteins by crystallography is very 
diffi cult, yet not impossible. Crystallography on integral membrane proteins requires the (preferably 
eukaryotic) expression of properly folded recombinant protein, purifi cation of the protein (usually 
requiring the use of detergents to solubilize the protein) and crystal growth, which can take place in the 
environment of the detergent or in a lipid bilayer environment [224]. Especially protein expression and 
crystal growth are particularly critical when examining membrane proteins, yet X-ray crystallography 
was recently proven successful for the determination of the structure of some eukaryotic membrane 
proteins [224]. Alternatively, the formation of transmembrane 2B pores can be studied using electron 
microscopy. Using transmission electron microscopy, the formation of pores by the hepatitis C virus p7 
protein was demonstrated in unilamellar lipid vesicles [225]. 
In conclusion, the data discussed in this paragraph are in agreement with the idea that the 
enterovirus 2B protein (homo)multimerizes to form membrane-integral pores that allow the passage of 
ions and small solutes across host cell membranes, i.e., that it permeates membranes analogous to the 
barrel-stave model.
II. EFFECTS OF 2B EXPRESSION ON CELLULAR ION HOMEOSTASIS
Analysis of the subcellular localization of 2B demonstrated that the protein (upon individual 
expression) is present in the ER and the Golgi complex [Chapter 3]. This suggests that ER and Golgi 
membranes display an increased permeability due to the formation of transmembrane pores by the 2B 
protein. Since both the ER and Golgi complex are intracellular Ca2+ stores, the formation of pores in 
these membranes likely affects cellular Ca2+ homeostasis. Indeed, the results presented in Chapters 
6 and 7 demonstrate that 2B expression results in a reduction in the Ca2+ concentration in the ER 
and Golgi complex. The Ca2+ concentrations in these two organelles are maintained by the SERCA, 
the ATPase that continuously pumps Ca2+ into their lumen. This Ca2+ uptake compensates for the 
permanent leakage of stored Ca2+ that occurs under physiological conditions through as yet undefi ned 
channels in ER and Golgi membranes [173]. Bioluminescence measurement of intra-organelle free 
Ca2+ in permeabilized cells revealed that the 2B effect was preserved at steady ATP. Moreover, 
biochemical analysis of the SERCA activity in a cell-free system showed that 2B had no adverse effect 
on the activity of this enzyme. This strongly suggests that 2B causes an increased Ca2+ effl ux from the 
lumen of the ER and Golgi complex by directly increasing their membrane permeability. In agreement 
with this idea, in vitro studies by Agirre and co-workers showed that 2B increases the permeability of 
lipid vesicles in the absence of other proteins [127], indicating that interactions with other (membrane) 
proteins are not required for the 2B protein to exert its effect. 
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The in vivo data presented in this thesis indicate that pores formed by 2B multimers are not 
selective for the passage of Ca2+ . Using digital imaging microscopy, it was demonstrated that also 
protons leak from the lumen of the Golgi complex in 2B-expressing cells, resulting in an increased 
Golgi pH [Chapter 7]. In vitro experiments showed that different solutes up to approximately 600 
Da effi ciently diffuse from 2B-containg lipid vesicles [127]. The latter study also demonstrated that 
diffusion of solutes is bi-directional, i.e., in a concentration-dependent manner. Together, these fi ndings 
suggest that the pores that are formed by 2B multimers are non-selective, and that passage of solutes 
is restricted by size only. Agirre and co-workers calculated that a pore-size that allows diffusion of 
compounds with a molecular weight up to 600 Da corresponds with a pore that is build from four 2B 
monomers [127]. 
Expression of the 2B protein not only affects the Ca2+ levels of the ER and Golgi complex, but 
also results in an increase in cytosolic Ca2+ concentration [42; 49; Chapter 7]. The observation that this 
increase is dependent on the presence of extracellular Ca2+ [42] suggests that it is the result of an infl ux 
of Ca2+ ions across the plasma membrane [47; 48]. This is most likely the result a phenomenon that 
is called capacitative Ca2+ entry. This infl ux is most likely triggered by depletion of intracellular Ca2+ 
stores leading to the opening of specifi c Ca2+ channels in the plasma membrane. These channels are 
named store-operated Ca2+ channels (Ca2+ -SOC or CRAC) and the whole process is generally referred 
to as capacitative Ca2+ entry [226; 227]. The molecular identity of the Ca2+ -SOC and the mechanism 
of its activation by store-depletion are presently unknown [226; 227]. 
In addition to the enterovirus 2B protein, only a few other viral proteins that modify organelle 
ion homeostasis have been identifi ed. The NSP4 protein of rotavirus is a non-structural membrane 
glycoprotein that modifi es Ca2+ homeostasis [228]. NSP4 most likely reduces ER Ca2+ via two different 
mechanisms, as both endogenous and exogenous NSP4 have an effect on cellular Ca2+ homeostasis. It 
was shown that endogenous NSP4, which is present in membranes of the ER [229], reduces the amount 
of releasable Ca2+ from the ER [228]. In addition, a cleavage product of NSP4 that is secreted from 
virus-infected cells functions as an enterotoxin that increases cytosolic Ca2+ levels through receptor-
mediated phospholipase C activation and inositol 1,4,5-trisphosphate (InsP3) production [230; 231]. 
The increase in cytosolic Ca2+ by rotavirus NSP4 is involved in the process of virus maturation. It is 
at present unknown whether the NSP4-induced manipulation of Ca2+ homeostasis also plays a role 
in viral genome replication. The E5 protein of papillomavirus and the M2 protein of infl uenza virus 
are the only other viral proteins that were thus far recognized to modify the pH of the Golgi complex. 
Both proteins exploit a different mechanism to reduce the Golgi proton concentration. The HPV E5 
protein specifi cally interacts with the 16 kD subunit of the V-ATPase [232], the vacuolar ATPase that 
is responsible for the acidifi cation of the organelles of the secretory pathway [180], and thus inhibits 
proton uptake. The infl uenza M2 protein forms proton channels in Golgi membranes [233] and in this 
manner increases proton effl ux from the Golgi lumen. It has been demonstrated that modifi cation of the 
Golgi pH by these viral proteins affects protein traffi cking [234; 235]. How these viruses benefi t from 
the neutralization of the Golgi pH is as yet unclear.
In conclusion, the data discussed in this and the previous paragraph support the idea that the 
enterovirus 2B protein (homo)multimerizes to form pores in the membranes of the ER and Golgi 
complex, thus leading to the disturbance of host cell ion homeostasis. 
III. CELL BIOLOGICAL EFFECTS OF THE 2B PROTEIN
The 2B-induced alterations in ion homeostasis have important cell biological consequences. This 
paragraph deals with the effects of the 2B-induced changes in ER and Golgi Ca2+ levels and Golgi pH 
on host cell death programs, protein secretion routes and plasma membrane integrity. The relevance of 
these modifi cations for the viral life cycle is discussed in paragraph IV.
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MODULATION OF APOPTOTIC HOST CELL RESPONSES
The studies presented in this thesis have identifi ed 2B as an apoptosis-suppressing protein. 
Expression of the 2B protein was demonstrated to lend protection against apoptotic cell death induced 
by C2-ceramide, cycloheximide and actinomycin D, but not against etoposide-induced apoptosis 
[Chapter 6]. The interference with intracellular Ca2+ homeostasis was shown to play an important role 
in the 2B-induced suppression of apoptosis, as mutant 2B proteins that do not affect Ca2+ homeostasis 
do not protect against apoptotic cell death [Chapter 6].
How can the 2B-induced alterations of intracellular Ca2+ homeostasis be involved in 
the suppression of apoptosis? Recent work has implicated Ca2+ signaling between the ER and 
mitochondria as an important determinant in the suppression of apoptosis. Mitochondria are present in 
close proximity of the ER, and contact sites between these two organelles have been identifi ed [158]. 
These contact sites are thought to play a critical role in mitochondrial buffering of Ca2+ that is released 
from the ER via InsP3-gated Ca2+ channels [158]. Mitochondria are recognized to be key players in the 
execution of apoptosis, and cytotoxic mitochondrial Ca2+ levels play an important role in this process. 
Excessive Ca2+ load in mitochondria may induce apoptosis by activating the permeability transition 
pore (PTP) [236], a large protein complex that is composed of constituents of the both the inner 
and outer mitochondrial membranes [151; 237]. Opening of the PTP causes the release of apoptosis 
promoting factors from the mitochondrial intermembrane space into the cytoplasm (e.g., cytochrome 
C, apoptosis inducing factor (AIF), Smac/DIABLO) [236; 238], as well as in a drop in mitochondrial 
inner membrane potential [237], which may impair the respiratory chain, resulting in the generation of 
reactive oxygen species [238]. Recent data indicate that conditions that lowered Ca2+ levels in the ER 
protected HeLa cells from C2-ceramide-induced apoptosis, while conditions that increased these levels 
had the opposite effect [161]. As discussed in the previous paragraph, expression of the 2B protein 
causes a decrease of lumenal Ca2+ levels of the ER and Golgi complex, and in a subsequent down-
regulation of Ca2+ signaling between these stores and the mitochondria [Chapters 6 and 7]. Thus, the 
reduction in ER (and Golgi) Ca2+ levels by the 2B protein and the subsequent down-regulation of Ca2+ 
signaling between these stores and the mitochondria may protect mitochondria from Ca2+ overload 
after stimulus-induced release of Ca2+ from the stores and hence be responsible for the apoptosis-
suppressing function of the 2B protein.
Recently, a novel link between ER-stored Ca2+ and the release of cytochrome C from the 
mitochondria was uncovered, which may be involved in the 2B-induced protection against C2-
ceramide-, cycloheximide-, and actinomycin D-induced apoptosis. Boehning and colleagues described 
the existence of a direct interaction between cytochrome C and the InsP3 receptor (InsP3R), which 
may be involved in the amplifi cation of pro-apoptotic stimuli and the execution of apoptotic cell death 
[236]. The activity of the InsP3R is biphasically regulated by cytosolic Ca2+ concentrations. At resting 
Ca2+ concentrations (~100 nM), increases in Ca2+ augment InsP3-induced Ca2+ release, whereas Ca2+ 
concentrations greater than ~5 µM diminish the ability of InsP3 to release Ca2+ [236]. Binding of 
cytochrome C to the InsP3R was found to prevent this Ca2+-dependent inhibition of InsP3R function. 
Moreover, binding of cytochrome C to the InsP3R caused an increase in cytosolic Ca2+ levels. Thus, 
a feed-forward mechanism is proposed in which the release of small amounts of cytochrome C from 
the mitochondria causes the release of Ca2+ from the ER via the InsP3R, which in turn results in Ca2+-
overload of the mitochondria and further release of cytochrome C [236]. The reduction in ER-stored 
Ca2+ levels reduces the potential of this feed-forward loop and may thus protect against apoptosis. It is 
tempting to speculate that 2B, by reducing ER- and Golgi-stored Ca2+, interferes with this feed-forward 
loop and thus protects against C2-ceramide-, cycloheximide-, and actinomycin D-induced apoptosis 
(Fig. 3).
The fi nding that 2B failed to suppress etoposide-induced apoptosis indicates that the alterations 
in Ca2+ homeostasis suppress a specifi c apoptotic pathway rather than conferring a general protection 
to apoptosis. Recent studies on the Bcl-2 oncogene have provided evidence for the coexistence of 
spatially different apoptotic pathways in the same cell, an ER-dependent one and an mitochondrion-
dependent one, which eventually converge at the mitochondria [162; 163]. A Bcl-2 mutant that is 
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exclusively targeted to the ER effi ciently inhibits apoptosis induced by stimuli that lead to a decrease 
in the mitochondrial membrane potential prior to cytochrome C release, but not apoptosis induced by 
stimuli that act directly on the mitochondria and cause translocation of Bax and release of cytochrome 
C prior to the loss mitochondrial membrane potential [163]. The latter series of events occur in cells 
treated with etoposide [163], which may explain why 2B-expression does not lend protection against 
etoposide-induced apoptosis.
The possibility exists that alternative or additional mechanisms play a role in the protective 
effect of 2B expression against apoptotic stimuli. The altered ion homeostasis in the ER resulting from 
expression of the 2B protein most likely results in ER stress, to which the cell responds with a coordinated 
adaptive program called the unfolded protein response (UPR). The UPR is initiated whenever protein 
folding in the ER is compromised, and can be activated by a diverse set of events that lead to saturation 
of the protein folding capacity of the ER, including perturbation of ER Ca2+ homeostasis [239-241]. 
The UPR has been implicated in both the induction and the suppression of apoptosis [242]. It has been 
reported that conditions that perturb ER functions can activate NFκB [239], a transcription factor that 
has been implicated in protecting cells against apoptosis [239; 243]. On the other hand, caspase-4 (the 
human homolog of rodent caspase-12 [244]), a caspase that is predominantly localized to the ER, is 
activated by ER stress [244]. It is as yet unknown [240; 241] how specifi c pathways within the UPR are 
involved in making the decision between cell survival and cell death. 
Figure 3. Down-regulation of ER-mitochondrial Ca2+ signaling in apoptosis by 2B. Ca2+ fl uxes between the ER and 
mitochondria are recognized to play an important role in the orchestration of apoptosis. Boehning et al. described the existence 
of a direct interaction between cytochrome C (Cyt c) and the IP3 receptor (IP3R), which may be involved in the amplifi cation of 
pro-apoptotic stimuli and the execution of apoptotic cell death [236]. A feed-forward mechanism has been proposed in which 
the release of small amounts of cytochrome C from the mitochondria causes massive release of Ca2+ from the ER via the IP3R. 
This release of Ca2+ from the ER in turn results in Ca2+-overload of the mitochondria, leading to opening of the permeability 
transition pore (PTP), osmotic swelling of the mitochondria and rupture of the outer mitochondrial membrane, resulting in 
the mass exodus of cytochrome C and other apoptosis promoting factors (left). Expression of 2B may interfere with this Ca2+-
dependent apoptotic amplifi cation loop by reducing the lumenal Ca2+ concentrations of the ER (and Golgi complex), thereby 
down-regulating ER-mitochondrial Ca2+ fl uxes and protecting the mitochondria against cytotoxic Ca2+ overload (right). IMM, 
inner mitochondrial membrane; OMM, outer mitochondrial membrane; ∆ψ, membrane potential.
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Expression of the 2B protein not only affects organelle Ca2+ homeostasis; at later times, 2B-
expressing cells also display increased cytosolic Ca2+ concentrations [42; Chapters 6 and 7]. In general, 
the effect of elevated cytosolic Ca2+ levels on the implementation of proapoptotic and antiapoptotic 
pathways is rather unclear. Increased cytosolic Ca2+ levels may activate Ca2+-senstitive proteases, like 
calpain and the Ca2+-senstitive, cytosolic serine/threonine phosphatase calcineurin. On the one hand, 
calpain has been suggested to exert antiapoptotic effects by cleaving caspases 8 and 9 [169; 170]. 
On the other hand, both calpain and calcineurin have been implicated in the execution of apoptosis 
through their effects on different substrates [151; 238; 245]. Thus, the possible contribution of increased 
cytosolic Ca2+ levels to the apoptosis-suppressing activity of the 2B protein is unclear.  
Although a putative contribution of UPR-mediated antiapoptotic effects or the calpain-mediated 
inactivation of caspases cannot be excluded, it seems unlikely that these effect are solely responsible 
for the apoptosis-suppressing function of 2B, because they cannot explain why 2B expression failed 
to protect against etoposide-induced apoptosis. Thus, it is most likely that (as discussed above) the 
2B-induced alterations in Ca2+ homeostasis suppress the action of apoptotic stimuli that act via an ER-
dependent pathway, but not of apoptotic stimuli that act via mitochondrion-dependent pathway. 
INHIBITION OF PROTEIN SECRETION
The results presented in this thesis demonstrate that 2B expression leads to accumulation of 
secretory proteins in the Golgi complex [Chapter 7](Fig. 4). This inhibition of secretion is most 
likely a downstream consequence of the increased permeability of ER and Golgi membranes, and the 
subsequent alterations in organelle ion homeostasis. Mutant 2B proteins that did not form pores in ER 
and Golgi membranes were found to be unable to inhibit protein secretion, whereas mutations upstream 
and downstream the (putative) pore forming region did not affect the secretion inhibiting function of 
2B [Chapter 7]. The exact molecular mechanism by which the 2B protein inhibits protein secretion is 
as yet unknown.
It has been demonstrated previously that secretory glycoproteins do not acquire resistance 
to endoglycosidase H (endo H) treatment in 2B-expressing cells [46]. Possibly, the altered ionic 
conditions in the Golgi lumen lead to in the inhibition of the sugar-modifying enzymes of the Golgi 
complex (i.e., glycosyltransferases and glycosidases). The accumulation in the Golgi complex of 
secretory glycoproteins in the ER-specifi c, endo H-sensitive glycosylation state may be the result of 
the quality control of protein folding that takes place in the Golgi complex [184; 185]. The 2B-induced 
accumulation of glycoproteins in the Golgi complex in an endo H-sensitive glycosylation state is 
very similar to that in cells treated with monensin, a Na+/H+-ionophore that disturbs the pH of the 
Golgi complex [117]. This strongly suggests that the disturbance of the Golgi pH is responsible for 
the 2B-induced inhibition of protein secretion. In addition, the 2B-induced reduction of lumenal Ca2+ 
concentrations may also be involved in the inhibition of protein secretion. Reductions in organelle 
Ca2+ levels may interfere with Ca2+-dependent membrane fusion events, which require local release of 
lumenal Ca2+ [144; 187]. 
Studies on the secretion inhibiting function of the 2B protein used alpha-1-proteinase inhibitor 
(A1PI) [46; 47] and the envelope glycoprotein of vesicular stomatitis virus (VSV-G) [46; Chapter 7], 
which are both glycosylated proteins. It is at present unknown whether traffi cking of non-glycosylated 
proteins is also inhibited upon 2B expression. Analysis of the fate of non-glycosylated secretory 
proteins in 2B-expressing cells might provide more insight into the mechanism by which protein 
secretion is inhibited by 2B, i.e., whether the accumulation of secretory proteins is related to defects 
in glycosylation of glycoproteins, or whether there is a more general blockage in transport of secretory 
proteins. Non-glycosylated proteins that have been used previously in protein secretion studies and that 
may thus be useful in analyzing the effect of 2B expression are for example albumin [246] and human 
growth hormone [247].
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EFFECTS OF 2B EXPRESSION ON PLASMA MEMBRANE PERMEABILITY
Enterovirus infection also results in the modifi cation of plasma membrane permeability. At 2-3 
hours postinfection, ion gradients over the plasma membrane are disturbed, as demonstrated by the 
effl ux of K+ and the infl ux of Na+ [43]. From 4-5 hours postinfection, low-molecular weight compounds 
like hygromycin B (HgB, a small translation inhibitor that under physiological conditions poorly enters 
the cell) effi ciently enter infected cells. 
It was shown previously that expression of the enterovirus 2B protein alone is suffi cient to 
increase the entry of HgB [46]. It has long been thought that 2B expression results in the formation of 
pores or ‘holes’ in the plasma membrane, or in a more general disruption of plasma membrane integrity, 
allowing diffusion of ions and small molecules. However, recent data indicate that this idea requires 
reconsideration. First, accumulating evidence indicates that the 2B protein is present at intracellular 
membranes (rather than at the plasma membrane) [103; Chapters 3 and 7]. Second, if the 2B protein 
would actually form pores in the plasma membrane that allow concentration-dependent, bi-directional 
passage of compounds up to 660 Da (HgB ≈ 450 Da) [127], these pores are expected to also allow the 
diffusion of ATP (≈ 500 Da) out of the cell. This, however, appears not to be the case. Under normal 
conditions (i.e., in the absence of HgB), protein synthesis in 2B-expressing cells is not affected at the 
time at which HgB can enter the cell [Chapters 3 and 4]. Thus, 2B-expressing cells are metabolically 
active at this time, arguing that there is no massive leakage of ATP from these cells. Taken together, 
these fi ndings lend support to the idea that the 2B protein modifi es plasma membrane permeability 
indirectly (Fig. 4). 
The results presented in this thesis imply that the increased HgB entry in 2B-expressing cells is a 
downstream consequence of the increased Golgi membrane permeability and the subsequent alterations 
in Golgi ion homeostasis. First, HgB entry is not increased by 2B mutants that do not form pores in 
Golgi membranes [Chapters 4 and 6]. Second, the genetically and structurally related 2B proteins of 
poliovirus and rhinovirus are also predominantly present in the Golgi complex and increase the entry of 
HgB [Chapter 8]. How can the 2B protein by increasing Golgi membrane permeability and disturbing 
Golgi ion homeostasis modify HgB entry? HgB is an antibiotic that is widely used as a selection marker. 
This means that under physiological conditions, small amounts of the compound can pass the plasma 
membrane. The mechanism by which HgB normally enters the cell is at present unknown, yet may be 
of critical importance for our understanding of how 2B increases its entry.
In addition to its use as a selection marker, HgB is also used to analyze modifi cations of the 
plasma membrane potential. The entry of HgB is enhanced in cells that display hyperpolarization of 
the plasma membrane, and decreased in cells that show depolarization of the plasma membrane [248; 
249]. Thus, the increased entry of HgB in 2B-expressing cells may be the result of hyperpolarization of 
the plasma membrane. This idea raises the question of how 2B would induce hyperpolarization of the 
plasma membrane. In the resting cell, the plasma membrane potential is largely determined by the effl ux 
Figure 4. Putative mode of 
action of the enterovirus 
2B protein. Multimers of the 
2B protein form pores in the 
membranes of the ER that are 
transported to the Golgi complex, 
leading to the disturbance of 
ER and Golgi Ca2+ levels and 
Golgi pH (i). The disturbance 
in ER and/or Golgi Ca2+ levels 
results in the inhibition of protein 
secretion by the accumulation of 
secretory proteins in the Golgi 
complex (ii), and (via an as 
yet unknown mechanism) the 
increase in permeability of the 
plasma membrane (iii).
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of K+, and an increase thereof leads to hyperpolarization. Hyperpolarization of the plasma membrane 
may be due to the 2B-induced activation of store-operated channels (SOCs). In addition to the Ca2+-
selective SOC (Ca2+-SOC, see above), non-selective cation SOCs (cat-SOCs) have been described 
[226]. The activation of cat-SOCs may possibly disturb ion gradients over the plasma membrane in 
such a way that there is a net effl ux of K+ to the extracellular medium, resulting in hyperpolarization 
of the plasma membrane. Alternatively, the 2B-induced increase in cytosolic Ca2+ concentration may 
activate the Ca2+-dependent K+-channel [250]. This possibility is unlikely, however, because 2B-
expressing cells that are incubated in the absence of extracellular Ca2+ display no increase in cytosolic 
Ca2+ concentration, yet they do show increased HgB entry [42]. 
To date, the membrane potential in 2B-expressing cells has not been analyzed. Previous studies 
have addressed the K+ content of poliovirus-infected cells using the potassium analogue 86Rb+ [43; 251; 
252]. These studies showed in increased release of K+ from infected cells [43; 251-253], suggesting that 
the plasma membrane is hyperpolarized, which would be consistent with the increased entry of HgB. 
Interestingly, the release of K+ from the infected cell (3-4 h postinfection) coincides with the increase 
in HgB entry [253]. Further studies are required to gain more insight into the membrane potential of 
enterovirus-infected cells and 2B-expressing cells, and to correlate these results to HgB uptake.
The increased entry of HgB in 2B-expressing cells may also be explained by alternative 
mechanisms. One possibility is that the 2B-induced inhibition of secretion [46; 47; Chapter 7] somehow 
interferes with transport of lipids or proteins that are required to maintain plasma membrane integrity. 
This possibility seems unlikely, however, because expression of the enterovirus 3A protein, which 
also inhibits protein secretion [46; 66], did not result in increased entry of HgB [46; de Jong, et al., 
unpublished observations). Similarly, prolonged incubation of cells (up to 40 h) with either monensin 
or brefeldin A, compounds that inhibit protein secretion via different mechanisms [117], did not alter 
plasma membrane permeability to HgB (de Jong, et al., unpublished observations). Alternatively, it 
might be possible that HgB under normal conditions readily enters cells, yet is effi ciently exported from 
the cell, for instance by multi-drug resistance proteins (MDR’s). In 2B-expressing cells, the alterations 
in ion homeostasis and the cytosolic milieu may, via an as yet unknown mechanism, impair MDR-
mediated export of HgB from the cell, hence resulting in an increase in the net infl ux of HgB.
Remarkably, the results presented in this thesis demonstrate that the ability of the 2B protein to 
increase HgB entry [Chapter 3] is abolished when the 2B protein is retained in the ER upon C-terminal 
fusion of the ER retention signal KKAA [111]. Thus, it is very likely that the disruption of Golgi ion 
homeostasis, but not of ER ion homeostasis, is somehow connected to the increased HgB entry. How 
this observation fi ts with the possible mechanisms for plasma membrane permeation as discussed above 
is as yet unclear. The possibility exists that plasma membrane permeation by 2B may involve other 
(unknown) mechanisms/signaling pathways.
From the data discussed in this and the previous two paragraphs, the following picture emerges. 
Multimers of the 2B protein form pores in the membranes of the ER that are transported to the Golgi 
complex, leading to an early disturbance of ER and Golgi Ca2+ levels and Golgi pH. The disturbance in 
ER and/or Golgi Ca2+ levels results in (i) opening of SOCs, leading to alterations in plasma membrane 
permeability for Ca2+ and other cations, (ii) suppression of apoptotic host cell responses, most probably 
by reducing mitochondrial Ca2+ accumulation in response to apoptotic stimuli, (iii) accumulation of 
secretory proteins in the Golgi complex, most likely resulting from alterations in Golgi ion homeostasis, 
and (iv) an increased entry of HgB via an as yet unknown mechanism.
IV. FUNCTIONS OF 2B IN RNA REPLICATION
This paragraph discusses the relevance of the 2B-induced changes in host cell structures and 
functions for the viral life cycle.
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THE ROLE OF THE 2B-INDUCED MEMBRANE ALTERATIONS IN VIRAL RNA REPLICATION
Mutations in the 2B protein cause early defects in viral RNA replication [83], indicating that 2B 
plays an essential role in the replication process [82; 84]. All mutations that interfere with its ability to 
increase membrane permeability abolished virus replication [Chapter 4], suggesting that the membrane-
active character of 2B is absolutely required for RNA replication. Replication is also abolished by 
mutations in 2B that do not affect its membrane-active character, suggesting that 2B has (an) additional 
function(s) in replication [Chapter 4]. How the 2B protein functions in replication is as yet unknown. 
Moreover, it is unclear whether 2B itself has a role in replication, or whether the 2B functions are 
fulfi lled by the 2BC precursor protein, which displays all known properties of the 2B protein.
The 2B moiety is essential for the function(s) of the 2BC protein, the viral protein that is 
responsible for the cytosolic accumulation of the membrane vesicles. These vesicles are derived from 
the early secretory pathway and constitute the site at which viral RNA replication takes place. Although 
the replication vesicles are absolutely required for the process of viral RNA replication, the mechanism 
by which they are generated is as yet largely unknown. It has been demonstrated that early in infection 
(3-4 h postinfection) these vesicles are homologous to the anterograde transport vesicles of the cell 
[57]. This suggests that their formation is not induced by the expression of viral proteins, but rather 
that they are derived from preexisting membrane pathways and that they accumulate in the cytoplasm 
as the result of viral protein expression. It is tempting to speculate that the membrane-active character 
of 2B(C) is involved in the accumulation of these vesicles. The 2B(C)-induced reduction in Ca2+ 
concentration in organelles of the early secretory pathway [Chapters 5 and 6] may interfere with Ca2+-
dependent vesicle fusion events that require the release of Ca2+ from the vesicle lumen [144; 187], and 
thus result in the accumulation of these vesicles in the cytosol. Similarly, the effect of 2B(C) on the pH 
of secretory vesicles may somehow contribute to their cytosolic accumulation. The increased cytosolic 
Ca2+ concentration is not required for the process of viral replication, as the replication kinetics was not 
altered in the absence of extracellular Ca2+ [42]. 
In addition to its role in vesicle accumulation, the 2BC protein may fulfi ll other functions in 
the viral life cycle. One possible function of 2BC may involve the putative helicase activity of the 2C 
protein. The 2C protein shares three motifs with the superfamily III helicases; the ‘A’ and ‘B’ motifs of 
the ‘Walker’ NTP binding domain and a ‘C’ motif that is specifi c for the helicase superfamily III [94; 
95]. Based on the presence of these domains, the 2C protein was classifi ed as a helicase [94], although 
helicase activity of 2C could not be demonstrated in vitro [91]. Helicases usually act as multimers 
[254].  Interestingly, the results presented in Chapter 2 demonstrate that the 2C protein cannot 
multimerize, whereas the 2BC protein has the ability to form both 2BC:2BC homomultimers and 2BC:
2C heteromultimers. Both 2BC:2BC and 2BC:2C interactions are dependent on determinants within 
the 2B moiety [Chapter 2]. It is tempting to speculate that the 2B moiety of the 2BC precursor protein 
facilitates multimerization thus providing the 2C protein with helicase activity. 
The function of 2B in replication that is not related to its membrane-active character may involve 
the (putative) interaction of the 2B protein with (an)other protein(s) of viral or host cell origin. Recently, 
it was demonstrated that severe replication defects of poliovirus genomes containing a poliovirus/
human rhinovirus chimeric 3AB protein could be rescued by a compensating Thr33 → Ile mutation 
in the 2B protein [145], a mutation that is located upstream the pore-forming region. This observation 
suggests that a functional interaction between 2B(C) and 3A(B) may exist and that this interaction is 
involved in some step of viral replication. How the 2B(C):3A(B) interaction functions in replication 
requires further investigation. 
THE 2B-INDUCED PROTECTION AGAINST APOPTOTIC STIMULI
In order to ensure effi cient reproduction, enteroviruses induce a number of alterations in 
metabolism and structures of their host cell. Some of these alterations may be sensed by the cell and 
turn on a defensive apoptotic reaction that is aimed at curtailing virus replication. Indeed, both viral 
proteases 2Apro and 3Cpro, which inhibit translation and transcription respectively, have the ability 
to induce apoptosis [68; 69]. However, enterovirus-infected cells do not die of massive apoptosis. 
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Enterovirus infection results in the development of a necrosis-like type of cell death called cytopathic 
effect (CPE). This suggests that enteroviruses also encode proteins that suppress the pro-apoptotic 
effects of the virus-induced cellular alterations. Upon the production of viral antiapoptotic protein(s), 
infected cells were brought in an anti-apoptotic state that could also protect against non-viral apoptotic 
stimuli like cycloheximide and actinomycin D [71]. It should be kept in mind, however, that later 
in infection signs of apoptosis (cytochrome C release and caspase activation) become apparent in 
enterovirus-infected cells [149; 171; 172], and it has been suggested that this may contribute to the 
killing of the host cell and the release of virus progeny [172]. Thus, the antiapoptotic activity most 
likely serves to delay apoptotic responses, thereby providing the virus the time required for genome 
replication, rather than to completely prevent all signs of apoptosis.
The results presented in this thesis provide evidence that the 2B protein has the ability to 
suppress cycloheximide- and actinomycin D-induced apoptosis. This suggests that the 2B protein is 
responsible for conferring an anti-apoptotic state to enterovirus-infected cells, thereby preventing the 
cells from premature abortion of the viral life cycle. The 2B protein most likely lends protection against 
apoptosis by interfering with Ca2+ signaling between ER and Golgi stores and the mitochondria as 
discussed above. The observation that the implementation of the anti-apoptotic state in virus-infected 
cells coincides with the release of Ca2+ from the intracellular stores (approximately 2 h postinfection 
[42; 70]), while the increase in cytosolic Ca2+ levels occurs at later time points (approximately 5 h 
postinfection [42]), suggests that rises in cytosolic Ca2+ levels have little, if any, contribution to the 2B-
induced suppression of apoptosis. 
THE 2B-INDUCED INHIBITION OF PROTEIN SECRETION
Expression of the enterovirus 2B protein was shown to inhibit protein secretion. Enteroviruses 
are cytolytic viruses that leave the cell by disruption of the plasma membrane, rather than that they 
use the secretory pathway to bud from the host cell. Thus, the interference of enteroviral proteins with 
the secretory pathway does not interfere with the release of virus progeny. The inhibition of protein 
secretion may contribute to the down-regulation of transport of signaling molecules that communicate 
the virus-infected status of the cell to the environment, thus preventing anti-viral host cell responses. 
In addition to the 2B protein, the enterovirus 3A protein was also shown to have the ability to 
inhibit protein secretion [46; 65]. The 3A protein reduces ER-to-Golgi transport via an as yet unknown 
mechanism, thereby reducing the plasma membrane exposure of major histocompatibility complex 
(MHC I) and the TNF receptor [63; 65], and the secretion of interferon and interleukines (IFN-ß, IL-6, 
IL-8 [64]. It is at present unclear if and how they would benefi t from producing two secretion inhibiting 
proteins. It is diffi cult to dissect the relative importance of the secretion inhibition functions of 2B and 
3A for the evasion of anti-viral immune responses in infected cells. For this, enteroviruses must be 
obtained that carry mutations in the 2B or 3A protein that interfere with the secretion inhibition activity 
but that do not affect virus growth. Until now, only one 3A mutant has been described that fulfi ls these 
requirements [255]. This mutant showed a reduced ability to inhibit cytokine secretion and MHC-I 
exposure, confi rming the importance of the secretion blockage induced by the 3A protein for the evasion 
of anti-viral immune responses in infected cells [64]. Unfortunately, no enterovirus 2B mutants have yet 
been described with a reduced ability to inhibit protein secretion but which show a wild-type growth, 
most likely because the effect 2B on ER and Golgi membrane permeability is connected to its function 
in viral RNA replication. It is therefore as yet impossible to defi ne the importance of the secretion 
inhibition function of the 2B protein for the suppression of immune responses by the host cell.
V. CONCLUDING REMARKS
The results presented in this thesis support the idea that the enterovirus 2B protein forms pores 
in membranes of the early secretory pathway. They provide evidence that 2B-expression alters host cell 
ion homeostasis and that the consequent down-regulation of Ca2+ signaling is involved in the ability 
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of 2B to lend protection against certain apoptotic stimuli. In addition, they show that the modifi cation 
of Golgi membranes (and the Golgi milieu) is involved in the inhibition of protein secretion and the 
increased entry of HgB. The results described in Chapter 8 suggest that the same holds true for the 
rhinovirus 2B protein. Moreover, the data described in this thesis demonstrate that the increase in 
membrane permeability of early secretory pathway organelles is somehow involved in virus RNA 
replication, and that the enterovirus 2B protein has another function in replication not connected to its 
membrane-active character. Further research is required to elucidate (i) the exact membrane topology 
of 2B, (ii) the molecular mechanisms by which 2B protects against apoptotic stimuli, inhibits protein 
secretion through the Golgi complex, and increases HgB entry, and (iii) the exact nature of the 2B 
functions in viral replication.
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ENTEROVIRUSSEN
Het genus Enterovirus behoort tot de familie van de Picornaviridae, een familie van kleine RNA 
virussen. Enkele bekende enterovirussen zijn de poliovirussen, coxsackievirussen en ECHO-virussen. 
Andere vertegenwoordigers van deze familie van virussen zijn bijvoorbeeld de rhinovirussen (de 
veroorzakers van verkoudheid), het hepatitis A virus en het mond- en klauwzeervirus. Enterovirussen 
zijn veel voorkomende humaan pathogenen. Infecties door deze virussen verlopen meestal mild of 
asymptomatisch. Deze virussen kunnen echter ernstige aandoeningen veroorzaken zoals poliomyelitis 
en meningoencefalitis. Ook worden enterovirus infecties in verband gebracht met chronische 
(ontstekings-)ziekten als myocarditis en diabetes mellitus.
Het erfelijk materiaal van enterovirussen bestaat uit een enkelstrengs RNA molecuul dat ingepakt 
is in een eiwitmantel (het capside). Een infectie begint met de binding van het virus aan een specifi ek 
molecuul (een receptor) op het oppervlak van de gastheercel, waarna het virus door de cel wordt 
opgenomen. Het virale RNA wordt vervolgens ontdaan van zijn eiwitmantel en komt in het cytoplasma 
van de cel terecht. Het virale RNA wordt in de cel direct vertaald tot een enkel groot eiwitmolecuul. Dit 
zogenaamde polyproteïne wordt door virale enzymen gesplitst in een klein aantal kleinere afzonderlijke 
eiwitten. Deze eiwitten worden onderverdeeld in capside-eiwitten en replicatie-eiwitten. De capside-
eiwitten vormen de bouwstenen van de eiwitmantel en de replicatie-eiwitten zijn betrokken bij de 
vermenigvuldiging van het erfelijk materiaal van het virus (een proces dat replicatie genoemd wordt). 
Na de replicatie van het erfelijk materiaal worden de nieuw gevormde RNA moleculen ingepakt in de 
eveneens nieuw gevormde eiwitmantels. Enterovirussen vergroten de doorlaatbaarheid (permeabiliteit) 
van de buitenmembraan van de cel (de plasmamembraan) om deze te kunnen passeren en de cel te 
verlaten. Hierdoor nemen ze tijdens het verlaten van de cel geen fragment van de plasmamembraan 
mee en worden, in tegenstelling tot sommige andere virussen, niet omgeven door membranen van de 
gastheercel (een zogenaamde envelop). Om de replicatie effi ciënt te laten verlopen manipuleert het 
virus verschillende functies en structuren van de gastheercel, zonder dat de cel direct gedood wordt. In 
hoofdstuk 1 worden deze veranderingen beschreven en wordt aangegeven welke viruseiwitten hiervoor 
verantwoordelijk zijn. 
HET ENTEROVIRUS 2B EIWIT
In dit proefschrift staat het enterovirus 2B eiwit centraal. Het 2B eiwit speelt een belangrijke rol 
bij een aantal van de veranderingen die plaatsvinden in de geïnfecteerde gastheercel. Het 2B eiwit vormt 
een essentiële component van het 2BC eiwit, een eiwit dat is opgebouwd uit een 2B en een 2C eenheid 
en dat in de afzonderlijke eenheden kan worden gesplitst. Het 2BC eiwit is verantwoordelijk voor de 
ophoping van membraanblaasjes (vesicles) in het cytoplasma. Deze membraanblaasjes zijn afkomstig 
van het endoplasmatisch reticulum (ER) en het Golgi complex; dit zijn speciale membraansystemen in 
de cel (organellen) met specifi eke functies en eigenschappen. De ophoping van deze membraanblaasjes 
is van essentieel belang voor het virus, omdat het proces van RNA replicatie zich op deze membranen 
afspeelt. Verder is 2B verantwoordelijk voor de verhoging van de doorlaatbaarheid van membranen van 
de gastheercel en remt 2B het transport van eiwitten die naar de plasmamembraan of naar buiten de cel 
moeten worden getransporteerd (een proces dat eiwitsecretie wordt genoemd). Het 2B eiwit is essentieel 
voor het proces van RNA replicatie; uit eerdere bevindingen is gebleken dat veranderingen (mutaties) in 
het 2B eiwit dit proces verstoren. Verder is gebleken dat het vermogen van 2B om de doorlaatbaarheid 
van membranen te verhogen van groot belang is voor zijn functie(s) in replicatie. 
Het doel van het onderzoek dat in dit proefschrift is beschreven was om het inzicht te vergroten 
in hoe het 2B eiwit in staat is de doorlaatbaarheid van cellulaire membranen te verhogen. Daarnaast 
is onderzocht hoe deze membraanveranderingen bijdragen aan de veranderingen die plaatsvinden in 
de geïnfecteerde cel en (daarmee) aan de replicatie van het virale RNA. Het 2B eiwit is een klein 
hydrofoob (waterafstotend) eiwit van ongeveer 100 aminozuren dat zich op membranen van de vroege 
secretieroute bevindt. In de geïnfecteerde cel is 2B aanwezig op de membraanblaasjes waaraan de 
replicatie plaatsvindt. Wanneer het 2B eiwit zonder de andere viruseiwitten in de cel aanwezig is, 
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worden de membraanblaasjes niet gevormd en bevindt het zich op membranen van het ER en het Golgi 
complex. Het 2B eiwit bevat twee hydrofobe regio’s, waarvan werd verondersteld dat ze nodig zijn om 
2B op de juiste manier in membranen te verankeren.
HOE VERANDERT HET 2B EIWIT DE DOORLAATBAARHEID VAN CELLULAIRE MEMBRANEN?
Er zijn twee modellen beschreven die kunnen verklaren hoe het 2B eiwit membranen lek zou 
kunnen maken. Het eerste model gaat er van uit dat meerdere 2B eiwitten zich samenvoegen tot 
zogenaamde multimeren om zo een porie te vormen in het membraan. In deze multimeren rangschikken 
de individuele eiwitten zich zodanig dat hun hydrofobe zijdes naar de lipide bilaag zijn gericht en 
hun hydrofi ele (waterminnende) zijdes naar elkaar (en daarmee naar de opening van de porie). Kleine 
moleculen zouden dan door deze poriën van de ene naar de andere kant van de membraan kunnen gaan. 
Volgens het alternatieve model liggen individuele 2B eiwitten parallel aan de membraan, waarbij de 
hydrofobe zijdes zich naar de lipide bilaag richten en de hydrofi ele zijdes naar de waterige omgeving. 
Wanneer in deze situatie het aantal individuele eiwitten in een bepaald membraanoppervlak voldoende 
groot is, wordt de membraan als het ware opgelost.
Aan het begin van dit project was het onbekend hoe het 2B eiwit de doorlaatbaarheid van 
membranen van de gastheercel verandert. De experimenten die beschreven staan in de hoofdstukken 
2, 3, 4, en 5 waren er met name op gericht om te onderzoeken of 2B eigenschappen bezit die in 
overeenstemming zijn met één van de twee hierboven beschreven modellen. Uit deze studies bleek dat 
2B de eigenschap bezit om multimeren te vormen, hetgeen een vereiste is voor het poriemodel. Verder 
bleek dat beide hydrofobe regio’s betrokken zijn bij de eigenschap van 2B om de doorlaatbaarheid 
van membranen te vergroten. Bovendien lieten deze studies zien dat beide hydrofobe regio’s aanwezig 
moeten zijn om 2B op de juiste manier in de membraan te plaatsen. Dit geeft aan dat ze allebei inderdaad 
als membraanankers dienen en suggereert dat ze beide door de membraan heen steken. Verder werd 
duidelijk dat de eigenschap van 2B om multimeren te vormen vereist is voor zijn eigenschap om de 
doorlaatbaarheid van membranen te vergroten. Gezamenlijk ondersteunen deze resultaten uit de eerste 
hoofdstukken de hypothese dat 2B poriën vormt waarin beide hydrofobe regio’s door de membraan 
steken.
WAT ZIJN DE GEVOLGEN VAN DE VERHOOGDE DOORLAATBAARHEID VAN CELLULAIRE MEMBRANEN?
Hoofdstuk 3 laat zien dat het 2B eiwit zich voornamelijk in het Golgi complex en het ER bevindt. 
Deze twee organellen doen (onder andere) dienst als intracellulaire opslagplaatsen voor calcium. Het 
was dus aannemelijk om te veronderstellen dat wanneer 2B de doorlaatbaarheid van deze membranen 
verhoogt dit zou leiden tot een verstoring van de calciumhuishouding in de cel. In hoofdstukken 6 en 7 
worden experimenten beschreven die laten zien dat de aanwezigheid van het 2B eiwit inderdaad leidt 
tot een verlaagde calciumconcentratie in het Golgi complex en het ER. Daarnaast wordt aangetoond 
dat de aanwezigheid van 2B ook leidt tot een verhoging van de calciumconcentratie in het cytoplasma. 
De activiteit van de enzymen die calcium vanuit het cytosol naar binnen pompen bleek niet veranderd, 
zodat geconcludeerd kan worden dat het 2B eiwit de uitstroom van calciumionen uit deze organellen 
verhoogt. Verder blijkt dat de verhoogde doorlaatbaarheid van Golgi en ER membranen niet alleen 
effect heeft op de calciumhuishouding, maar ook leidt tot een verandering in de zuurtegraad van het 
Golgi complex. Onder normale omstandigheden is het Golgi milieu zuurder dan het cytoplasma, 
maar als gevolg van de aanwezigheid van 2B wordt het Golgi milieu minder zuur. Dit suggereert dat 
ook protonen de Golgi membranen kunnen passeren. Gezamenlijk ondersteunen deze resultaten de 
hypothese dat 2B poriën vormt in het ER en het Golgi complex, waardoor calcium en protonen naar 
buiten kunnen lekken. Deze resultaten worden bediscussieerd in hoofdstuk 9.
De veranderingen in de calcium- en protonenhuishouding van de cel (de zogenaamde 
ionhuishouding) door 2B kunnen belangrijke consequenties hebben voor het functioneren van de cel. 
In het tweede deel van dit proefschrift (hoofdstukken 6 en 7) worden experimenten beschreven waarin 
is gekeken naar mogelijke effecten hiervan op de overleving van de cel, het transport van eiwitten en de 
doorlaatbaarheid van de plasmamembraan. 
CHAPTER 10 134
10
De aanwezigheid van het virus kan door de cel worden opgemerkt en aanleiding geven tot het 
aanschakelen van een beschermingsmechanisme. Dit beschermingsmechanisme is erop gericht de cel 
te doden en zo te voorkomen dat het virus zich kan vermenigvuldigen en verspreiden naar naburige 
cellen. Het proces van zelfdoding door de cel wordt apoptose genoemd en kan door verschillende 
prikkels (zoals een virusinfectie, maar ook door bepaalde cytotoxische drugs) worden aangeschakeld. 
Niet alle prikkels die apoptose teweegbrengen werken via hetzelfde mechanisme en het onderzoek 
dat wordt beschreven in hoofdstuk 6 laat zien dat het 2B eiwit bepaalde vormen van apoptose wel kan 
onderdrukken en andere niet. Deze eigenschap is afhankelijk van het vermogen van 2B om poriën in 
membranen te vormen en zo de ionhuishouding te ontregelen. Calciumionen vervullen een belangrijke 
functie als signaalmolecuul in de cel en de aanwezigheid van 2B leidt inderdaad tot een verlaagde 
overdracht van calciumsignalen vanuit het ER en het Golgi complex naar de mitochondriën. Een 
verlaging van de calciumionconcentratie in het mitochondrion zal leiden tot remming van die vormen 
van apoptose waarvoor een verhoogde calciumionconcentratie in dit organel van belang is. Het lijkt 
er dus op dat 2B door  de verstoring van de calciumhuishouding ervoor zorgt dat de cel langer in 
leven blijft, waardoor het virus langer de tijd heeft zich te vermenigvuldigen. Deze resultaten worden 
bediscussieerd in hoofdstuk 9.
In dit proefschrift is aangetoond dat het 2B eiwit ervoor zorgt dat eiwitten die normaal naar de 
plasmamembraan en naar buiten de cel worden getransporteerd zich ophopen in het Golgi complex. 
Daarnaast verhoogt 2B ook de doorlaatbaarheid van de plasmamembraan, terwijl het eiwit daar zelf niet 
op aanwezig lijkt te zijn. Zowel de remming van het eiwittransport als de verhoogde doorlaatbaarheid 
van de plasmamembraan is zeer waarschijnlijk een direct gevolg van de verhoogde doorlaatbaarheid 
van de Golgi membranen. De mechanismen die aan deze veranderingen ten grondslag liggen zijn 
vooralsnog onbekend. In hoofdstuk 9 wordt gespeculeerd over de vraag hoe de verhoging van de 
doorlaatbaarheid van Golgi membranen kan leiden tot deze effecten.
Tenslotte is in hoofdstuk 8 onderzocht in hoeverre de 2B eiwitten van andere picornavirussen 
functionele overeenkomsten vertonen met het enterovirus 2B eiwit. Uit het onderzoek bleek dat de 
eigenschappen van de 2B eiwitten van enterovirussen en rhinovirussen een grote mate van gelijkenis 
vertonen. De andere 2B eiwitten die zijn onderzocht vertonen weinig tot geen overeenkomst met het 
enterovirus 2B eiwit en vervullen waarschijnlijk een andere functie in de replicatie van die virussen. 
CONCLUSIES EN OPMERKINGEN
Het werk dat in dit proefschrift is beschreven ondersteunt de hypothese dat het enterovirus 2B 
eiwit poriën vormt in membranen van de vroege secretieroute (ER en Golgi complex). De porievorming 
door multimeren van het 2B eiwit leidt tot veranderingen in de cellulaire ionhuishouding. Hierdoor 
wordt ook het afgeven en ontvangen van calciumsignalen binnen de cel verstoord en dat lijkt betrokken 
te zijn bij het vermogen van 2B om apoptose te onderdrukken. Daarnaast is de modifi catie van Golgi 
membranen (en als gevolg daarvan het milieu in het Golgi complex) verantwoordelijk voor de remming 
van eiwitsecretie en voor de verhoogde doorlaatbaarheid van de plasmamembraan. Deze resultaten 
hebben ons inzicht vergroot in de wijze waarop een klein viraal eiwit in staat is membranen van zijn 
gastheercel te manipuleren en hoe het daardoor verschillende processen van deze gastheercel kan 
ontregelen. De mogelijkheid bestaat dat ook andere, minder verwante virussen gebruik maken van 
vergelijkbare mechanismen om het gedrag van hun gastheercel naar hun hand te zetten. Deze inzichten 
kunnen ons begrip vergroten over normale biologische processen in de cel en hoe virussen deze 
processen manipuleren. Op den duur zou deze kennis mogelijk bij kunnen dragen aan het bestrijden 
van deze virussen.
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Chapter 3, fi gure 5. Subcellular localization of the wild-type and mutant 2B-EGFP proteins.  (A-E) Cells were cotransfected 
with EGFP-Golgi and the indicated 2B-myc constructs, fi xed at 24 h posttransfection and stained with the anti-C-myc antiserum. 
(F-G) Cells were transfected with the indicated 2B-myc constructs, fi xed at 24 h posttransfection and stained with the anti-C-myc 
and the anti-calreticulin (ER-marker) antisera. Cells were analyzed by CLSM. The wild-type 2B-myc protein (A), the 2B(∆14C)-
myc protein (B), and the 2B(∆20N)-myc protein (C) show clear colocalization with EGFP-Golgi. The 2B(∆HR1)-myc protein 
does not colocalize with the Golgi marker (D), but is present in the ER (F). The 2B(∆HR2)-myc protein partially colocalizes with 
the Golgi marker (E) and with the ER marker (G). (bar = 10µm)
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mergedHR2-EGFPp58
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Chapter 3, fi gure 6. Subcellular localization of the 
HR1-EGFP, HR2-EGFP and (HR1+HR2)-EGFP 
proteins. Cells were transfected with the indicated 
constructs, fi xed at 24 h posttransfection, stained 
using the anti-Golgi 58K antiserum and analyzed 
using CLSM. (A) HR1-EGFP is partially present in 
the Golgi complex. (B) HR2-EGFP is absent from the 
Golgi comlpex, and stains a reticular, ER-like pattern. 
(C) (HR1+HR2)-EGFP is predominantly present in the 
Golgi complex. (bar = 10 µm)
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Chapter 4, fi gure 5. Subcellular localization of 2B mutants. (A-I, K-M, O-Q) Cells were co-transfected with the indicated 
mutant 2B-myc construct and EGFP-Golgi, fi xed at 24 h posttransfection and stained with the anti-C-myc antiserum. (J,N) Cells 
were transfected with the indicated mutant 2B-myc construct, fi xed at 24 h posttransfection and stained with the anti-C-myc and 
anti-calreticulin antisera. Cells were analyzed by CLSM. (bar = 10µm)
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Chapter 5, fi gure 2. (A) Subcellular localization 
of the myc-tagged wild-type 2B protein (left) and 
the EGFP-tagged 2B-K41L/K44L/K48L mutant 
(right) upon individual expression. The wild-
type 2B protein localized to Golgi membranes, 
whereas the 2B-K41L/K44L/K48L mutant showed 
ER localization. (B) Upon coexpression with the 
wild-type 2B protein, the 2B-K41L/K44L/K48L 
mutant colocalized with the wild-type 2B protein 
to Golgi membranes. Bar = 10µm.
Chapter 5, fi gure 3. Subcellular localization 
of the EGFP-tagged 2B-K41L/K44L/K48L 
mutant in the presence of the myc-tagged 
mutants 2B-ins(5)linker (A), 2B-ins(34)linker 
(B), 2B-D61V/D62V (C), 2B-I64S/V66S (D), and 
2B-R81A/K84A/K86A (E). The 2B-K41L/K44L/
K48L mutant localized to Golgi membranes 
upon coexpression with 2B-ins(5)linker, 2B-
ins(34)linker, or 2B-R81A/K84A/K86A. Upon 
coexpression with 2B-D61V/D62V or 2B-I64S/
V66S, the ER localization of the 2B-K41L/K44L/
K48L mutant was not restored. Bar = 10µm.
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Chapter 7, fi gure 3. The 2B protein increases the pH of the Golgi complex. (A and C) BGM cells were transfected with the 
indicated constructs, fi xed at 18 h posttransfection, stained with the anti-C-myc antiserum and processed for CLSM analysis. (B 
and D) BGM cells were transfected with the indicated constructs, and processed for digital imaging microscopy of individual 
cells. At the indicated times posttransfection, the 395/470-nm excitation ratio of individual cells, which is indicative for the pH 
value, was determined as described under Experimental Procedures. The mean value ± SD of two  experiments is shown. R395/
470, 395/470-nm excitation ratio. *, P<0.05; **, P<0.005 
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Chapter 7, fi gure 4. The 2B protein 
inhibits VSV-G traffi cking through the 
Golgi complex. BGM cells were transfected 
with VSV-G-GFP, or cotransfected with VSV-
G-GFP and 2B-myc expression constructs. 
Cells were incubated at 40°C for 18 h to 
accumulate VSV-G-GFP in the ER. Cells 
were additionally incubated for 2 h at 
40°C (A), or at 32°C to allow VSV-G-GFP 
traffi cking along the secretory pathway (B-
D). Cells were fi xed, stained with the anti-
C-myc antiserum and processed for CLSM 
analysis. (A) VSV-G-GFP accumulation in 
the ER upon incubation at 40°C. (B) VSV-
G-GFP exposure on the plasma membrane 
upon subsequent incubation at 32°C. (C) 
VSV-G-GFP accumulation in the Golgi 
complex upon treatment with 5 µM monensin 
for 20 h. (D-F) VSV-G-GFP accumulation in 
the Golgi complex upon co-expression with 
the 2B-myc protein. (bar = 10 µm)
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Chapter 7, fi gure 5. The ability of 2B 
to increase membrane permeability is 
responsible for the inhibition of VSV-G 
traffi cking. BGM cells were cotransfected 
with expression constructs of VSV-G-
GFP and the indicated mutant 2B-myc 
proteins, and incubated at 40°C for 18 h 
and additionally incubated for 2 h at 32°C. 
Cells were fi xed, stained with the anti-C-myc 
antiserum and processed for CLSM analysis. 
The K41L/K44L/K48L mutant (A) and 
I64S/V66S mutant (B)  were impaired in the 
ability to inhibit VSV-G-GFP traffi cking. The 
ins(5)linker mutant (C), the ins(34)linker 
(D), and the ins(94)linker mutant (E) 
inhibited VSV-G-GFP traffi cking through the 
Golgi complex. (bar = 10µm).
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Chapter 8, fi gure 2. Subcellular localization of picornavirus 2B proteins. (A-D,F,H) BGM cells were cotransfected with 
EGFP-Golgi and the indicated 2B-myc constructs, fi xed at 24 h posttransfection and stained with the anti-C-myc antiserum. 
(E,G,I) BGM cells were transfected with the indicated 2B-myc constructs, fi xed at 24 h posttransfection and stained with the 
anti-C-myc and the anti-calreticulin  antisera. Cells were analyzed by CLSM. The 2B-myc proteins of CBV3 (A), PV1 (B), HRV14 
(C) colocalize with the Golgi marker. The 2B protein of HAV does not colocalize with the Golgi marker (D), but is predominantly 
colocalized with the ER marker (E). The 2B proteins of FMDV (F,G), and EMCV (H,I) do not colocalize with the Golgi and ER 
markers. (bar = 10µm)
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Chapter 8, fi gure 3. Analysis of protein secretion in cells expressing the picornavirus 2B proteins. BGM cells were 
transfected with the VSV-G-GFP construct (A), or cotransfected with the VSV-G-GFP and the picornavirus 2B-myc constructs 
(B-G). Cells were incubated at 40°C for 18 h to accumulate the VSV-G-GFP protein in the ER, and subsequently incubated at 
32°C for 2 h (B-G). Cells were fi xed, stained with the anti-C-myc antiserum and processed for CLSM analysis. (A) Accumulation 
of VSV-G-GFP in the ER upon incubation at 40°C (left image) and on the plasma membrane upon additional incubation at 32°C 
(right image). The VSV-G-GFP protein accumulates in the Golgi complex upon incubation with the 2B proteins of CBV3 (B), PV1 
(C), and HRV14 (D). VSV-G-GFP is exposed on the plasma membrane in cells expressing the 2B proteins of HAV (E), FMDV 
(F), or EMCV (G). (bar = 10µm)
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